{
  "file_name": "CUAD_v1/full_contract_pdf\\Part_I\\Development\\ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.pdf",
  "annotations": [
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Document Name_0",
      "question": "Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract",
      "answer_text": "DEVELOPMENT AGREEMENT",
      "page_number": 0,
      "words": [
        {
          "text": "DEVELOPMENT AGREEMENT",
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ],
          "confidence": 0.9884270429611206
        }
      ],
      "nearby_headers": [
        {
          "text": "DEVELOPMENT AGREEMENT",
          "page": 0,
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ]
        },
        {
          "text": "ARTICLE I",
          "page": 0,
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ]
        },
        {
          "text": "DEFINITIONS",
          "page": 0,
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ]
        }
      ]
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Parties_0",
      "question": "Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract",
      "answer_text": "Stryker and Conformis are collectively referred to herein as the \"Parties\" and   individually as a \"Party.\"",
      "page_number": 0,
      "words": [
        {
          "text": "Drive, Billerica, MA O1821 (Conformis'). Stryker and Conformis are collectively referred to herein as the \"Parties' and",
          "bbox": [
            281.0,
            1091.0,
            3029.0,
            1135.0
          ],
          "confidence": 0.9795650243759155
        },
        {
          "text": "individually as a \"Party.\"",
          "bbox": [
            277.0,
            1186.0,
            814.0,
            1235.0
          ],
          "confidence": 0.9837418794631958
        }
      ],
      "nearby_headers": [
        {
          "text": "DEVELOPMENT AGREEMENT",
          "page": 0,
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ]
        },
        {
          "text": "ARTICLE I",
          "page": 0,
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ]
        },
        {
          "text": "DEFINITIONS",
          "page": 0,
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ]
        }
      ]
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Parties_0",
      "question": "Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract",
      "answer_text": "Conformis, Inc.",
      "page_number": 0,
      "words": [
        {
          "text": "(\"Stryker'), and Conformis, Inc., a Delaware corporation having a principal place of business located at 600 Technology Park",
          "bbox": [
            279.0,
            987.0,
            3027.0,
            1043.0
          ],
          "confidence": 0.9912907481193542
        }
      ],
      "nearby_headers": [
        {
          "text": "DEVELOPMENT AGREEMENT",
          "page": 0,
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ]
        },
        {
          "text": "ARTICLE I",
          "page": 0,
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ]
        },
        {
          "text": "DEFINITIONS",
          "page": 0,
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ]
        }
      ]
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Parties_0",
      "question": "Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract",
      "answer_text": "also known as Stryker Orthopaedics   (\"Stryker\")",
      "page_number": 0,
      "words": [
        {
          "text": "Date') by and between Howmedica Osteonics Corp., a New Jersey corporation, also known as Stryker Orthopaedics",
          "bbox": [
            281.0,
            895.0,
            3023.0,
            939.0
          ],
          "confidence": 0.9990173578262329
        },
        {
          "text": "(\"Stryker'), and Conformis, Inc., a Delaware corporation having a principal place of business located at 600 Technology Park",
          "bbox": [
            279.0,
            987.0,
            3027.0,
            1043.0
          ],
          "confidence": 0.9912907481193542
        }
      ],
      "nearby_headers": [
        {
          "text": "DEVELOPMENT AGREEMENT",
          "page": 0,
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ]
        },
        {
          "text": "ARTICLE I",
          "page": 0,
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ]
        },
        {
          "text": "DEFINITIONS",
          "page": 0,
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ]
        }
      ]
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Parties_0",
      "question": "Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract",
      "answer_text": "Howmedica Osteonics Corp.",
      "page_number": 0,
      "words": [
        {
          "text": "Date') by and between Howmedica Osteonics Corp., a New Jersey corporation, also known as Stryker Orthopaedics",
          "bbox": [
            281.0,
            895.0,
            3023.0,
            939.0
          ],
          "confidence": 0.9990173578262329
        }
      ],
      "nearby_headers": [
        {
          "text": "DEVELOPMENT AGREEMENT",
          "page": 0,
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ]
        },
        {
          "text": "ARTICLE I",
          "page": 0,
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ]
        },
        {
          "text": "DEFINITIONS",
          "page": 0,
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ]
        }
      ]
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Parties_0",
      "question": "Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract",
      "answer_text": "Conformis",
      "page_number": 0,
      "words": [
        {
          "text": "(\"Stryker'), and Conformis, Inc., a Delaware corporation having a principal place of business located at 600 Technology Park",
          "bbox": [
            279.0,
            987.0,
            3027.0,
            1043.0
          ],
          "confidence": 0.9912907481193542
        }
      ],
      "nearby_headers": [
        {
          "text": "DEVELOPMENT AGREEMENT",
          "page": 0,
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ]
        },
        {
          "text": "ARTICLE I",
          "page": 0,
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ]
        },
        {
          "text": "DEFINITIONS",
          "page": 0,
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ]
        }
      ]
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Agreement Date_0",
      "question": "Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract",
      "answer_text": "September 30, 2019",
      "page_number": 0,
      "words": [
        {
          "text": "This Development Agreement (\"this Agreement'') is entered into and effective as of September 30, 2019 (\"Effective.",
          "bbox": [
            448.0,
            795.0,
            3025.0,
            844.0
          ],
          "confidence": 0.9763412475585938
        }
      ],
      "nearby_headers": [
        {
          "text": "DEVELOPMENT AGREEMENT",
          "page": 0,
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ]
        },
        {
          "text": "ARTICLE I",
          "page": 0,
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ]
        },
        {
          "text": "DEFINITIONS",
          "page": 0,
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ]
        }
      ]
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Effective Date_0",
      "question": "Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective ",
      "answer_text": "September 30, 2019",
      "page_number": 0,
      "words": [
        {
          "text": "This Development Agreement (\"this Agreement'') is entered into and effective as of September 30, 2019 (\"Effective.",
          "bbox": [
            448.0,
            795.0,
            3025.0,
            844.0
          ],
          "confidence": 0.9763412475585938
        }
      ],
      "nearby_headers": [
        {
          "text": "DEVELOPMENT AGREEMENT",
          "page": 0,
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ]
        },
        {
          "text": "ARTICLE I",
          "page": 0,
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ]
        },
        {
          "text": "DEFINITIONS",
          "page": 0,
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ]
        }
      ]
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Expiration Date_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract's initial term expire?",
      "answer_text": "The term of this Agreement shall begin as of the Effective Date and continue until Acceptance of all Deliverables   for Milestones #1 and #2 pursuant to Section 3.4 and completion of Milestone #3, unless earlier terminated under Section 8.2, as   provided for under the Other Agreements, or as mutually agreed by the Parties.",
      "page_number": 0,
      "words": [
        {
          "text": "Execution Version",
          "bbox": [
            2601.0,
            294.0,
            3020.0,
            333.0
          ],
          "confidence": 0.9843302369117737
        },
        {
          "text": "Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause.",
          "bbox": [
            350.0,
            354.0,
            2953.0,
            404.0
          ],
          "confidence": 0.9875192642211914
        },
        {
          "text": "competitive harm to the Company, if publicly disclosed. Double asterisks denote omissions.",
          "bbox": [
            696.0,
            424.0,
            2610.0,
            470.0
          ],
          "confidence": 0.9918519854545593
        },
        {
          "text": "DEVELOPMENT AGREEMENT",
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ],
          "confidence": 0.9884270429611206
        },
        {
          "text": "This Development Agreement (\"this Agreement'') is entered into and effective as of September 30, 2019 (\"Effective.",
          "bbox": [
            448.0,
            795.0,
            3025.0,
            844.0
          ],
          "confidence": 0.9763412475585938
        },
        {
          "text": "Date') by and between Howmedica Osteonics Corp., a New Jersey corporation, also known as Stryker Orthopaedics",
          "bbox": [
            281.0,
            895.0,
            3023.0,
            939.0
          ],
          "confidence": 0.9990173578262329
        },
        {
          "text": "(\"Stryker'), and Conformis, Inc., a Delaware corporation having a principal place of business located at 600 Technology Park",
          "bbox": [
            279.0,
            987.0,
            3027.0,
            1043.0
          ],
          "confidence": 0.9912907481193542
        },
        {
          "text": "Drive, Billerica, MA O1821 (Conformis'). Stryker and Conformis are collectively referred to herein as the \"Parties' and",
          "bbox": [
            281.0,
            1091.0,
            3029.0,
            1135.0
          ],
          "confidence": 0.9795650243759155
        },
        {
          "text": "individually as a \"Party.\"",
          "bbox": [
            277.0,
            1186.0,
            814.0,
            1235.0
          ],
          "confidence": 0.9837418794631958
        },
        {
          "text": "WHEREAS, the Parties are concurrently entering into an asset purchase agreement for Stryker's purchase of certain",
          "bbox": [
            444.0,
            1281.0,
            3029.0,
            1338.0
          ],
          "confidence": 0.9927125573158264
        },
        {
          "text": "Conformis assets concerning Patient-Specific Instrumentation (\"Asset Purchase Agreement\"), and a License Agreement, a",
          "bbox": [
            275.0,
            1378.0,
            3029.0,
            1436.0
          ],
          "confidence": 0.9887849688529968
        },
        {
          "text": "Distribution Agreement and a Quality Agreement, as defined in and attached to the Asset Purchase Agreement (collectively, such",
          "bbox": [
            279.0,
            1482.0,
            3025.0,
            1531.0
          ],
          "confidence": 0.9973982572555542
        },
        {
          "text": "agreements are referred to herein as the \"Other Agreements')",
          "bbox": [
            277.0,
            1577.0,
            1640.0,
            1632.0
          ],
          "confidence": 0.9893602132797241
        },
        {
          "text": "WHEREAS, Stryker and its Affiliates have developed and commercialized an Off-The-Shelf Knee Implant offered under.",
          "bbox": [
            448.0,
            1678.0,
            3029.0,
            1727.0
          ],
          "confidence": 0.9939711093902588
        },
        {
          "text": "the trademark Triathlon.",
          "bbox": [
            281.0,
            1778.0,
            776.0,
            1820.0
          ],
          "confidence": 0.9796398282051086
        },
        {
          "text": "WHEREAS, Conformis currently offers Patient-Specific Instrumentation for use with its Patient-Specific Implants,",
          "bbox": [
            446.0,
            1869.0,
            3025.0,
            1926.0
          ],
          "confidence": 0.9971562623977661
        },
        {
          "text": "including partial and total knee and hip arthroplasty.",
          "bbox": [
            281.0,
            1970.0,
            1352.0,
            2025.0
          ],
          "confidence": 0.9856063723564148
        },
        {
          "text": "WHEREAS, Stryker desires that Conformis develop, in accordance with the R&D Program, certain Patient-Specific.",
          "bbox": [
            450.0,
            2072.0,
            3021.0,
            2116.0
          ],
          "confidence": 0.9856840372085571
        },
        {
          "text": "Instrumentation to be used with the current version of the Off-The-Shelf Knee Implant offered under the trademark Triathlon (such",
          "bbox": [
            281.0,
            2171.0,
            3023.0,
            2215.0
          ],
          "confidence": 0.9951096177101135
        },
        {
          "text": "Patient-Specific Instrumentation as so developed, the \"KIB Product')",
          "bbox": [
            283.0,
            2270.0,
            1784.0,
            2313.0
          ],
          "confidence": 0.9868863224983215
        },
        {
          "text": "THEREFORE, in consideration of the mutual representations, warranties and covenants herein and in the Other.",
          "bbox": [
            444.0,
            2363.0,
            3029.0,
            2414.0
          ],
          "confidence": 0.9940667748451233
        },
        {
          "text": "Agreements constituting good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties",
          "bbox": [
            279.0,
            2463.0,
            3025.0,
            2514.0
          ],
          "confidence": 0.9964366555213928
        },
        {
          "text": "hereby agree as follows:",
          "bbox": [
            279.0,
            2564.0,
            781.0,
            2608.0
          ],
          "confidence": 0.9871907234191895
        },
        {
          "text": "ARTICLE I",
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ],
          "confidence": 0.9906837940216064
        },
        {
          "text": "DEFINITIONS",
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ],
          "confidence": 0.9980525374412537
        },
        {
          "text": "1.1 Definitions. For purposes of this Agreement, the following terms shall have the following meanings, and to the extent",
          "bbox": [
            448.0,
            2854.0,
            2994.0,
            2907.0
          ],
          "confidence": 0.9955382943153381
        },
        {
          "text": "not defined in this section or otherwise in this Agreement, a term shall have the meaning ascribed to it in any of the Other.",
          "bbox": [
            275.0,
            2953.0,
            2800.0,
            3004.0
          ],
          "confidence": 0.99052894115448
        },
        {
          "text": "Agreements:",
          "bbox": [
            281.0,
            3053.0,
            540.0,
            3103.0
          ],
          "confidence": 0.9999290704727173
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1180.0,
            4479.0
          ],
          "confidence": 0.9975276589393616
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "DEVELOPMENT AGREEMENT",
          "page": 0,
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ]
        },
        {
          "text": "ARTICLE I",
          "page": 0,
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ]
        },
        {
          "text": "DEFINITIONS",
          "page": 0,
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ]
        }
      ]
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Expiration Date_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract's initial term expire?",
      "answer_text": "The term of this Agreement shall begin as of the Effective Date and continue until Acceptance of all Deliverables   for Milestones #1 and #2 pursuant to Section 3.4 and completion of Milestone #3, unless earlier terminated under Section 8.2, as   provided for under the Other Agreements, or as mutually agreed by the Parties.",
      "page_number": 1,
      "words": [
        {
          "text": "\"Acceptance\"' and \"Accept' have the meaning set forth in Article 3.4 of this Agreement.",
          "bbox": [
            446.0,
            481.0,
            2340.0,
            539.0
          ],
          "confidence": 0.977286696434021
        },
        {
          "text": "\"Acceptance Criteria' has the meaning set forth in the R&D Work Plan.",
          "bbox": [
            450.0,
            682.0,
            2008.0,
            731.0
          ],
          "confidence": 0.9961835145950317
        },
        {
          "text": "\"Acceptance Notification Period' has the meaning set forth in Article 3.3 of this Agreement..",
          "bbox": [
            450.0,
            879.0,
            2438.0,
            928.0
          ],
          "confidence": 0.9805790781974792
        },
        {
          "text": "\"Affiliate\" has the meaning set forth in the Asset Purchase Agreement",
          "bbox": [
            448.0,
            1071.0,
            1950.0,
            1124.0
          ],
          "confidence": 0.9933743476867676
        },
        {
          "text": "\"Agents\" means Third Parties who are acting under the direction or control of a Party.",
          "bbox": [
            448.0,
            1268.0,
            2284.0,
            1321.0
          ],
          "confidence": 0.9984568953514099
        },
        {
          "text": "\"Applicable Laws\" means all applicable federal, state, local and foreign laws, ordinances, rules, regulations, orders,.",
          "bbox": [
            448.0,
            1466.0,
            3025.0,
            1520.0
          ],
          "confidence": 0.9899159073829651
        },
        {
          "text": "writs, injunctions and decrees of any kind.",
          "bbox": [
            283.0,
            1566.0,
            1155.0,
            1614.0
          ],
          "confidence": 0.9892303943634033
        },
        {
          "text": "\"Asset Purchase Agreement\"' has the meaning set forth in the recitals",
          "bbox": [
            448.0,
            1762.0,
            1948.0,
            1811.0
          ],
          "confidence": 0.9865401983261108
        },
        {
          "text": "\"Change of Control'' has the meaning set forth in the Asset Purchase Agreement.",
          "bbox": [
            448.0,
            1955.0,
            2170.0,
            2010.0
          ],
          "confidence": 0.9961836338043213
        },
        {
          "text": "\"Claims\" has the meaning set forth in Article 7.3(a) of this Agreement.",
          "bbox": [
            446.0,
            2147.0,
            1947.0,
            2209.0
          ],
          "confidence": 0.9971343278884888
        },
        {
          "text": "\"Confidential Information\" has the meaning set forth in the Asset Purchase Agreement",
          "bbox": [
            448.0,
            2346.0,
            2335.0,
            2401.0
          ],
          "confidence": 0.999515175819397
        },
        {
          "text": "\"Conformis Background IP\" means any Invention, and all Intellectual Property rights underlying such Invention, that is,.",
          "bbox": [
            446.0,
            2540.0,
            3025.0,
            2602.0
          ],
          "confidence": 0.9841423630714417
        },
        {
          "text": "as of the Effective Date, owned or licensable by Conformis without causing a breach of, or incurring any obligation to, a third.",
          "bbox": [
            279.0,
            2644.0,
            3029.0,
            2699.0
          ],
          "confidence": 0.9918943643569946
        },
        {
          "text": "party, in each case to the extent necessary or reasonably useful to design, develop, manufacture, sell or otherwise exploit the KIB.",
          "bbox": [
            275.0,
            2739.0,
            3027.0,
            2798.0
          ],
          "confidence": 0.9918000102043152
        },
        {
          "text": "Product, and for the avoidance of doubt, excluding the Purchased Assets, Conformis Foreground IP, Stryker Background IP.",
          "bbox": [
            279.0,
            2843.0,
            3023.0,
            2893.0
          ],
          "confidence": 0.9966443181037903
        },
        {
          "text": "Improved Stryker Background IP and Improved Conformis Background IP",
          "bbox": [
            279.0,
            2938.0,
            1874.0,
            2990.0
          ],
          "confidence": 0.9942641854286194
        },
        {
          "text": "2",
          "bbox": [
            1633.0,
            3176.0,
            1669.0,
            3225.0
          ],
          "confidence": 0.9901198148727417
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1178.0,
            4477.0
          ],
          "confidence": 0.9950919151306152
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Governing Law_10",
      "question": "Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country's law governs the interpretation of the contract?",
      "answer_text": "This Agreement shall be governed and construed in accordance with the laws of New York State   (without regard to the conflict of laws provisions thereof).",
      "page_number": 10,
      "words": [
        {
          "text": "(b) Milestone #2 - Within thirty (30) days following the date on which there is a design freeze of the Patient-Specific",
          "bbox": [
            451.0,
            492.0,
            3021.0,
            535.0
          ],
          "confidence": 0.9902281165122986
        },
        {
          "text": "Instrumentation for the KIB Product in accordance with the R&D Work Plan, Stryker shall pay to Conformis a total of three",
          "bbox": [
            277.0,
            585.0,
            3025.0,
            638.0
          ],
          "confidence": 0.9894645810127258
        },
        {
          "text": "million U.S dollars ($3,000,000)",
          "bbox": [
            279.0,
            685.0,
            972.0,
            733.0
          ],
          "confidence": 0.979433536529541
        },
        {
          "text": "3.6 Payment. Stryker shall make all payments to Conformis required herein by wire transfer in accordance with the Wire",
          "bbox": [
            448.0,
            784.0,
            3023.0,
            833.0
          ],
          "confidence": 0.9926160573959351
        },
        {
          "text": "Instructions. Such payments are non-refundable and non-creditable except as set forth in the Other Agreements",
          "bbox": [
            279.0,
            883.0,
            2626.0,
            932.0
          ],
          "confidence": 0.9959061145782471
        },
        {
          "text": "ARTICLE IV ",
          "bbox": [
            1497.0,
            983.0,
            1807.0,
            1021.0
          ],
          "confidence": 0.9365985989570618
        },
        {
          "text": "RESTRICTIVE COVENANT",
          "bbox": [
            1307.0,
            1082.0,
            1999.0,
            1118.0
          ],
          "confidence": 0.977649986743927
        },
        {
          "text": "4.1 Exclusivity. Except as specifically provided in the Distribution Agreement, Conformis shall be prohibited from",
          "bbox": [
            448.0,
            1177.0,
            3025.0,
            1226.0
          ],
          "confidence": 0.9973055720329285
        },
        {
          "text": "developing or assisting another in developing, or causing another to develop, Patient-Specific Instrumentation for Off-The-Shelf",
          "bbox": [
            277.0,
            1270.0,
            3034.0,
            1327.0
          ],
          "confidence": 0.9954086542129517
        },
        {
          "text": "Knee Implants for any Third Party in the field of orthopedics until January 1, 2032 (or earlier, to the extent set forth in Section",
          "bbox": [
            281.0,
            1376.0,
            3025.0,
            1420.0
          ],
          "confidence": 0.9929195642471313
        },
        {
          "text": "2.3.3.4 or Section 2.3.5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a",
          "bbox": [
            277.0,
            1469.0,
            3025.0,
            1522.0
          ],
          "confidence": 0.9989263415336609
        },
        {
          "text": "Change of Control of Conformis, any such entity an \"Acquirer'), may develop Patient-Specific Instrumentation for any Off-The-",
          "bbox": [
            279.0,
            1568.0,
            3023.0,
            1619.0
          ],
          "confidence": 0.9903354644775391
        },
        {
          "text": "Shelf Implants of Conformis, an Acquirer or any of their Affiliates. For purposes of clarity, the foregoing does not prevent",
          "bbox": [
            277.0,
            1667.0,
            3029.0,
            1720.0
          ],
          "confidence": 0.9960777759552002
        },
        {
          "text": "Conformis from granting any license, release, covenant not to sue or other immunity to any third party under any Patents, including",
          "bbox": [
            277.0,
            1763.0,
            3025.0,
            1818.0
          ],
          "confidence": 0.9921333193778992
        },
        {
          "text": "any such immunity that would authorize manufacture, use or sale of Patient-Specific Instrumentation for Off-The-Shelf Knee",
          "bbox": [
            281.0,
            1864.0,
            3027.0,
            1911.0
          ],
          "confidence": 0.9951606392860413
        },
        {
          "text": "Implants outside the Buyer Field.",
          "bbox": [
            277.0,
            1961.0,
            968.0,
            2012.0
          ],
          "confidence": 0.9880734086036682
        },
        {
          "text": "ARTICLE V",
          "bbox": [
            1506.0,
            2158.0,
            1798.0,
            2206.0
          ],
          "confidence": 0.9991874694824219
        },
        {
          "text": "INTELLECTUAL PROPERTY",
          "bbox": [
            1292.0,
            2262.0,
            2010.0,
            2299.0
          ],
          "confidence": 0.9819167852401733
        },
        {
          "text": "5.1 Inventions..",
          "bbox": [
            446.0,
            2357.0,
            785.0,
            2405.0
          ],
          "confidence": 0.9786468148231506
        },
        {
          "text": "(a) Inventorship of all Inventions developed by either Party, or both Parties, in the performance of the R&D Program, shall",
          "bbox": [
            448.0,
            2456.0,
            3025.0,
            2507.0
          ],
          "confidence": 0.9936838746070862
        },
        {
          "text": "be determined in accordance with the inventorship laws of the United States, even to the extent such Invention is not pursued in",
          "bbox": [
            279.0,
            2555.0,
            3023.0,
            2600.0
          ],
          "confidence": 0.9940375089645386
        },
        {
          "text": "patent applications.",
          "bbox": [
            277.0,
            2651.0,
            678.0,
            2705.0
          ],
          "confidence": 0.998713493347168
        },
        {
          "text": "(b) All right, title and interest in and to the Improved Stryker Background IP will vest solely in Stryker. Conformis agrees",
          "bbox": [
            450.0,
            2752.0,
            3027.0,
            2801.0
          ],
          "confidence": 0.9880363345146179
        },
        {
          "text": "in same has vested in",
          "bbox": [
            277.0,
            2947.0,
            716.0,
            2993.0
          ],
          "confidence": 0.9724188446998596
        },
        {
          "text": "11",
          "bbox": [
            1624.0,
            3083.0,
            1684.0,
            3138.0
          ],
          "confidence": 0.9979571104049683
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1178.0,
            4477.0
          ],
          "confidence": 0.9952178597450256
        }
      ],
      "nearby_headers": [
        {
          "text": "ARTICLE IV",
          "page": 10,
          "bbox": [
            1497.0,
            983.0,
            1807.0,
            1021.0
          ]
        },
        {
          "text": "RESTRICTIVE COVENANT",
          "page": 10,
          "bbox": [
            1307.0,
            1082.0,
            1999.0,
            1118.0
          ]
        },
        {
          "text": "ARTICLE V",
          "page": 10,
          "bbox": [
            1506.0,
            2158.0,
            1798.0,
            2206.0
          ]
        },
        {
          "text": "INTELLECTUAL PROPERTY",
          "page": 10,
          "bbox": [
            1292.0,
            2262.0,
            2010.0,
            2299.0
          ]
        }
      ]
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Exclusivity_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Exclusivity\" that should be reviewed by a lawyer. Details: Is there an exclusive dealing  commitment with the counterparty? This includes a commitment to procure all “requirements” from one party of certain technology, goods, or services or a prohibition on licensing or selling technology, goods or services to third parties, or a prohibition on  collaborating or working with other parties), whether during the contract or  after the contract ends (or both).",
      "answer_text": "Except as specifically provided in the Distribution Agreement, Conformis shall be prohibited from   developing or assisting another in developing, or causing another to develop, Patient-Specific Instrumentation for Off-The-Shelf   Knee Implants for any Third Party in the field of orthopedics until January 1, 2032 (or earlier, to the extent set forth in Section   2.3.3.4 or Section 2.3.5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates.",
      "page_number": 0,
      "words": [
        {
          "text": "Execution Version",
          "bbox": [
            2601.0,
            294.0,
            3020.0,
            333.0
          ],
          "confidence": 0.9843302369117737
        },
        {
          "text": "Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause.",
          "bbox": [
            350.0,
            354.0,
            2953.0,
            404.0
          ],
          "confidence": 0.9875192642211914
        },
        {
          "text": "competitive harm to the Company, if publicly disclosed. Double asterisks denote omissions.",
          "bbox": [
            696.0,
            424.0,
            2610.0,
            470.0
          ],
          "confidence": 0.9918519854545593
        },
        {
          "text": "DEVELOPMENT AGREEMENT",
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ],
          "confidence": 0.9884270429611206
        },
        {
          "text": "This Development Agreement (\"this Agreement'') is entered into and effective as of September 30, 2019 (\"Effective.",
          "bbox": [
            448.0,
            795.0,
            3025.0,
            844.0
          ],
          "confidence": 0.9763412475585938
        },
        {
          "text": "Date') by and between Howmedica Osteonics Corp., a New Jersey corporation, also known as Stryker Orthopaedics",
          "bbox": [
            281.0,
            895.0,
            3023.0,
            939.0
          ],
          "confidence": 0.9990173578262329
        },
        {
          "text": "(\"Stryker'), and Conformis, Inc., a Delaware corporation having a principal place of business located at 600 Technology Park",
          "bbox": [
            279.0,
            987.0,
            3027.0,
            1043.0
          ],
          "confidence": 0.9912907481193542
        },
        {
          "text": "Drive, Billerica, MA O1821 (Conformis'). Stryker and Conformis are collectively referred to herein as the \"Parties' and",
          "bbox": [
            281.0,
            1091.0,
            3029.0,
            1135.0
          ],
          "confidence": 0.9795650243759155
        },
        {
          "text": "individually as a \"Party.\"",
          "bbox": [
            277.0,
            1186.0,
            814.0,
            1235.0
          ],
          "confidence": 0.9837418794631958
        },
        {
          "text": "WHEREAS, the Parties are concurrently entering into an asset purchase agreement for Stryker's purchase of certain",
          "bbox": [
            444.0,
            1281.0,
            3029.0,
            1338.0
          ],
          "confidence": 0.9927125573158264
        },
        {
          "text": "Conformis assets concerning Patient-Specific Instrumentation (\"Asset Purchase Agreement\"), and a License Agreement, a",
          "bbox": [
            275.0,
            1378.0,
            3029.0,
            1436.0
          ],
          "confidence": 0.9887849688529968
        },
        {
          "text": "Distribution Agreement and a Quality Agreement, as defined in and attached to the Asset Purchase Agreement (collectively, such",
          "bbox": [
            279.0,
            1482.0,
            3025.0,
            1531.0
          ],
          "confidence": 0.9973982572555542
        },
        {
          "text": "agreements are referred to herein as the \"Other Agreements')",
          "bbox": [
            277.0,
            1577.0,
            1640.0,
            1632.0
          ],
          "confidence": 0.9893602132797241
        },
        {
          "text": "WHEREAS, Stryker and its Affiliates have developed and commercialized an Off-The-Shelf Knee Implant offered under.",
          "bbox": [
            448.0,
            1678.0,
            3029.0,
            1727.0
          ],
          "confidence": 0.9939711093902588
        },
        {
          "text": "the trademark Triathlon.",
          "bbox": [
            281.0,
            1778.0,
            776.0,
            1820.0
          ],
          "confidence": 0.9796398282051086
        },
        {
          "text": "WHEREAS, Conformis currently offers Patient-Specific Instrumentation for use with its Patient-Specific Implants,",
          "bbox": [
            446.0,
            1869.0,
            3025.0,
            1926.0
          ],
          "confidence": 0.9971562623977661
        },
        {
          "text": "including partial and total knee and hip arthroplasty.",
          "bbox": [
            281.0,
            1970.0,
            1352.0,
            2025.0
          ],
          "confidence": 0.9856063723564148
        },
        {
          "text": "WHEREAS, Stryker desires that Conformis develop, in accordance with the R&D Program, certain Patient-Specific.",
          "bbox": [
            450.0,
            2072.0,
            3021.0,
            2116.0
          ],
          "confidence": 0.9856840372085571
        },
        {
          "text": "Instrumentation to be used with the current version of the Off-The-Shelf Knee Implant offered under the trademark Triathlon (such",
          "bbox": [
            281.0,
            2171.0,
            3023.0,
            2215.0
          ],
          "confidence": 0.9951096177101135
        },
        {
          "text": "Patient-Specific Instrumentation as so developed, the \"KIB Product')",
          "bbox": [
            283.0,
            2270.0,
            1784.0,
            2313.0
          ],
          "confidence": 0.9868863224983215
        },
        {
          "text": "THEREFORE, in consideration of the mutual representations, warranties and covenants herein and in the Other.",
          "bbox": [
            444.0,
            2363.0,
            3029.0,
            2414.0
          ],
          "confidence": 0.9940667748451233
        },
        {
          "text": "Agreements constituting good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties",
          "bbox": [
            279.0,
            2463.0,
            3025.0,
            2514.0
          ],
          "confidence": 0.9964366555213928
        },
        {
          "text": "hereby agree as follows:",
          "bbox": [
            279.0,
            2564.0,
            781.0,
            2608.0
          ],
          "confidence": 0.9871907234191895
        },
        {
          "text": "ARTICLE I",
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ],
          "confidence": 0.9906837940216064
        },
        {
          "text": "DEFINITIONS",
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ],
          "confidence": 0.9980525374412537
        },
        {
          "text": "1.1 Definitions. For purposes of this Agreement, the following terms shall have the following meanings, and to the extent",
          "bbox": [
            448.0,
            2854.0,
            2994.0,
            2907.0
          ],
          "confidence": 0.9955382943153381
        },
        {
          "text": "not defined in this section or otherwise in this Agreement, a term shall have the meaning ascribed to it in any of the Other.",
          "bbox": [
            275.0,
            2953.0,
            2800.0,
            3004.0
          ],
          "confidence": 0.99052894115448
        },
        {
          "text": "Agreements:",
          "bbox": [
            281.0,
            3053.0,
            540.0,
            3103.0
          ],
          "confidence": 0.9999290704727173
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1180.0,
            4479.0
          ],
          "confidence": 0.9975276589393616
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "DEVELOPMENT AGREEMENT",
          "page": 0,
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ]
        },
        {
          "text": "ARTICLE I",
          "page": 0,
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ]
        },
        {
          "text": "DEFINITIONS",
          "page": 0,
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ]
        }
      ]
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Exclusivity_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Exclusivity\" that should be reviewed by a lawyer. Details: Is there an exclusive dealing  commitment with the counterparty? This includes a commitment to procure all “requirements” from one party of certain technology, goods, or services or a prohibition on licensing or selling technology, goods or services to third parties, or a prohibition on  collaborating or working with other parties), whether during the contract or  after the contract ends (or both).",
      "answer_text": "Except as specifically provided in the Distribution Agreement, Conformis shall be prohibited from   developing or assisting another in developing, or causing another to develop, Patient-Specific Instrumentation for Off-The-Shelf   Knee Implants for any Third Party in the field of orthopedics until January 1, 2032 (or earlier, to the extent set forth in Section   2.3.3.4 or Section 2.3.5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates.",
      "page_number": 1,
      "words": [
        {
          "text": "\"Acceptance\"' and \"Accept' have the meaning set forth in Article 3.4 of this Agreement.",
          "bbox": [
            446.0,
            481.0,
            2340.0,
            539.0
          ],
          "confidence": 0.977286696434021
        },
        {
          "text": "\"Acceptance Criteria' has the meaning set forth in the R&D Work Plan.",
          "bbox": [
            450.0,
            682.0,
            2008.0,
            731.0
          ],
          "confidence": 0.9961835145950317
        },
        {
          "text": "\"Acceptance Notification Period' has the meaning set forth in Article 3.3 of this Agreement..",
          "bbox": [
            450.0,
            879.0,
            2438.0,
            928.0
          ],
          "confidence": 0.9805790781974792
        },
        {
          "text": "\"Affiliate\" has the meaning set forth in the Asset Purchase Agreement",
          "bbox": [
            448.0,
            1071.0,
            1950.0,
            1124.0
          ],
          "confidence": 0.9933743476867676
        },
        {
          "text": "\"Agents\" means Third Parties who are acting under the direction or control of a Party.",
          "bbox": [
            448.0,
            1268.0,
            2284.0,
            1321.0
          ],
          "confidence": 0.9984568953514099
        },
        {
          "text": "\"Applicable Laws\" means all applicable federal, state, local and foreign laws, ordinances, rules, regulations, orders,.",
          "bbox": [
            448.0,
            1466.0,
            3025.0,
            1520.0
          ],
          "confidence": 0.9899159073829651
        },
        {
          "text": "writs, injunctions and decrees of any kind.",
          "bbox": [
            283.0,
            1566.0,
            1155.0,
            1614.0
          ],
          "confidence": 0.9892303943634033
        },
        {
          "text": "\"Asset Purchase Agreement\"' has the meaning set forth in the recitals",
          "bbox": [
            448.0,
            1762.0,
            1948.0,
            1811.0
          ],
          "confidence": 0.9865401983261108
        },
        {
          "text": "\"Change of Control'' has the meaning set forth in the Asset Purchase Agreement.",
          "bbox": [
            448.0,
            1955.0,
            2170.0,
            2010.0
          ],
          "confidence": 0.9961836338043213
        },
        {
          "text": "\"Claims\" has the meaning set forth in Article 7.3(a) of this Agreement.",
          "bbox": [
            446.0,
            2147.0,
            1947.0,
            2209.0
          ],
          "confidence": 0.9971343278884888
        },
        {
          "text": "\"Confidential Information\" has the meaning set forth in the Asset Purchase Agreement",
          "bbox": [
            448.0,
            2346.0,
            2335.0,
            2401.0
          ],
          "confidence": 0.999515175819397
        },
        {
          "text": "\"Conformis Background IP\" means any Invention, and all Intellectual Property rights underlying such Invention, that is,.",
          "bbox": [
            446.0,
            2540.0,
            3025.0,
            2602.0
          ],
          "confidence": 0.9841423630714417
        },
        {
          "text": "as of the Effective Date, owned or licensable by Conformis without causing a breach of, or incurring any obligation to, a third.",
          "bbox": [
            279.0,
            2644.0,
            3029.0,
            2699.0
          ],
          "confidence": 0.9918943643569946
        },
        {
          "text": "party, in each case to the extent necessary or reasonably useful to design, develop, manufacture, sell or otherwise exploit the KIB.",
          "bbox": [
            275.0,
            2739.0,
            3027.0,
            2798.0
          ],
          "confidence": 0.9918000102043152
        },
        {
          "text": "Product, and for the avoidance of doubt, excluding the Purchased Assets, Conformis Foreground IP, Stryker Background IP.",
          "bbox": [
            279.0,
            2843.0,
            3023.0,
            2893.0
          ],
          "confidence": 0.9966443181037903
        },
        {
          "text": "Improved Stryker Background IP and Improved Conformis Background IP",
          "bbox": [
            279.0,
            2938.0,
            1874.0,
            2990.0
          ],
          "confidence": 0.9942641854286194
        },
        {
          "text": "2",
          "bbox": [
            1633.0,
            3176.0,
            1669.0,
            3225.0
          ],
          "confidence": 0.9901198148727417
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1178.0,
            4477.0
          ],
          "confidence": 0.9950919151306152
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Competitive Restriction Exception_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Competitive Restriction Exception\" that should be reviewed by a lawyer. Details: This category includes the exceptions or carveouts to Non-Compete, Exclusivity and No-Solicit of Customers above.",
      "answer_text": "Except as specifically provided in the Distribution Agreement, Conformis shall be prohibited from   developing or assisting another in developing, or causing another to develop, Patient-Specific Instrumentation for Off-The-Shelf   Knee Implants for any Third Party in the field of orthopedics until January 1, 2032 (or earlier, to the extent set forth in Section   2.3.3.4 or Section 2.3.5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates.",
      "page_number": 0,
      "words": [
        {
          "text": "Execution Version",
          "bbox": [
            2601.0,
            294.0,
            3020.0,
            333.0
          ],
          "confidence": 0.9843302369117737
        },
        {
          "text": "Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause.",
          "bbox": [
            350.0,
            354.0,
            2953.0,
            404.0
          ],
          "confidence": 0.9875192642211914
        },
        {
          "text": "competitive harm to the Company, if publicly disclosed. Double asterisks denote omissions.",
          "bbox": [
            696.0,
            424.0,
            2610.0,
            470.0
          ],
          "confidence": 0.9918519854545593
        },
        {
          "text": "DEVELOPMENT AGREEMENT",
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ],
          "confidence": 0.9884270429611206
        },
        {
          "text": "This Development Agreement (\"this Agreement'') is entered into and effective as of September 30, 2019 (\"Effective.",
          "bbox": [
            448.0,
            795.0,
            3025.0,
            844.0
          ],
          "confidence": 0.9763412475585938
        },
        {
          "text": "Date') by and between Howmedica Osteonics Corp., a New Jersey corporation, also known as Stryker Orthopaedics",
          "bbox": [
            281.0,
            895.0,
            3023.0,
            939.0
          ],
          "confidence": 0.9990173578262329
        },
        {
          "text": "(\"Stryker'), and Conformis, Inc., a Delaware corporation having a principal place of business located at 600 Technology Park",
          "bbox": [
            279.0,
            987.0,
            3027.0,
            1043.0
          ],
          "confidence": 0.9912907481193542
        },
        {
          "text": "Drive, Billerica, MA O1821 (Conformis'). Stryker and Conformis are collectively referred to herein as the \"Parties' and",
          "bbox": [
            281.0,
            1091.0,
            3029.0,
            1135.0
          ],
          "confidence": 0.9795650243759155
        },
        {
          "text": "individually as a \"Party.\"",
          "bbox": [
            277.0,
            1186.0,
            814.0,
            1235.0
          ],
          "confidence": 0.9837418794631958
        },
        {
          "text": "WHEREAS, the Parties are concurrently entering into an asset purchase agreement for Stryker's purchase of certain",
          "bbox": [
            444.0,
            1281.0,
            3029.0,
            1338.0
          ],
          "confidence": 0.9927125573158264
        },
        {
          "text": "Conformis assets concerning Patient-Specific Instrumentation (\"Asset Purchase Agreement\"), and a License Agreement, a",
          "bbox": [
            275.0,
            1378.0,
            3029.0,
            1436.0
          ],
          "confidence": 0.9887849688529968
        },
        {
          "text": "Distribution Agreement and a Quality Agreement, as defined in and attached to the Asset Purchase Agreement (collectively, such",
          "bbox": [
            279.0,
            1482.0,
            3025.0,
            1531.0
          ],
          "confidence": 0.9973982572555542
        },
        {
          "text": "agreements are referred to herein as the \"Other Agreements')",
          "bbox": [
            277.0,
            1577.0,
            1640.0,
            1632.0
          ],
          "confidence": 0.9893602132797241
        },
        {
          "text": "WHEREAS, Stryker and its Affiliates have developed and commercialized an Off-The-Shelf Knee Implant offered under.",
          "bbox": [
            448.0,
            1678.0,
            3029.0,
            1727.0
          ],
          "confidence": 0.9939711093902588
        },
        {
          "text": "the trademark Triathlon.",
          "bbox": [
            281.0,
            1778.0,
            776.0,
            1820.0
          ],
          "confidence": 0.9796398282051086
        },
        {
          "text": "WHEREAS, Conformis currently offers Patient-Specific Instrumentation for use with its Patient-Specific Implants,",
          "bbox": [
            446.0,
            1869.0,
            3025.0,
            1926.0
          ],
          "confidence": 0.9971562623977661
        },
        {
          "text": "including partial and total knee and hip arthroplasty.",
          "bbox": [
            281.0,
            1970.0,
            1352.0,
            2025.0
          ],
          "confidence": 0.9856063723564148
        },
        {
          "text": "WHEREAS, Stryker desires that Conformis develop, in accordance with the R&D Program, certain Patient-Specific.",
          "bbox": [
            450.0,
            2072.0,
            3021.0,
            2116.0
          ],
          "confidence": 0.9856840372085571
        },
        {
          "text": "Instrumentation to be used with the current version of the Off-The-Shelf Knee Implant offered under the trademark Triathlon (such",
          "bbox": [
            281.0,
            2171.0,
            3023.0,
            2215.0
          ],
          "confidence": 0.9951096177101135
        },
        {
          "text": "Patient-Specific Instrumentation as so developed, the \"KIB Product')",
          "bbox": [
            283.0,
            2270.0,
            1784.0,
            2313.0
          ],
          "confidence": 0.9868863224983215
        },
        {
          "text": "THEREFORE, in consideration of the mutual representations, warranties and covenants herein and in the Other.",
          "bbox": [
            444.0,
            2363.0,
            3029.0,
            2414.0
          ],
          "confidence": 0.9940667748451233
        },
        {
          "text": "Agreements constituting good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties",
          "bbox": [
            279.0,
            2463.0,
            3025.0,
            2514.0
          ],
          "confidence": 0.9964366555213928
        },
        {
          "text": "hereby agree as follows:",
          "bbox": [
            279.0,
            2564.0,
            781.0,
            2608.0
          ],
          "confidence": 0.9871907234191895
        },
        {
          "text": "ARTICLE I",
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ],
          "confidence": 0.9906837940216064
        },
        {
          "text": "DEFINITIONS",
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ],
          "confidence": 0.9980525374412537
        },
        {
          "text": "1.1 Definitions. For purposes of this Agreement, the following terms shall have the following meanings, and to the extent",
          "bbox": [
            448.0,
            2854.0,
            2994.0,
            2907.0
          ],
          "confidence": 0.9955382943153381
        },
        {
          "text": "not defined in this section or otherwise in this Agreement, a term shall have the meaning ascribed to it in any of the Other.",
          "bbox": [
            275.0,
            2953.0,
            2800.0,
            3004.0
          ],
          "confidence": 0.99052894115448
        },
        {
          "text": "Agreements:",
          "bbox": [
            281.0,
            3053.0,
            540.0,
            3103.0
          ],
          "confidence": 0.9999290704727173
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1180.0,
            4479.0
          ],
          "confidence": 0.9975276589393616
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "DEVELOPMENT AGREEMENT",
          "page": 0,
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ]
        },
        {
          "text": "ARTICLE I",
          "page": 0,
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ]
        },
        {
          "text": "DEFINITIONS",
          "page": 0,
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ]
        }
      ]
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Competitive Restriction Exception_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Competitive Restriction Exception\" that should be reviewed by a lawyer. Details: This category includes the exceptions or carveouts to Non-Compete, Exclusivity and No-Solicit of Customers above.",
      "answer_text": "Except as specifically provided in the Distribution Agreement, Conformis shall be prohibited from   developing or assisting another in developing, or causing another to develop, Patient-Specific Instrumentation for Off-The-Shelf   Knee Implants for any Third Party in the field of orthopedics until January 1, 2032 (or earlier, to the extent set forth in Section   2.3.3.4 or Section 2.3.5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates.",
      "page_number": 1,
      "words": [
        {
          "text": "\"Acceptance\"' and \"Accept' have the meaning set forth in Article 3.4 of this Agreement.",
          "bbox": [
            446.0,
            481.0,
            2340.0,
            539.0
          ],
          "confidence": 0.977286696434021
        },
        {
          "text": "\"Acceptance Criteria' has the meaning set forth in the R&D Work Plan.",
          "bbox": [
            450.0,
            682.0,
            2008.0,
            731.0
          ],
          "confidence": 0.9961835145950317
        },
        {
          "text": "\"Acceptance Notification Period' has the meaning set forth in Article 3.3 of this Agreement..",
          "bbox": [
            450.0,
            879.0,
            2438.0,
            928.0
          ],
          "confidence": 0.9805790781974792
        },
        {
          "text": "\"Affiliate\" has the meaning set forth in the Asset Purchase Agreement",
          "bbox": [
            448.0,
            1071.0,
            1950.0,
            1124.0
          ],
          "confidence": 0.9933743476867676
        },
        {
          "text": "\"Agents\" means Third Parties who are acting under the direction or control of a Party.",
          "bbox": [
            448.0,
            1268.0,
            2284.0,
            1321.0
          ],
          "confidence": 0.9984568953514099
        },
        {
          "text": "\"Applicable Laws\" means all applicable federal, state, local and foreign laws, ordinances, rules, regulations, orders,.",
          "bbox": [
            448.0,
            1466.0,
            3025.0,
            1520.0
          ],
          "confidence": 0.9899159073829651
        },
        {
          "text": "writs, injunctions and decrees of any kind.",
          "bbox": [
            283.0,
            1566.0,
            1155.0,
            1614.0
          ],
          "confidence": 0.9892303943634033
        },
        {
          "text": "\"Asset Purchase Agreement\"' has the meaning set forth in the recitals",
          "bbox": [
            448.0,
            1762.0,
            1948.0,
            1811.0
          ],
          "confidence": 0.9865401983261108
        },
        {
          "text": "\"Change of Control'' has the meaning set forth in the Asset Purchase Agreement.",
          "bbox": [
            448.0,
            1955.0,
            2170.0,
            2010.0
          ],
          "confidence": 0.9961836338043213
        },
        {
          "text": "\"Claims\" has the meaning set forth in Article 7.3(a) of this Agreement.",
          "bbox": [
            446.0,
            2147.0,
            1947.0,
            2209.0
          ],
          "confidence": 0.9971343278884888
        },
        {
          "text": "\"Confidential Information\" has the meaning set forth in the Asset Purchase Agreement",
          "bbox": [
            448.0,
            2346.0,
            2335.0,
            2401.0
          ],
          "confidence": 0.999515175819397
        },
        {
          "text": "\"Conformis Background IP\" means any Invention, and all Intellectual Property rights underlying such Invention, that is,.",
          "bbox": [
            446.0,
            2540.0,
            3025.0,
            2602.0
          ],
          "confidence": 0.9841423630714417
        },
        {
          "text": "as of the Effective Date, owned or licensable by Conformis without causing a breach of, or incurring any obligation to, a third.",
          "bbox": [
            279.0,
            2644.0,
            3029.0,
            2699.0
          ],
          "confidence": 0.9918943643569946
        },
        {
          "text": "party, in each case to the extent necessary or reasonably useful to design, develop, manufacture, sell or otherwise exploit the KIB.",
          "bbox": [
            275.0,
            2739.0,
            3027.0,
            2798.0
          ],
          "confidence": 0.9918000102043152
        },
        {
          "text": "Product, and for the avoidance of doubt, excluding the Purchased Assets, Conformis Foreground IP, Stryker Background IP.",
          "bbox": [
            279.0,
            2843.0,
            3023.0,
            2893.0
          ],
          "confidence": 0.9966443181037903
        },
        {
          "text": "Improved Stryker Background IP and Improved Conformis Background IP",
          "bbox": [
            279.0,
            2938.0,
            1874.0,
            2990.0
          ],
          "confidence": 0.9942641854286194
        },
        {
          "text": "2",
          "bbox": [
            1633.0,
            3176.0,
            1669.0,
            3225.0
          ],
          "confidence": 0.9901198148727417
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1178.0,
            4477.0
          ],
          "confidence": 0.9950919151306152
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Competitive Restriction Exception_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Competitive Restriction Exception\" that should be reviewed by a lawyer. Details: This category includes the exceptions or carveouts to Non-Compete, Exclusivity and No-Solicit of Customers above.",
      "answer_text": "For purposes of clarity, the foregoing does not prevent   Conformis from granting any license, release, covenant not to sue or other immunity to any third party under any Patents, including   any such immunity that would authorize manufacture, use or sale of Patient-Specific Instrumentation for Off-The-Shelf Knee   Implants outside the Buyer Field.",
      "page_number": 0,
      "words": [
        {
          "text": "Execution Version",
          "bbox": [
            2601.0,
            294.0,
            3020.0,
            333.0
          ],
          "confidence": 0.9843302369117737
        },
        {
          "text": "Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause.",
          "bbox": [
            350.0,
            354.0,
            2953.0,
            404.0
          ],
          "confidence": 0.9875192642211914
        },
        {
          "text": "competitive harm to the Company, if publicly disclosed. Double asterisks denote omissions.",
          "bbox": [
            696.0,
            424.0,
            2610.0,
            470.0
          ],
          "confidence": 0.9918519854545593
        },
        {
          "text": "DEVELOPMENT AGREEMENT",
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ],
          "confidence": 0.9884270429611206
        },
        {
          "text": "This Development Agreement (\"this Agreement'') is entered into and effective as of September 30, 2019 (\"Effective.",
          "bbox": [
            448.0,
            795.0,
            3025.0,
            844.0
          ],
          "confidence": 0.9763412475585938
        },
        {
          "text": "Date') by and between Howmedica Osteonics Corp., a New Jersey corporation, also known as Stryker Orthopaedics",
          "bbox": [
            281.0,
            895.0,
            3023.0,
            939.0
          ],
          "confidence": 0.9990173578262329
        },
        {
          "text": "(\"Stryker'), and Conformis, Inc., a Delaware corporation having a principal place of business located at 600 Technology Park",
          "bbox": [
            279.0,
            987.0,
            3027.0,
            1043.0
          ],
          "confidence": 0.9912907481193542
        },
        {
          "text": "Drive, Billerica, MA O1821 (Conformis'). Stryker and Conformis are collectively referred to herein as the \"Parties' and",
          "bbox": [
            281.0,
            1091.0,
            3029.0,
            1135.0
          ],
          "confidence": 0.9795650243759155
        },
        {
          "text": "individually as a \"Party.\"",
          "bbox": [
            277.0,
            1186.0,
            814.0,
            1235.0
          ],
          "confidence": 0.9837418794631958
        },
        {
          "text": "WHEREAS, the Parties are concurrently entering into an asset purchase agreement for Stryker's purchase of certain",
          "bbox": [
            444.0,
            1281.0,
            3029.0,
            1338.0
          ],
          "confidence": 0.9927125573158264
        },
        {
          "text": "Conformis assets concerning Patient-Specific Instrumentation (\"Asset Purchase Agreement\"), and a License Agreement, a",
          "bbox": [
            275.0,
            1378.0,
            3029.0,
            1436.0
          ],
          "confidence": 0.9887849688529968
        },
        {
          "text": "Distribution Agreement and a Quality Agreement, as defined in and attached to the Asset Purchase Agreement (collectively, such",
          "bbox": [
            279.0,
            1482.0,
            3025.0,
            1531.0
          ],
          "confidence": 0.9973982572555542
        },
        {
          "text": "agreements are referred to herein as the \"Other Agreements')",
          "bbox": [
            277.0,
            1577.0,
            1640.0,
            1632.0
          ],
          "confidence": 0.9893602132797241
        },
        {
          "text": "WHEREAS, Stryker and its Affiliates have developed and commercialized an Off-The-Shelf Knee Implant offered under.",
          "bbox": [
            448.0,
            1678.0,
            3029.0,
            1727.0
          ],
          "confidence": 0.9939711093902588
        },
        {
          "text": "the trademark Triathlon.",
          "bbox": [
            281.0,
            1778.0,
            776.0,
            1820.0
          ],
          "confidence": 0.9796398282051086
        },
        {
          "text": "WHEREAS, Conformis currently offers Patient-Specific Instrumentation for use with its Patient-Specific Implants,",
          "bbox": [
            446.0,
            1869.0,
            3025.0,
            1926.0
          ],
          "confidence": 0.9971562623977661
        },
        {
          "text": "including partial and total knee and hip arthroplasty.",
          "bbox": [
            281.0,
            1970.0,
            1352.0,
            2025.0
          ],
          "confidence": 0.9856063723564148
        },
        {
          "text": "WHEREAS, Stryker desires that Conformis develop, in accordance with the R&D Program, certain Patient-Specific.",
          "bbox": [
            450.0,
            2072.0,
            3021.0,
            2116.0
          ],
          "confidence": 0.9856840372085571
        },
        {
          "text": "Instrumentation to be used with the current version of the Off-The-Shelf Knee Implant offered under the trademark Triathlon (such",
          "bbox": [
            281.0,
            2171.0,
            3023.0,
            2215.0
          ],
          "confidence": 0.9951096177101135
        },
        {
          "text": "Patient-Specific Instrumentation as so developed, the \"KIB Product')",
          "bbox": [
            283.0,
            2270.0,
            1784.0,
            2313.0
          ],
          "confidence": 0.9868863224983215
        },
        {
          "text": "THEREFORE, in consideration of the mutual representations, warranties and covenants herein and in the Other.",
          "bbox": [
            444.0,
            2363.0,
            3029.0,
            2414.0
          ],
          "confidence": 0.9940667748451233
        },
        {
          "text": "Agreements constituting good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties",
          "bbox": [
            279.0,
            2463.0,
            3025.0,
            2514.0
          ],
          "confidence": 0.9964366555213928
        },
        {
          "text": "hereby agree as follows:",
          "bbox": [
            279.0,
            2564.0,
            781.0,
            2608.0
          ],
          "confidence": 0.9871907234191895
        },
        {
          "text": "ARTICLE I",
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ],
          "confidence": 0.9906837940216064
        },
        {
          "text": "DEFINITIONS",
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ],
          "confidence": 0.9980525374412537
        },
        {
          "text": "1.1 Definitions. For purposes of this Agreement, the following terms shall have the following meanings, and to the extent",
          "bbox": [
            448.0,
            2854.0,
            2994.0,
            2907.0
          ],
          "confidence": 0.9955382943153381
        },
        {
          "text": "not defined in this section or otherwise in this Agreement, a term shall have the meaning ascribed to it in any of the Other.",
          "bbox": [
            275.0,
            2953.0,
            2800.0,
            3004.0
          ],
          "confidence": 0.99052894115448
        },
        {
          "text": "Agreements:",
          "bbox": [
            281.0,
            3053.0,
            540.0,
            3103.0
          ],
          "confidence": 0.9999290704727173
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1180.0,
            4479.0
          ],
          "confidence": 0.9975276589393616
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "DEVELOPMENT AGREEMENT",
          "page": 0,
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ]
        },
        {
          "text": "ARTICLE I",
          "page": 0,
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ]
        },
        {
          "text": "DEFINITIONS",
          "page": 0,
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ]
        }
      ]
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Competitive Restriction Exception_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Competitive Restriction Exception\" that should be reviewed by a lawyer. Details: This category includes the exceptions or carveouts to Non-Compete, Exclusivity and No-Solicit of Customers above.",
      "answer_text": "For purposes of clarity, the foregoing does not prevent   Conformis from granting any license, release, covenant not to sue or other immunity to any third party under any Patents, including   any such immunity that would authorize manufacture, use or sale of Patient-Specific Instrumentation for Off-The-Shelf Knee   Implants outside the Buyer Field.",
      "page_number": 1,
      "words": [
        {
          "text": "\"Acceptance\"' and \"Accept' have the meaning set forth in Article 3.4 of this Agreement.",
          "bbox": [
            446.0,
            481.0,
            2340.0,
            539.0
          ],
          "confidence": 0.977286696434021
        },
        {
          "text": "\"Acceptance Criteria' has the meaning set forth in the R&D Work Plan.",
          "bbox": [
            450.0,
            682.0,
            2008.0,
            731.0
          ],
          "confidence": 0.9961835145950317
        },
        {
          "text": "\"Acceptance Notification Period' has the meaning set forth in Article 3.3 of this Agreement..",
          "bbox": [
            450.0,
            879.0,
            2438.0,
            928.0
          ],
          "confidence": 0.9805790781974792
        },
        {
          "text": "\"Affiliate\" has the meaning set forth in the Asset Purchase Agreement",
          "bbox": [
            448.0,
            1071.0,
            1950.0,
            1124.0
          ],
          "confidence": 0.9933743476867676
        },
        {
          "text": "\"Agents\" means Third Parties who are acting under the direction or control of a Party.",
          "bbox": [
            448.0,
            1268.0,
            2284.0,
            1321.0
          ],
          "confidence": 0.9984568953514099
        },
        {
          "text": "\"Applicable Laws\" means all applicable federal, state, local and foreign laws, ordinances, rules, regulations, orders,.",
          "bbox": [
            448.0,
            1466.0,
            3025.0,
            1520.0
          ],
          "confidence": 0.9899159073829651
        },
        {
          "text": "writs, injunctions and decrees of any kind.",
          "bbox": [
            283.0,
            1566.0,
            1155.0,
            1614.0
          ],
          "confidence": 0.9892303943634033
        },
        {
          "text": "\"Asset Purchase Agreement\"' has the meaning set forth in the recitals",
          "bbox": [
            448.0,
            1762.0,
            1948.0,
            1811.0
          ],
          "confidence": 0.9865401983261108
        },
        {
          "text": "\"Change of Control'' has the meaning set forth in the Asset Purchase Agreement.",
          "bbox": [
            448.0,
            1955.0,
            2170.0,
            2010.0
          ],
          "confidence": 0.9961836338043213
        },
        {
          "text": "\"Claims\" has the meaning set forth in Article 7.3(a) of this Agreement.",
          "bbox": [
            446.0,
            2147.0,
            1947.0,
            2209.0
          ],
          "confidence": 0.9971343278884888
        },
        {
          "text": "\"Confidential Information\" has the meaning set forth in the Asset Purchase Agreement",
          "bbox": [
            448.0,
            2346.0,
            2335.0,
            2401.0
          ],
          "confidence": 0.999515175819397
        },
        {
          "text": "\"Conformis Background IP\" means any Invention, and all Intellectual Property rights underlying such Invention, that is,.",
          "bbox": [
            446.0,
            2540.0,
            3025.0,
            2602.0
          ],
          "confidence": 0.9841423630714417
        },
        {
          "text": "as of the Effective Date, owned or licensable by Conformis without causing a breach of, or incurring any obligation to, a third.",
          "bbox": [
            279.0,
            2644.0,
            3029.0,
            2699.0
          ],
          "confidence": 0.9918943643569946
        },
        {
          "text": "party, in each case to the extent necessary or reasonably useful to design, develop, manufacture, sell or otherwise exploit the KIB.",
          "bbox": [
            275.0,
            2739.0,
            3027.0,
            2798.0
          ],
          "confidence": 0.9918000102043152
        },
        {
          "text": "Product, and for the avoidance of doubt, excluding the Purchased Assets, Conformis Foreground IP, Stryker Background IP.",
          "bbox": [
            279.0,
            2843.0,
            3023.0,
            2893.0
          ],
          "confidence": 0.9966443181037903
        },
        {
          "text": "Improved Stryker Background IP and Improved Conformis Background IP",
          "bbox": [
            279.0,
            2938.0,
            1874.0,
            2990.0
          ],
          "confidence": 0.9942641854286194
        },
        {
          "text": "2",
          "bbox": [
            1633.0,
            3176.0,
            1669.0,
            3225.0
          ],
          "confidence": 0.9901198148727417
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1178.0,
            4477.0
          ],
          "confidence": 0.9950919151306152
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Rofr/Rofo/Rofn_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Rofr/Rofo/Rofn\" that should be reviewed by a lawyer. Details: Is there a clause granting one party a right of first refusal, right of first offer or right of first negotiation to purchase, license, market, or distribute equity interest, technology, assets, products or services?",
      "answer_text": "Notwithstanding the foregoing, in the event that the applicable Party decides not to file at all or not to file a continuing or other   application to maintain the viability of the U.S part of a family of patents to which an application belongs, or decides to abandon or   discontinue the prosecution or maintenance of any of the Joint IP Rights, such Party shall notify the other Party thereof, and such   other Party may elect to continue the prosecution (including non-provisional application and PCT entry) or maintenance of such   Joint IP Rights at its sole expense and in the name(s) of both Stryker and Conformis",
      "page_number": 0,
      "words": [
        {
          "text": "Execution Version",
          "bbox": [
            2601.0,
            294.0,
            3020.0,
            333.0
          ],
          "confidence": 0.9843302369117737
        },
        {
          "text": "Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause.",
          "bbox": [
            350.0,
            354.0,
            2953.0,
            404.0
          ],
          "confidence": 0.9875192642211914
        },
        {
          "text": "competitive harm to the Company, if publicly disclosed. Double asterisks denote omissions.",
          "bbox": [
            696.0,
            424.0,
            2610.0,
            470.0
          ],
          "confidence": 0.9918519854545593
        },
        {
          "text": "DEVELOPMENT AGREEMENT",
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ],
          "confidence": 0.9884270429611206
        },
        {
          "text": "This Development Agreement (\"this Agreement'') is entered into and effective as of September 30, 2019 (\"Effective.",
          "bbox": [
            448.0,
            795.0,
            3025.0,
            844.0
          ],
          "confidence": 0.9763412475585938
        },
        {
          "text": "Date') by and between Howmedica Osteonics Corp., a New Jersey corporation, also known as Stryker Orthopaedics",
          "bbox": [
            281.0,
            895.0,
            3023.0,
            939.0
          ],
          "confidence": 0.9990173578262329
        },
        {
          "text": "(\"Stryker'), and Conformis, Inc., a Delaware corporation having a principal place of business located at 600 Technology Park",
          "bbox": [
            279.0,
            987.0,
            3027.0,
            1043.0
          ],
          "confidence": 0.9912907481193542
        },
        {
          "text": "Drive, Billerica, MA O1821 (Conformis'). Stryker and Conformis are collectively referred to herein as the \"Parties' and",
          "bbox": [
            281.0,
            1091.0,
            3029.0,
            1135.0
          ],
          "confidence": 0.9795650243759155
        },
        {
          "text": "individually as a \"Party.\"",
          "bbox": [
            277.0,
            1186.0,
            814.0,
            1235.0
          ],
          "confidence": 0.9837418794631958
        },
        {
          "text": "WHEREAS, the Parties are concurrently entering into an asset purchase agreement for Stryker's purchase of certain",
          "bbox": [
            444.0,
            1281.0,
            3029.0,
            1338.0
          ],
          "confidence": 0.9927125573158264
        },
        {
          "text": "Conformis assets concerning Patient-Specific Instrumentation (\"Asset Purchase Agreement\"), and a License Agreement, a",
          "bbox": [
            275.0,
            1378.0,
            3029.0,
            1436.0
          ],
          "confidence": 0.9887849688529968
        },
        {
          "text": "Distribution Agreement and a Quality Agreement, as defined in and attached to the Asset Purchase Agreement (collectively, such",
          "bbox": [
            279.0,
            1482.0,
            3025.0,
            1531.0
          ],
          "confidence": 0.9973982572555542
        },
        {
          "text": "agreements are referred to herein as the \"Other Agreements')",
          "bbox": [
            277.0,
            1577.0,
            1640.0,
            1632.0
          ],
          "confidence": 0.9893602132797241
        },
        {
          "text": "WHEREAS, Stryker and its Affiliates have developed and commercialized an Off-The-Shelf Knee Implant offered under.",
          "bbox": [
            448.0,
            1678.0,
            3029.0,
            1727.0
          ],
          "confidence": 0.9939711093902588
        },
        {
          "text": "the trademark Triathlon.",
          "bbox": [
            281.0,
            1778.0,
            776.0,
            1820.0
          ],
          "confidence": 0.9796398282051086
        },
        {
          "text": "WHEREAS, Conformis currently offers Patient-Specific Instrumentation for use with its Patient-Specific Implants,",
          "bbox": [
            446.0,
            1869.0,
            3025.0,
            1926.0
          ],
          "confidence": 0.9971562623977661
        },
        {
          "text": "including partial and total knee and hip arthroplasty.",
          "bbox": [
            281.0,
            1970.0,
            1352.0,
            2025.0
          ],
          "confidence": 0.9856063723564148
        },
        {
          "text": "WHEREAS, Stryker desires that Conformis develop, in accordance with the R&D Program, certain Patient-Specific.",
          "bbox": [
            450.0,
            2072.0,
            3021.0,
            2116.0
          ],
          "confidence": 0.9856840372085571
        },
        {
          "text": "Instrumentation to be used with the current version of the Off-The-Shelf Knee Implant offered under the trademark Triathlon (such",
          "bbox": [
            281.0,
            2171.0,
            3023.0,
            2215.0
          ],
          "confidence": 0.9951096177101135
        },
        {
          "text": "Patient-Specific Instrumentation as so developed, the \"KIB Product')",
          "bbox": [
            283.0,
            2270.0,
            1784.0,
            2313.0
          ],
          "confidence": 0.9868863224983215
        },
        {
          "text": "THEREFORE, in consideration of the mutual representations, warranties and covenants herein and in the Other.",
          "bbox": [
            444.0,
            2363.0,
            3029.0,
            2414.0
          ],
          "confidence": 0.9940667748451233
        },
        {
          "text": "Agreements constituting good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties",
          "bbox": [
            279.0,
            2463.0,
            3025.0,
            2514.0
          ],
          "confidence": 0.9964366555213928
        },
        {
          "text": "hereby agree as follows:",
          "bbox": [
            279.0,
            2564.0,
            781.0,
            2608.0
          ],
          "confidence": 0.9871907234191895
        },
        {
          "text": "ARTICLE I",
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ],
          "confidence": 0.9906837940216064
        },
        {
          "text": "DEFINITIONS",
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ],
          "confidence": 0.9980525374412537
        },
        {
          "text": "1.1 Definitions. For purposes of this Agreement, the following terms shall have the following meanings, and to the extent",
          "bbox": [
            448.0,
            2854.0,
            2994.0,
            2907.0
          ],
          "confidence": 0.9955382943153381
        },
        {
          "text": "not defined in this section or otherwise in this Agreement, a term shall have the meaning ascribed to it in any of the Other.",
          "bbox": [
            275.0,
            2953.0,
            2800.0,
            3004.0
          ],
          "confidence": 0.99052894115448
        },
        {
          "text": "Agreements:",
          "bbox": [
            281.0,
            3053.0,
            540.0,
            3103.0
          ],
          "confidence": 0.9999290704727173
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1180.0,
            4479.0
          ],
          "confidence": 0.9975276589393616
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "DEVELOPMENT AGREEMENT",
          "page": 0,
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ]
        },
        {
          "text": "ARTICLE I",
          "page": 0,
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ]
        },
        {
          "text": "DEFINITIONS",
          "page": 0,
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ]
        }
      ]
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Rofr/Rofo/Rofn_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Rofr/Rofo/Rofn\" that should be reviewed by a lawyer. Details: Is there a clause granting one party a right of first refusal, right of first offer or right of first negotiation to purchase, license, market, or distribute equity interest, technology, assets, products or services?",
      "answer_text": "Notwithstanding the foregoing, in the event that the applicable Party decides not to file at all or not to file a continuing or other   application to maintain the viability of the U.S part of a family of patents to which an application belongs, or decides to abandon or   discontinue the prosecution or maintenance of any of the Joint IP Rights, such Party shall notify the other Party thereof, and such   other Party may elect to continue the prosecution (including non-provisional application and PCT entry) or maintenance of such   Joint IP Rights at its sole expense and in the name(s) of both Stryker and Conformis",
      "page_number": 1,
      "words": [
        {
          "text": "\"Acceptance\"' and \"Accept' have the meaning set forth in Article 3.4 of this Agreement.",
          "bbox": [
            446.0,
            481.0,
            2340.0,
            539.0
          ],
          "confidence": 0.977286696434021
        },
        {
          "text": "\"Acceptance Criteria' has the meaning set forth in the R&D Work Plan.",
          "bbox": [
            450.0,
            682.0,
            2008.0,
            731.0
          ],
          "confidence": 0.9961835145950317
        },
        {
          "text": "\"Acceptance Notification Period' has the meaning set forth in Article 3.3 of this Agreement..",
          "bbox": [
            450.0,
            879.0,
            2438.0,
            928.0
          ],
          "confidence": 0.9805790781974792
        },
        {
          "text": "\"Affiliate\" has the meaning set forth in the Asset Purchase Agreement",
          "bbox": [
            448.0,
            1071.0,
            1950.0,
            1124.0
          ],
          "confidence": 0.9933743476867676
        },
        {
          "text": "\"Agents\" means Third Parties who are acting under the direction or control of a Party.",
          "bbox": [
            448.0,
            1268.0,
            2284.0,
            1321.0
          ],
          "confidence": 0.9984568953514099
        },
        {
          "text": "\"Applicable Laws\" means all applicable federal, state, local and foreign laws, ordinances, rules, regulations, orders,.",
          "bbox": [
            448.0,
            1466.0,
            3025.0,
            1520.0
          ],
          "confidence": 0.9899159073829651
        },
        {
          "text": "writs, injunctions and decrees of any kind.",
          "bbox": [
            283.0,
            1566.0,
            1155.0,
            1614.0
          ],
          "confidence": 0.9892303943634033
        },
        {
          "text": "\"Asset Purchase Agreement\"' has the meaning set forth in the recitals",
          "bbox": [
            448.0,
            1762.0,
            1948.0,
            1811.0
          ],
          "confidence": 0.9865401983261108
        },
        {
          "text": "\"Change of Control'' has the meaning set forth in the Asset Purchase Agreement.",
          "bbox": [
            448.0,
            1955.0,
            2170.0,
            2010.0
          ],
          "confidence": 0.9961836338043213
        },
        {
          "text": "\"Claims\" has the meaning set forth in Article 7.3(a) of this Agreement.",
          "bbox": [
            446.0,
            2147.0,
            1947.0,
            2209.0
          ],
          "confidence": 0.9971343278884888
        },
        {
          "text": "\"Confidential Information\" has the meaning set forth in the Asset Purchase Agreement",
          "bbox": [
            448.0,
            2346.0,
            2335.0,
            2401.0
          ],
          "confidence": 0.999515175819397
        },
        {
          "text": "\"Conformis Background IP\" means any Invention, and all Intellectual Property rights underlying such Invention, that is,.",
          "bbox": [
            446.0,
            2540.0,
            3025.0,
            2602.0
          ],
          "confidence": 0.9841423630714417
        },
        {
          "text": "as of the Effective Date, owned or licensable by Conformis without causing a breach of, or incurring any obligation to, a third.",
          "bbox": [
            279.0,
            2644.0,
            3029.0,
            2699.0
          ],
          "confidence": 0.9918943643569946
        },
        {
          "text": "party, in each case to the extent necessary or reasonably useful to design, develop, manufacture, sell or otherwise exploit the KIB.",
          "bbox": [
            275.0,
            2739.0,
            3027.0,
            2798.0
          ],
          "confidence": 0.9918000102043152
        },
        {
          "text": "Product, and for the avoidance of doubt, excluding the Purchased Assets, Conformis Foreground IP, Stryker Background IP.",
          "bbox": [
            279.0,
            2843.0,
            3023.0,
            2893.0
          ],
          "confidence": 0.9966443181037903
        },
        {
          "text": "Improved Stryker Background IP and Improved Conformis Background IP",
          "bbox": [
            279.0,
            2938.0,
            1874.0,
            2990.0
          ],
          "confidence": 0.9942641854286194
        },
        {
          "text": "2",
          "bbox": [
            1633.0,
            3176.0,
            1669.0,
            3225.0
          ],
          "confidence": 0.9901198148727417
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1178.0,
            4477.0
          ],
          "confidence": 0.9950919151306152
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Change Of Control_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Change Of Control\" that should be reviewed by a lawyer. Details: Does one party have the right to terminate or is consent or notice required of the counterparty if such party undergoes a change of control, such as a merger, stock sale, transfer of all or substantially all of its assets or business, or assignment by operation of law?",
      "answer_text": "obligations of the assigning Party in a written instrument, a copy of which is provided to the other Party; and (ii) any assignment of   this Agreement must be accompanied by a simultaneous assignment of the Other Agreements to the same assignee, and the   assigning Party's interest in the Purchased Assets to the same assignee unless otherwise agreed by Conformis in advance, which   agreement shall not be unreasonably withheld.",
      "page_number": 0,
      "words": [
        {
          "text": "Execution Version",
          "bbox": [
            2601.0,
            294.0,
            3020.0,
            333.0
          ],
          "confidence": 0.9843302369117737
        },
        {
          "text": "Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause.",
          "bbox": [
            350.0,
            354.0,
            2953.0,
            404.0
          ],
          "confidence": 0.9875192642211914
        },
        {
          "text": "competitive harm to the Company, if publicly disclosed. Double asterisks denote omissions.",
          "bbox": [
            696.0,
            424.0,
            2610.0,
            470.0
          ],
          "confidence": 0.9918519854545593
        },
        {
          "text": "DEVELOPMENT AGREEMENT",
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ],
          "confidence": 0.9884270429611206
        },
        {
          "text": "This Development Agreement (\"this Agreement'') is entered into and effective as of September 30, 2019 (\"Effective.",
          "bbox": [
            448.0,
            795.0,
            3025.0,
            844.0
          ],
          "confidence": 0.9763412475585938
        },
        {
          "text": "Date') by and between Howmedica Osteonics Corp., a New Jersey corporation, also known as Stryker Orthopaedics",
          "bbox": [
            281.0,
            895.0,
            3023.0,
            939.0
          ],
          "confidence": 0.9990173578262329
        },
        {
          "text": "(\"Stryker'), and Conformis, Inc., a Delaware corporation having a principal place of business located at 600 Technology Park",
          "bbox": [
            279.0,
            987.0,
            3027.0,
            1043.0
          ],
          "confidence": 0.9912907481193542
        },
        {
          "text": "Drive, Billerica, MA O1821 (Conformis'). Stryker and Conformis are collectively referred to herein as the \"Parties' and",
          "bbox": [
            281.0,
            1091.0,
            3029.0,
            1135.0
          ],
          "confidence": 0.9795650243759155
        },
        {
          "text": "individually as a \"Party.\"",
          "bbox": [
            277.0,
            1186.0,
            814.0,
            1235.0
          ],
          "confidence": 0.9837418794631958
        },
        {
          "text": "WHEREAS, the Parties are concurrently entering into an asset purchase agreement for Stryker's purchase of certain",
          "bbox": [
            444.0,
            1281.0,
            3029.0,
            1338.0
          ],
          "confidence": 0.9927125573158264
        },
        {
          "text": "Conformis assets concerning Patient-Specific Instrumentation (\"Asset Purchase Agreement\"), and a License Agreement, a",
          "bbox": [
            275.0,
            1378.0,
            3029.0,
            1436.0
          ],
          "confidence": 0.9887849688529968
        },
        {
          "text": "Distribution Agreement and a Quality Agreement, as defined in and attached to the Asset Purchase Agreement (collectively, such",
          "bbox": [
            279.0,
            1482.0,
            3025.0,
            1531.0
          ],
          "confidence": 0.9973982572555542
        },
        {
          "text": "agreements are referred to herein as the \"Other Agreements')",
          "bbox": [
            277.0,
            1577.0,
            1640.0,
            1632.0
          ],
          "confidence": 0.9893602132797241
        },
        {
          "text": "WHEREAS, Stryker and its Affiliates have developed and commercialized an Off-The-Shelf Knee Implant offered under.",
          "bbox": [
            448.0,
            1678.0,
            3029.0,
            1727.0
          ],
          "confidence": 0.9939711093902588
        },
        {
          "text": "the trademark Triathlon.",
          "bbox": [
            281.0,
            1778.0,
            776.0,
            1820.0
          ],
          "confidence": 0.9796398282051086
        },
        {
          "text": "WHEREAS, Conformis currently offers Patient-Specific Instrumentation for use with its Patient-Specific Implants,",
          "bbox": [
            446.0,
            1869.0,
            3025.0,
            1926.0
          ],
          "confidence": 0.9971562623977661
        },
        {
          "text": "including partial and total knee and hip arthroplasty.",
          "bbox": [
            281.0,
            1970.0,
            1352.0,
            2025.0
          ],
          "confidence": 0.9856063723564148
        },
        {
          "text": "WHEREAS, Stryker desires that Conformis develop, in accordance with the R&D Program, certain Patient-Specific.",
          "bbox": [
            450.0,
            2072.0,
            3021.0,
            2116.0
          ],
          "confidence": 0.9856840372085571
        },
        {
          "text": "Instrumentation to be used with the current version of the Off-The-Shelf Knee Implant offered under the trademark Triathlon (such",
          "bbox": [
            281.0,
            2171.0,
            3023.0,
            2215.0
          ],
          "confidence": 0.9951096177101135
        },
        {
          "text": "Patient-Specific Instrumentation as so developed, the \"KIB Product')",
          "bbox": [
            283.0,
            2270.0,
            1784.0,
            2313.0
          ],
          "confidence": 0.9868863224983215
        },
        {
          "text": "THEREFORE, in consideration of the mutual representations, warranties and covenants herein and in the Other.",
          "bbox": [
            444.0,
            2363.0,
            3029.0,
            2414.0
          ],
          "confidence": 0.9940667748451233
        },
        {
          "text": "Agreements constituting good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties",
          "bbox": [
            279.0,
            2463.0,
            3025.0,
            2514.0
          ],
          "confidence": 0.9964366555213928
        },
        {
          "text": "hereby agree as follows:",
          "bbox": [
            279.0,
            2564.0,
            781.0,
            2608.0
          ],
          "confidence": 0.9871907234191895
        },
        {
          "text": "ARTICLE I",
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ],
          "confidence": 0.9906837940216064
        },
        {
          "text": "DEFINITIONS",
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ],
          "confidence": 0.9980525374412537
        },
        {
          "text": "1.1 Definitions. For purposes of this Agreement, the following terms shall have the following meanings, and to the extent",
          "bbox": [
            448.0,
            2854.0,
            2994.0,
            2907.0
          ],
          "confidence": 0.9955382943153381
        },
        {
          "text": "not defined in this section or otherwise in this Agreement, a term shall have the meaning ascribed to it in any of the Other.",
          "bbox": [
            275.0,
            2953.0,
            2800.0,
            3004.0
          ],
          "confidence": 0.99052894115448
        },
        {
          "text": "Agreements:",
          "bbox": [
            281.0,
            3053.0,
            540.0,
            3103.0
          ],
          "confidence": 0.9999290704727173
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1180.0,
            4479.0
          ],
          "confidence": 0.9975276589393616
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "DEVELOPMENT AGREEMENT",
          "page": 0,
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ]
        },
        {
          "text": "ARTICLE I",
          "page": 0,
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ]
        },
        {
          "text": "DEFINITIONS",
          "page": 0,
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ]
        }
      ]
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Change Of Control_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Change Of Control\" that should be reviewed by a lawyer. Details: Does one party have the right to terminate or is consent or notice required of the counterparty if such party undergoes a change of control, such as a merger, stock sale, transfer of all or substantially all of its assets or business, or assignment by operation of law?",
      "answer_text": "obligations of the assigning Party in a written instrument, a copy of which is provided to the other Party; and (ii) any assignment of   this Agreement must be accompanied by a simultaneous assignment of the Other Agreements to the same assignee, and the   assigning Party's interest in the Purchased Assets to the same assignee unless otherwise agreed by Conformis in advance, which   agreement shall not be unreasonably withheld.",
      "page_number": 1,
      "words": [
        {
          "text": "\"Acceptance\"' and \"Accept' have the meaning set forth in Article 3.4 of this Agreement.",
          "bbox": [
            446.0,
            481.0,
            2340.0,
            539.0
          ],
          "confidence": 0.977286696434021
        },
        {
          "text": "\"Acceptance Criteria' has the meaning set forth in the R&D Work Plan.",
          "bbox": [
            450.0,
            682.0,
            2008.0,
            731.0
          ],
          "confidence": 0.9961835145950317
        },
        {
          "text": "\"Acceptance Notification Period' has the meaning set forth in Article 3.3 of this Agreement..",
          "bbox": [
            450.0,
            879.0,
            2438.0,
            928.0
          ],
          "confidence": 0.9805790781974792
        },
        {
          "text": "\"Affiliate\" has the meaning set forth in the Asset Purchase Agreement",
          "bbox": [
            448.0,
            1071.0,
            1950.0,
            1124.0
          ],
          "confidence": 0.9933743476867676
        },
        {
          "text": "\"Agents\" means Third Parties who are acting under the direction or control of a Party.",
          "bbox": [
            448.0,
            1268.0,
            2284.0,
            1321.0
          ],
          "confidence": 0.9984568953514099
        },
        {
          "text": "\"Applicable Laws\" means all applicable federal, state, local and foreign laws, ordinances, rules, regulations, orders,.",
          "bbox": [
            448.0,
            1466.0,
            3025.0,
            1520.0
          ],
          "confidence": 0.9899159073829651
        },
        {
          "text": "writs, injunctions and decrees of any kind.",
          "bbox": [
            283.0,
            1566.0,
            1155.0,
            1614.0
          ],
          "confidence": 0.9892303943634033
        },
        {
          "text": "\"Asset Purchase Agreement\"' has the meaning set forth in the recitals",
          "bbox": [
            448.0,
            1762.0,
            1948.0,
            1811.0
          ],
          "confidence": 0.9865401983261108
        },
        {
          "text": "\"Change of Control'' has the meaning set forth in the Asset Purchase Agreement.",
          "bbox": [
            448.0,
            1955.0,
            2170.0,
            2010.0
          ],
          "confidence": 0.9961836338043213
        },
        {
          "text": "\"Claims\" has the meaning set forth in Article 7.3(a) of this Agreement.",
          "bbox": [
            446.0,
            2147.0,
            1947.0,
            2209.0
          ],
          "confidence": 0.9971343278884888
        },
        {
          "text": "\"Confidential Information\" has the meaning set forth in the Asset Purchase Agreement",
          "bbox": [
            448.0,
            2346.0,
            2335.0,
            2401.0
          ],
          "confidence": 0.999515175819397
        },
        {
          "text": "\"Conformis Background IP\" means any Invention, and all Intellectual Property rights underlying such Invention, that is,.",
          "bbox": [
            446.0,
            2540.0,
            3025.0,
            2602.0
          ],
          "confidence": 0.9841423630714417
        },
        {
          "text": "as of the Effective Date, owned or licensable by Conformis without causing a breach of, or incurring any obligation to, a third.",
          "bbox": [
            279.0,
            2644.0,
            3029.0,
            2699.0
          ],
          "confidence": 0.9918943643569946
        },
        {
          "text": "party, in each case to the extent necessary or reasonably useful to design, develop, manufacture, sell or otherwise exploit the KIB.",
          "bbox": [
            275.0,
            2739.0,
            3027.0,
            2798.0
          ],
          "confidence": 0.9918000102043152
        },
        {
          "text": "Product, and for the avoidance of doubt, excluding the Purchased Assets, Conformis Foreground IP, Stryker Background IP.",
          "bbox": [
            279.0,
            2843.0,
            3023.0,
            2893.0
          ],
          "confidence": 0.9966443181037903
        },
        {
          "text": "Improved Stryker Background IP and Improved Conformis Background IP",
          "bbox": [
            279.0,
            2938.0,
            1874.0,
            2990.0
          ],
          "confidence": 0.9942641854286194
        },
        {
          "text": "2",
          "bbox": [
            1633.0,
            3176.0,
            1669.0,
            3225.0
          ],
          "confidence": 0.9901198148727417
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1178.0,
            4477.0
          ],
          "confidence": 0.9950919151306152
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Change Of Control_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Change Of Control\" that should be reviewed by a lawyer. Details: Does one party have the right to terminate or is consent or notice required of the counterparty if such party undergoes a change of control, such as a merger, stock sale, transfer of all or substantially all of its assets or business, or assignment by operation of law?",
      "answer_text": "Except as otherwise provided herein, a Party shall not have the right to   assign any of its rights or obligations under this Agreement (whether through a merger, sale of stock, or otherwise) without the   prior written consent of the other Party; except that, either Party shall be permitted, without any need for the other Party's   consent, to assign this Agreement (a) in whole or in part to an Affiliate (provided, however, that once such Person is no longer an   Affiliate of the assigning Party, such former Affiliate shall assign this Agreement back to the assigning Party), provided that the   assigning Party provides the other Party notice of any such assignment provided further that failure to provide such notice of such   assignment shall not render such assignment void; or (b) to a Third Party in connection with sale or transfer of all or substantially all   of the assigning Party's business or assets relating to the subject matter of this Agreement, whether by Change of Control, merger,   sale of assets or otherwise; provided, however, that, with respect to clause (b), (i) any assignment of this Agreement shall be void   and have no effect unless and until the assignee assumes the",
      "page_number": 0,
      "words": [
        {
          "text": "Execution Version",
          "bbox": [
            2601.0,
            294.0,
            3020.0,
            333.0
          ],
          "confidence": 0.9843302369117737
        },
        {
          "text": "Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause.",
          "bbox": [
            350.0,
            354.0,
            2953.0,
            404.0
          ],
          "confidence": 0.9875192642211914
        },
        {
          "text": "competitive harm to the Company, if publicly disclosed. Double asterisks denote omissions.",
          "bbox": [
            696.0,
            424.0,
            2610.0,
            470.0
          ],
          "confidence": 0.9918519854545593
        },
        {
          "text": "DEVELOPMENT AGREEMENT",
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ],
          "confidence": 0.9884270429611206
        },
        {
          "text": "This Development Agreement (\"this Agreement'') is entered into and effective as of September 30, 2019 (\"Effective.",
          "bbox": [
            448.0,
            795.0,
            3025.0,
            844.0
          ],
          "confidence": 0.9763412475585938
        },
        {
          "text": "Date') by and between Howmedica Osteonics Corp., a New Jersey corporation, also known as Stryker Orthopaedics",
          "bbox": [
            281.0,
            895.0,
            3023.0,
            939.0
          ],
          "confidence": 0.9990173578262329
        },
        {
          "text": "(\"Stryker'), and Conformis, Inc., a Delaware corporation having a principal place of business located at 600 Technology Park",
          "bbox": [
            279.0,
            987.0,
            3027.0,
            1043.0
          ],
          "confidence": 0.9912907481193542
        },
        {
          "text": "Drive, Billerica, MA O1821 (Conformis'). Stryker and Conformis are collectively referred to herein as the \"Parties' and",
          "bbox": [
            281.0,
            1091.0,
            3029.0,
            1135.0
          ],
          "confidence": 0.9795650243759155
        },
        {
          "text": "individually as a \"Party.\"",
          "bbox": [
            277.0,
            1186.0,
            814.0,
            1235.0
          ],
          "confidence": 0.9837418794631958
        },
        {
          "text": "WHEREAS, the Parties are concurrently entering into an asset purchase agreement for Stryker's purchase of certain",
          "bbox": [
            444.0,
            1281.0,
            3029.0,
            1338.0
          ],
          "confidence": 0.9927125573158264
        },
        {
          "text": "Conformis assets concerning Patient-Specific Instrumentation (\"Asset Purchase Agreement\"), and a License Agreement, a",
          "bbox": [
            275.0,
            1378.0,
            3029.0,
            1436.0
          ],
          "confidence": 0.9887849688529968
        },
        {
          "text": "Distribution Agreement and a Quality Agreement, as defined in and attached to the Asset Purchase Agreement (collectively, such",
          "bbox": [
            279.0,
            1482.0,
            3025.0,
            1531.0
          ],
          "confidence": 0.9973982572555542
        },
        {
          "text": "agreements are referred to herein as the \"Other Agreements')",
          "bbox": [
            277.0,
            1577.0,
            1640.0,
            1632.0
          ],
          "confidence": 0.9893602132797241
        },
        {
          "text": "WHEREAS, Stryker and its Affiliates have developed and commercialized an Off-The-Shelf Knee Implant offered under.",
          "bbox": [
            448.0,
            1678.0,
            3029.0,
            1727.0
          ],
          "confidence": 0.9939711093902588
        },
        {
          "text": "the trademark Triathlon.",
          "bbox": [
            281.0,
            1778.0,
            776.0,
            1820.0
          ],
          "confidence": 0.9796398282051086
        },
        {
          "text": "WHEREAS, Conformis currently offers Patient-Specific Instrumentation for use with its Patient-Specific Implants,",
          "bbox": [
            446.0,
            1869.0,
            3025.0,
            1926.0
          ],
          "confidence": 0.9971562623977661
        },
        {
          "text": "including partial and total knee and hip arthroplasty.",
          "bbox": [
            281.0,
            1970.0,
            1352.0,
            2025.0
          ],
          "confidence": 0.9856063723564148
        },
        {
          "text": "WHEREAS, Stryker desires that Conformis develop, in accordance with the R&D Program, certain Patient-Specific.",
          "bbox": [
            450.0,
            2072.0,
            3021.0,
            2116.0
          ],
          "confidence": 0.9856840372085571
        },
        {
          "text": "Instrumentation to be used with the current version of the Off-The-Shelf Knee Implant offered under the trademark Triathlon (such",
          "bbox": [
            281.0,
            2171.0,
            3023.0,
            2215.0
          ],
          "confidence": 0.9951096177101135
        },
        {
          "text": "Patient-Specific Instrumentation as so developed, the \"KIB Product')",
          "bbox": [
            283.0,
            2270.0,
            1784.0,
            2313.0
          ],
          "confidence": 0.9868863224983215
        },
        {
          "text": "THEREFORE, in consideration of the mutual representations, warranties and covenants herein and in the Other.",
          "bbox": [
            444.0,
            2363.0,
            3029.0,
            2414.0
          ],
          "confidence": 0.9940667748451233
        },
        {
          "text": "Agreements constituting good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties",
          "bbox": [
            279.0,
            2463.0,
            3025.0,
            2514.0
          ],
          "confidence": 0.9964366555213928
        },
        {
          "text": "hereby agree as follows:",
          "bbox": [
            279.0,
            2564.0,
            781.0,
            2608.0
          ],
          "confidence": 0.9871907234191895
        },
        {
          "text": "ARTICLE I",
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ],
          "confidence": 0.9906837940216064
        },
        {
          "text": "DEFINITIONS",
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ],
          "confidence": 0.9980525374412537
        },
        {
          "text": "1.1 Definitions. For purposes of this Agreement, the following terms shall have the following meanings, and to the extent",
          "bbox": [
            448.0,
            2854.0,
            2994.0,
            2907.0
          ],
          "confidence": 0.9955382943153381
        },
        {
          "text": "not defined in this section or otherwise in this Agreement, a term shall have the meaning ascribed to it in any of the Other.",
          "bbox": [
            275.0,
            2953.0,
            2800.0,
            3004.0
          ],
          "confidence": 0.99052894115448
        },
        {
          "text": "Agreements:",
          "bbox": [
            281.0,
            3053.0,
            540.0,
            3103.0
          ],
          "confidence": 0.9999290704727173
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1180.0,
            4479.0
          ],
          "confidence": 0.9975276589393616
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "DEVELOPMENT AGREEMENT",
          "page": 0,
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ]
        },
        {
          "text": "ARTICLE I",
          "page": 0,
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ]
        },
        {
          "text": "DEFINITIONS",
          "page": 0,
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ]
        }
      ]
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Change Of Control_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Change Of Control\" that should be reviewed by a lawyer. Details: Does one party have the right to terminate or is consent or notice required of the counterparty if such party undergoes a change of control, such as a merger, stock sale, transfer of all or substantially all of its assets or business, or assignment by operation of law?",
      "answer_text": "Except as otherwise provided herein, a Party shall not have the right to   assign any of its rights or obligations under this Agreement (whether through a merger, sale of stock, or otherwise) without the   prior written consent of the other Party; except that, either Party shall be permitted, without any need for the other Party's   consent, to assign this Agreement (a) in whole or in part to an Affiliate (provided, however, that once such Person is no longer an   Affiliate of the assigning Party, such former Affiliate shall assign this Agreement back to the assigning Party), provided that the   assigning Party provides the other Party notice of any such assignment provided further that failure to provide such notice of such   assignment shall not render such assignment void; or (b) to a Third Party in connection with sale or transfer of all or substantially all   of the assigning Party's business or assets relating to the subject matter of this Agreement, whether by Change of Control, merger,   sale of assets or otherwise; provided, however, that, with respect to clause (b), (i) any assignment of this Agreement shall be void   and have no effect unless and until the assignee assumes the",
      "page_number": 1,
      "words": [
        {
          "text": "\"Acceptance\"' and \"Accept' have the meaning set forth in Article 3.4 of this Agreement.",
          "bbox": [
            446.0,
            481.0,
            2340.0,
            539.0
          ],
          "confidence": 0.977286696434021
        },
        {
          "text": "\"Acceptance Criteria' has the meaning set forth in the R&D Work Plan.",
          "bbox": [
            450.0,
            682.0,
            2008.0,
            731.0
          ],
          "confidence": 0.9961835145950317
        },
        {
          "text": "\"Acceptance Notification Period' has the meaning set forth in Article 3.3 of this Agreement..",
          "bbox": [
            450.0,
            879.0,
            2438.0,
            928.0
          ],
          "confidence": 0.9805790781974792
        },
        {
          "text": "\"Affiliate\" has the meaning set forth in the Asset Purchase Agreement",
          "bbox": [
            448.0,
            1071.0,
            1950.0,
            1124.0
          ],
          "confidence": 0.9933743476867676
        },
        {
          "text": "\"Agents\" means Third Parties who are acting under the direction or control of a Party.",
          "bbox": [
            448.0,
            1268.0,
            2284.0,
            1321.0
          ],
          "confidence": 0.9984568953514099
        },
        {
          "text": "\"Applicable Laws\" means all applicable federal, state, local and foreign laws, ordinances, rules, regulations, orders,.",
          "bbox": [
            448.0,
            1466.0,
            3025.0,
            1520.0
          ],
          "confidence": 0.9899159073829651
        },
        {
          "text": "writs, injunctions and decrees of any kind.",
          "bbox": [
            283.0,
            1566.0,
            1155.0,
            1614.0
          ],
          "confidence": 0.9892303943634033
        },
        {
          "text": "\"Asset Purchase Agreement\"' has the meaning set forth in the recitals",
          "bbox": [
            448.0,
            1762.0,
            1948.0,
            1811.0
          ],
          "confidence": 0.9865401983261108
        },
        {
          "text": "\"Change of Control'' has the meaning set forth in the Asset Purchase Agreement.",
          "bbox": [
            448.0,
            1955.0,
            2170.0,
            2010.0
          ],
          "confidence": 0.9961836338043213
        },
        {
          "text": "\"Claims\" has the meaning set forth in Article 7.3(a) of this Agreement.",
          "bbox": [
            446.0,
            2147.0,
            1947.0,
            2209.0
          ],
          "confidence": 0.9971343278884888
        },
        {
          "text": "\"Confidential Information\" has the meaning set forth in the Asset Purchase Agreement",
          "bbox": [
            448.0,
            2346.0,
            2335.0,
            2401.0
          ],
          "confidence": 0.999515175819397
        },
        {
          "text": "\"Conformis Background IP\" means any Invention, and all Intellectual Property rights underlying such Invention, that is,.",
          "bbox": [
            446.0,
            2540.0,
            3025.0,
            2602.0
          ],
          "confidence": 0.9841423630714417
        },
        {
          "text": "as of the Effective Date, owned or licensable by Conformis without causing a breach of, or incurring any obligation to, a third.",
          "bbox": [
            279.0,
            2644.0,
            3029.0,
            2699.0
          ],
          "confidence": 0.9918943643569946
        },
        {
          "text": "party, in each case to the extent necessary or reasonably useful to design, develop, manufacture, sell or otherwise exploit the KIB.",
          "bbox": [
            275.0,
            2739.0,
            3027.0,
            2798.0
          ],
          "confidence": 0.9918000102043152
        },
        {
          "text": "Product, and for the avoidance of doubt, excluding the Purchased Assets, Conformis Foreground IP, Stryker Background IP.",
          "bbox": [
            279.0,
            2843.0,
            3023.0,
            2893.0
          ],
          "confidence": 0.9966443181037903
        },
        {
          "text": "Improved Stryker Background IP and Improved Conformis Background IP",
          "bbox": [
            279.0,
            2938.0,
            1874.0,
            2990.0
          ],
          "confidence": 0.9942641854286194
        },
        {
          "text": "2",
          "bbox": [
            1633.0,
            3176.0,
            1669.0,
            3225.0
          ],
          "confidence": 0.9901198148727417
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1178.0,
            4477.0
          ],
          "confidence": 0.9950919151306152
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Anti-Assignment_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Anti-Assignment\" that should be reviewed by a lawyer. Details: Is consent or notice required of a party if the contract is assigned to a third party?",
      "answer_text": "assigning Party in a written instrument, a copy of which is provided to the other Party; and (ii) any assignment of   this Agreement must be accompanied by a simultaneous assignment of the Other Agreements to the same assignee, and the   assigning Party's interest in the Purchased Assets to the same assignee unless otherwise agreed by Conformis in advance, which   agreement shall not be unreasonably withheld.",
      "page_number": 0,
      "words": [
        {
          "text": "Execution Version",
          "bbox": [
            2601.0,
            294.0,
            3020.0,
            333.0
          ],
          "confidence": 0.9843302369117737
        },
        {
          "text": "Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause.",
          "bbox": [
            350.0,
            354.0,
            2953.0,
            404.0
          ],
          "confidence": 0.9875192642211914
        },
        {
          "text": "competitive harm to the Company, if publicly disclosed. Double asterisks denote omissions.",
          "bbox": [
            696.0,
            424.0,
            2610.0,
            470.0
          ],
          "confidence": 0.9918519854545593
        },
        {
          "text": "DEVELOPMENT AGREEMENT",
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ],
          "confidence": 0.9884270429611206
        },
        {
          "text": "This Development Agreement (\"this Agreement'') is entered into and effective as of September 30, 2019 (\"Effective.",
          "bbox": [
            448.0,
            795.0,
            3025.0,
            844.0
          ],
          "confidence": 0.9763412475585938
        },
        {
          "text": "Date') by and between Howmedica Osteonics Corp., a New Jersey corporation, also known as Stryker Orthopaedics",
          "bbox": [
            281.0,
            895.0,
            3023.0,
            939.0
          ],
          "confidence": 0.9990173578262329
        },
        {
          "text": "(\"Stryker'), and Conformis, Inc., a Delaware corporation having a principal place of business located at 600 Technology Park",
          "bbox": [
            279.0,
            987.0,
            3027.0,
            1043.0
          ],
          "confidence": 0.9912907481193542
        },
        {
          "text": "Drive, Billerica, MA O1821 (Conformis'). Stryker and Conformis are collectively referred to herein as the \"Parties' and",
          "bbox": [
            281.0,
            1091.0,
            3029.0,
            1135.0
          ],
          "confidence": 0.9795650243759155
        },
        {
          "text": "individually as a \"Party.\"",
          "bbox": [
            277.0,
            1186.0,
            814.0,
            1235.0
          ],
          "confidence": 0.9837418794631958
        },
        {
          "text": "WHEREAS, the Parties are concurrently entering into an asset purchase agreement for Stryker's purchase of certain",
          "bbox": [
            444.0,
            1281.0,
            3029.0,
            1338.0
          ],
          "confidence": 0.9927125573158264
        },
        {
          "text": "Conformis assets concerning Patient-Specific Instrumentation (\"Asset Purchase Agreement\"), and a License Agreement, a",
          "bbox": [
            275.0,
            1378.0,
            3029.0,
            1436.0
          ],
          "confidence": 0.9887849688529968
        },
        {
          "text": "Distribution Agreement and a Quality Agreement, as defined in and attached to the Asset Purchase Agreement (collectively, such",
          "bbox": [
            279.0,
            1482.0,
            3025.0,
            1531.0
          ],
          "confidence": 0.9973982572555542
        },
        {
          "text": "agreements are referred to herein as the \"Other Agreements')",
          "bbox": [
            277.0,
            1577.0,
            1640.0,
            1632.0
          ],
          "confidence": 0.9893602132797241
        },
        {
          "text": "WHEREAS, Stryker and its Affiliates have developed and commercialized an Off-The-Shelf Knee Implant offered under.",
          "bbox": [
            448.0,
            1678.0,
            3029.0,
            1727.0
          ],
          "confidence": 0.9939711093902588
        },
        {
          "text": "the trademark Triathlon.",
          "bbox": [
            281.0,
            1778.0,
            776.0,
            1820.0
          ],
          "confidence": 0.9796398282051086
        },
        {
          "text": "WHEREAS, Conformis currently offers Patient-Specific Instrumentation for use with its Patient-Specific Implants,",
          "bbox": [
            446.0,
            1869.0,
            3025.0,
            1926.0
          ],
          "confidence": 0.9971562623977661
        },
        {
          "text": "including partial and total knee and hip arthroplasty.",
          "bbox": [
            281.0,
            1970.0,
            1352.0,
            2025.0
          ],
          "confidence": 0.9856063723564148
        },
        {
          "text": "WHEREAS, Stryker desires that Conformis develop, in accordance with the R&D Program, certain Patient-Specific.",
          "bbox": [
            450.0,
            2072.0,
            3021.0,
            2116.0
          ],
          "confidence": 0.9856840372085571
        },
        {
          "text": "Instrumentation to be used with the current version of the Off-The-Shelf Knee Implant offered under the trademark Triathlon (such",
          "bbox": [
            281.0,
            2171.0,
            3023.0,
            2215.0
          ],
          "confidence": 0.9951096177101135
        },
        {
          "text": "Patient-Specific Instrumentation as so developed, the \"KIB Product')",
          "bbox": [
            283.0,
            2270.0,
            1784.0,
            2313.0
          ],
          "confidence": 0.9868863224983215
        },
        {
          "text": "THEREFORE, in consideration of the mutual representations, warranties and covenants herein and in the Other.",
          "bbox": [
            444.0,
            2363.0,
            3029.0,
            2414.0
          ],
          "confidence": 0.9940667748451233
        },
        {
          "text": "Agreements constituting good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties",
          "bbox": [
            279.0,
            2463.0,
            3025.0,
            2514.0
          ],
          "confidence": 0.9964366555213928
        },
        {
          "text": "hereby agree as follows:",
          "bbox": [
            279.0,
            2564.0,
            781.0,
            2608.0
          ],
          "confidence": 0.9871907234191895
        },
        {
          "text": "ARTICLE I",
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ],
          "confidence": 0.9906837940216064
        },
        {
          "text": "DEFINITIONS",
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ],
          "confidence": 0.9980525374412537
        },
        {
          "text": "1.1 Definitions. For purposes of this Agreement, the following terms shall have the following meanings, and to the extent",
          "bbox": [
            448.0,
            2854.0,
            2994.0,
            2907.0
          ],
          "confidence": 0.9955382943153381
        },
        {
          "text": "not defined in this section or otherwise in this Agreement, a term shall have the meaning ascribed to it in any of the Other.",
          "bbox": [
            275.0,
            2953.0,
            2800.0,
            3004.0
          ],
          "confidence": 0.99052894115448
        },
        {
          "text": "Agreements:",
          "bbox": [
            281.0,
            3053.0,
            540.0,
            3103.0
          ],
          "confidence": 0.9999290704727173
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1180.0,
            4479.0
          ],
          "confidence": 0.9975276589393616
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "DEVELOPMENT AGREEMENT",
          "page": 0,
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ]
        },
        {
          "text": "ARTICLE I",
          "page": 0,
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ]
        },
        {
          "text": "DEFINITIONS",
          "page": 0,
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ]
        }
      ]
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Anti-Assignment_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Anti-Assignment\" that should be reviewed by a lawyer. Details: Is consent or notice required of a party if the contract is assigned to a third party?",
      "answer_text": "assigning Party in a written instrument, a copy of which is provided to the other Party; and (ii) any assignment of   this Agreement must be accompanied by a simultaneous assignment of the Other Agreements to the same assignee, and the   assigning Party's interest in the Purchased Assets to the same assignee unless otherwise agreed by Conformis in advance, which   agreement shall not be unreasonably withheld.",
      "page_number": 1,
      "words": [
        {
          "text": "\"Acceptance\"' and \"Accept' have the meaning set forth in Article 3.4 of this Agreement.",
          "bbox": [
            446.0,
            481.0,
            2340.0,
            539.0
          ],
          "confidence": 0.977286696434021
        },
        {
          "text": "\"Acceptance Criteria' has the meaning set forth in the R&D Work Plan.",
          "bbox": [
            450.0,
            682.0,
            2008.0,
            731.0
          ],
          "confidence": 0.9961835145950317
        },
        {
          "text": "\"Acceptance Notification Period' has the meaning set forth in Article 3.3 of this Agreement..",
          "bbox": [
            450.0,
            879.0,
            2438.0,
            928.0
          ],
          "confidence": 0.9805790781974792
        },
        {
          "text": "\"Affiliate\" has the meaning set forth in the Asset Purchase Agreement",
          "bbox": [
            448.0,
            1071.0,
            1950.0,
            1124.0
          ],
          "confidence": 0.9933743476867676
        },
        {
          "text": "\"Agents\" means Third Parties who are acting under the direction or control of a Party.",
          "bbox": [
            448.0,
            1268.0,
            2284.0,
            1321.0
          ],
          "confidence": 0.9984568953514099
        },
        {
          "text": "\"Applicable Laws\" means all applicable federal, state, local and foreign laws, ordinances, rules, regulations, orders,.",
          "bbox": [
            448.0,
            1466.0,
            3025.0,
            1520.0
          ],
          "confidence": 0.9899159073829651
        },
        {
          "text": "writs, injunctions and decrees of any kind.",
          "bbox": [
            283.0,
            1566.0,
            1155.0,
            1614.0
          ],
          "confidence": 0.9892303943634033
        },
        {
          "text": "\"Asset Purchase Agreement\"' has the meaning set forth in the recitals",
          "bbox": [
            448.0,
            1762.0,
            1948.0,
            1811.0
          ],
          "confidence": 0.9865401983261108
        },
        {
          "text": "\"Change of Control'' has the meaning set forth in the Asset Purchase Agreement.",
          "bbox": [
            448.0,
            1955.0,
            2170.0,
            2010.0
          ],
          "confidence": 0.9961836338043213
        },
        {
          "text": "\"Claims\" has the meaning set forth in Article 7.3(a) of this Agreement.",
          "bbox": [
            446.0,
            2147.0,
            1947.0,
            2209.0
          ],
          "confidence": 0.9971343278884888
        },
        {
          "text": "\"Confidential Information\" has the meaning set forth in the Asset Purchase Agreement",
          "bbox": [
            448.0,
            2346.0,
            2335.0,
            2401.0
          ],
          "confidence": 0.999515175819397
        },
        {
          "text": "\"Conformis Background IP\" means any Invention, and all Intellectual Property rights underlying such Invention, that is,.",
          "bbox": [
            446.0,
            2540.0,
            3025.0,
            2602.0
          ],
          "confidence": 0.9841423630714417
        },
        {
          "text": "as of the Effective Date, owned or licensable by Conformis without causing a breach of, or incurring any obligation to, a third.",
          "bbox": [
            279.0,
            2644.0,
            3029.0,
            2699.0
          ],
          "confidence": 0.9918943643569946
        },
        {
          "text": "party, in each case to the extent necessary or reasonably useful to design, develop, manufacture, sell or otherwise exploit the KIB.",
          "bbox": [
            275.0,
            2739.0,
            3027.0,
            2798.0
          ],
          "confidence": 0.9918000102043152
        },
        {
          "text": "Product, and for the avoidance of doubt, excluding the Purchased Assets, Conformis Foreground IP, Stryker Background IP.",
          "bbox": [
            279.0,
            2843.0,
            3023.0,
            2893.0
          ],
          "confidence": 0.9966443181037903
        },
        {
          "text": "Improved Stryker Background IP and Improved Conformis Background IP",
          "bbox": [
            279.0,
            2938.0,
            1874.0,
            2990.0
          ],
          "confidence": 0.9942641854286194
        },
        {
          "text": "2",
          "bbox": [
            1633.0,
            3176.0,
            1669.0,
            3225.0
          ],
          "confidence": 0.9901198148727417
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1178.0,
            4477.0
          ],
          "confidence": 0.9950919151306152
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Anti-Assignment_0",
      "question": "Highlight the parts (if any) of this contract related to \"Anti-Assignment\" that should be reviewed by a lawyer. Details: Is consent or notice required of a party if the contract is assigned to a third party?",
      "answer_text": "Any   assignment not in accordance with this Section 10.2 shall be void.",
      "page_number": 0,
      "words": [
        {
          "text": "Execution Version",
          "bbox": [
            2601.0,
            294.0,
            3020.0,
            333.0
          ],
          "confidence": 0.9843302369117737
        },
        {
          "text": "Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause.",
          "bbox": [
            350.0,
            354.0,
            2953.0,
            404.0
          ],
          "confidence": 0.9875192642211914
        },
        {
          "text": "competitive harm to the Company, if publicly disclosed. Double asterisks denote omissions.",
          "bbox": [
            696.0,
            424.0,
            2610.0,
            470.0
          ],
          "confidence": 0.9918519854545593
        },
        {
          "text": "DEVELOPMENT AGREEMENT",
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ],
          "confidence": 0.9884270429611206
        },
        {
          "text": "This Development Agreement (\"this Agreement'') is entered into and effective as of September 30, 2019 (\"Effective.",
          "bbox": [
            448.0,
            795.0,
            3025.0,
            844.0
          ],
          "confidence": 0.9763412475585938
        },
        {
          "text": "Date') by and between Howmedica Osteonics Corp., a New Jersey corporation, also known as Stryker Orthopaedics",
          "bbox": [
            281.0,
            895.0,
            3023.0,
            939.0
          ],
          "confidence": 0.9990173578262329
        },
        {
          "text": "(\"Stryker'), and Conformis, Inc., a Delaware corporation having a principal place of business located at 600 Technology Park",
          "bbox": [
            279.0,
            987.0,
            3027.0,
            1043.0
          ],
          "confidence": 0.9912907481193542
        },
        {
          "text": "Drive, Billerica, MA O1821 (Conformis'). Stryker and Conformis are collectively referred to herein as the \"Parties' and",
          "bbox": [
            281.0,
            1091.0,
            3029.0,
            1135.0
          ],
          "confidence": 0.9795650243759155
        },
        {
          "text": "individually as a \"Party.\"",
          "bbox": [
            277.0,
            1186.0,
            814.0,
            1235.0
          ],
          "confidence": 0.9837418794631958
        },
        {
          "text": "WHEREAS, the Parties are concurrently entering into an asset purchase agreement for Stryker's purchase of certain",
          "bbox": [
            444.0,
            1281.0,
            3029.0,
            1338.0
          ],
          "confidence": 0.9927125573158264
        },
        {
          "text": "Conformis assets concerning Patient-Specific Instrumentation (\"Asset Purchase Agreement\"), and a License Agreement, a",
          "bbox": [
            275.0,
            1378.0,
            3029.0,
            1436.0
          ],
          "confidence": 0.9887849688529968
        },
        {
          "text": "Distribution Agreement and a Quality Agreement, as defined in and attached to the Asset Purchase Agreement (collectively, such",
          "bbox": [
            279.0,
            1482.0,
            3025.0,
            1531.0
          ],
          "confidence": 0.9973982572555542
        },
        {
          "text": "agreements are referred to herein as the \"Other Agreements')",
          "bbox": [
            277.0,
            1577.0,
            1640.0,
            1632.0
          ],
          "confidence": 0.9893602132797241
        },
        {
          "text": "WHEREAS, Stryker and its Affiliates have developed and commercialized an Off-The-Shelf Knee Implant offered under.",
          "bbox": [
            448.0,
            1678.0,
            3029.0,
            1727.0
          ],
          "confidence": 0.9939711093902588
        },
        {
          "text": "the trademark Triathlon.",
          "bbox": [
            281.0,
            1778.0,
            776.0,
            1820.0
          ],
          "confidence": 0.9796398282051086
        },
        {
          "text": "WHEREAS, Conformis currently offers Patient-Specific Instrumentation for use with its Patient-Specific Implants,",
          "bbox": [
            446.0,
            1869.0,
            3025.0,
            1926.0
          ],
          "confidence": 0.9971562623977661
        },
        {
          "text": "including partial and total knee and hip arthroplasty.",
          "bbox": [
            281.0,
            1970.0,
            1352.0,
            2025.0
          ],
          "confidence": 0.9856063723564148
        },
        {
          "text": "WHEREAS, Stryker desires that Conformis develop, in accordance with the R&D Program, certain Patient-Specific.",
          "bbox": [
            450.0,
            2072.0,
            3021.0,
            2116.0
          ],
          "confidence": 0.9856840372085571
        },
        {
          "text": "Instrumentation to be used with the current version of the Off-The-Shelf Knee Implant offered under the trademark Triathlon (such",
          "bbox": [
            281.0,
            2171.0,
            3023.0,
            2215.0
          ],
          "confidence": 0.9951096177101135
        },
        {
          "text": "Patient-Specific Instrumentation as so developed, the \"KIB Product')",
          "bbox": [
            283.0,
            2270.0,
            1784.0,
            2313.0
          ],
          "confidence": 0.9868863224983215
        },
        {
          "text": "THEREFORE, in consideration of the mutual representations, warranties and covenants herein and in the Other.",
          "bbox": [
            444.0,
            2363.0,
            3029.0,
            2414.0
          ],
          "confidence": 0.9940667748451233
        },
        {
          "text": "Agreements constituting good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties",
          "bbox": [
            279.0,
            2463.0,
            3025.0,
            2514.0
          ],
          "confidence": 0.9964366555213928
        },
        {
          "text": "hereby agree as follows:",
          "bbox": [
            279.0,
            2564.0,
            781.0,
            2608.0
          ],
          "confidence": 0.9871907234191895
        },
        {
          "text": "ARTICLE I",
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ],
          "confidence": 0.9906837940216064
        },
        {
          "text": "DEFINITIONS",
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ],
          "confidence": 0.9980525374412537
        },
        {
          "text": "1.1 Definitions. For purposes of this Agreement, the following terms shall have the following meanings, and to the extent",
          "bbox": [
            448.0,
            2854.0,
            2994.0,
            2907.0
          ],
          "confidence": 0.9955382943153381
        },
        {
          "text": "not defined in this section or otherwise in this Agreement, a term shall have the meaning ascribed to it in any of the Other.",
          "bbox": [
            275.0,
            2953.0,
            2800.0,
            3004.0
          ],
          "confidence": 0.99052894115448
        },
        {
          "text": "Agreements:",
          "bbox": [
            281.0,
            3053.0,
            540.0,
            3103.0
          ],
          "confidence": 0.9999290704727173
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1180.0,
            4479.0
          ],
          "confidence": 0.9975276589393616
        }
      ],
      "nearby_headers": [
        {
          "text": "DEVELOPMENT AGREEMENT",
          "page": 0,
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ]
        },
        {
          "text": "ARTICLE I",
          "page": 0,
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ]
        },
        {
          "text": "DEFINITIONS",
          "page": 0,
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ]
        }
      ]
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Anti-Assignment_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Anti-Assignment\" that should be reviewed by a lawyer. Details: Is consent or notice required of a party if the contract is assigned to a third party?",
      "answer_text": "To the extent working with Agents or other Third Parties is permitted under the R&D Work   Plan, should a Party wish to engage an Agent or any other Third Party in connection with the R&D Work Plan or any other work   under this Agreement, such Party must obtain in advance a written agreement by such Agent or other Third Party (i) to assign to   the Party all Inventions conceived, created or generated by the Agent or other Third Party, and (ii) to maintain all Confidential   Information in confidence as set forth in Section 5.2.",
      "page_number": 0,
      "words": [
        {
          "text": "Execution Version",
          "bbox": [
            2601.0,
            294.0,
            3020.0,
            333.0
          ],
          "confidence": 0.9843302369117737
        },
        {
          "text": "Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause.",
          "bbox": [
            350.0,
            354.0,
            2953.0,
            404.0
          ],
          "confidence": 0.9875192642211914
        },
        {
          "text": "competitive harm to the Company, if publicly disclosed. Double asterisks denote omissions.",
          "bbox": [
            696.0,
            424.0,
            2610.0,
            470.0
          ],
          "confidence": 0.9918519854545593
        },
        {
          "text": "DEVELOPMENT AGREEMENT",
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ],
          "confidence": 0.9884270429611206
        },
        {
          "text": "This Development Agreement (\"this Agreement'') is entered into and effective as of September 30, 2019 (\"Effective.",
          "bbox": [
            448.0,
            795.0,
            3025.0,
            844.0
          ],
          "confidence": 0.9763412475585938
        },
        {
          "text": "Date') by and between Howmedica Osteonics Corp., a New Jersey corporation, also known as Stryker Orthopaedics",
          "bbox": [
            281.0,
            895.0,
            3023.0,
            939.0
          ],
          "confidence": 0.9990173578262329
        },
        {
          "text": "(\"Stryker'), and Conformis, Inc., a Delaware corporation having a principal place of business located at 600 Technology Park",
          "bbox": [
            279.0,
            987.0,
            3027.0,
            1043.0
          ],
          "confidence": 0.9912907481193542
        },
        {
          "text": "Drive, Billerica, MA O1821 (Conformis'). Stryker and Conformis are collectively referred to herein as the \"Parties' and",
          "bbox": [
            281.0,
            1091.0,
            3029.0,
            1135.0
          ],
          "confidence": 0.9795650243759155
        },
        {
          "text": "individually as a \"Party.\"",
          "bbox": [
            277.0,
            1186.0,
            814.0,
            1235.0
          ],
          "confidence": 0.9837418794631958
        },
        {
          "text": "WHEREAS, the Parties are concurrently entering into an asset purchase agreement for Stryker's purchase of certain",
          "bbox": [
            444.0,
            1281.0,
            3029.0,
            1338.0
          ],
          "confidence": 0.9927125573158264
        },
        {
          "text": "Conformis assets concerning Patient-Specific Instrumentation (\"Asset Purchase Agreement\"), and a License Agreement, a",
          "bbox": [
            275.0,
            1378.0,
            3029.0,
            1436.0
          ],
          "confidence": 0.9887849688529968
        },
        {
          "text": "Distribution Agreement and a Quality Agreement, as defined in and attached to the Asset Purchase Agreement (collectively, such",
          "bbox": [
            279.0,
            1482.0,
            3025.0,
            1531.0
          ],
          "confidence": 0.9973982572555542
        },
        {
          "text": "agreements are referred to herein as the \"Other Agreements')",
          "bbox": [
            277.0,
            1577.0,
            1640.0,
            1632.0
          ],
          "confidence": 0.9893602132797241
        },
        {
          "text": "WHEREAS, Stryker and its Affiliates have developed and commercialized an Off-The-Shelf Knee Implant offered under.",
          "bbox": [
            448.0,
            1678.0,
            3029.0,
            1727.0
          ],
          "confidence": 0.9939711093902588
        },
        {
          "text": "the trademark Triathlon.",
          "bbox": [
            281.0,
            1778.0,
            776.0,
            1820.0
          ],
          "confidence": 0.9796398282051086
        },
        {
          "text": "WHEREAS, Conformis currently offers Patient-Specific Instrumentation for use with its Patient-Specific Implants,",
          "bbox": [
            446.0,
            1869.0,
            3025.0,
            1926.0
          ],
          "confidence": 0.9971562623977661
        },
        {
          "text": "including partial and total knee and hip arthroplasty.",
          "bbox": [
            281.0,
            1970.0,
            1352.0,
            2025.0
          ],
          "confidence": 0.9856063723564148
        },
        {
          "text": "WHEREAS, Stryker desires that Conformis develop, in accordance with the R&D Program, certain Patient-Specific.",
          "bbox": [
            450.0,
            2072.0,
            3021.0,
            2116.0
          ],
          "confidence": 0.9856840372085571
        },
        {
          "text": "Instrumentation to be used with the current version of the Off-The-Shelf Knee Implant offered under the trademark Triathlon (such",
          "bbox": [
            281.0,
            2171.0,
            3023.0,
            2215.0
          ],
          "confidence": 0.9951096177101135
        },
        {
          "text": "Patient-Specific Instrumentation as so developed, the \"KIB Product')",
          "bbox": [
            283.0,
            2270.0,
            1784.0,
            2313.0
          ],
          "confidence": 0.9868863224983215
        },
        {
          "text": "THEREFORE, in consideration of the mutual representations, warranties and covenants herein and in the Other.",
          "bbox": [
            444.0,
            2363.0,
            3029.0,
            2414.0
          ],
          "confidence": 0.9940667748451233
        },
        {
          "text": "Agreements constituting good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties",
          "bbox": [
            279.0,
            2463.0,
            3025.0,
            2514.0
          ],
          "confidence": 0.9964366555213928
        },
        {
          "text": "hereby agree as follows:",
          "bbox": [
            279.0,
            2564.0,
            781.0,
            2608.0
          ],
          "confidence": 0.9871907234191895
        },
        {
          "text": "ARTICLE I",
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ],
          "confidence": 0.9906837940216064
        },
        {
          "text": "DEFINITIONS",
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ],
          "confidence": 0.9980525374412537
        },
        {
          "text": "1.1 Definitions. For purposes of this Agreement, the following terms shall have the following meanings, and to the extent",
          "bbox": [
            448.0,
            2854.0,
            2994.0,
            2907.0
          ],
          "confidence": 0.9955382943153381
        },
        {
          "text": "not defined in this section or otherwise in this Agreement, a term shall have the meaning ascribed to it in any of the Other.",
          "bbox": [
            275.0,
            2953.0,
            2800.0,
            3004.0
          ],
          "confidence": 0.99052894115448
        },
        {
          "text": "Agreements:",
          "bbox": [
            281.0,
            3053.0,
            540.0,
            3103.0
          ],
          "confidence": 0.9999290704727173
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1180.0,
            4479.0
          ],
          "confidence": 0.9975276589393616
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "DEVELOPMENT AGREEMENT",
          "page": 0,
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ]
        },
        {
          "text": "ARTICLE I",
          "page": 0,
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ]
        },
        {
          "text": "DEFINITIONS",
          "page": 0,
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ]
        }
      ]
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Anti-Assignment_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Anti-Assignment\" that should be reviewed by a lawyer. Details: Is consent or notice required of a party if the contract is assigned to a third party?",
      "answer_text": "To the extent working with Agents or other Third Parties is permitted under the R&D Work   Plan, should a Party wish to engage an Agent or any other Third Party in connection with the R&D Work Plan or any other work   under this Agreement, such Party must obtain in advance a written agreement by such Agent or other Third Party (i) to assign to   the Party all Inventions conceived, created or generated by the Agent or other Third Party, and (ii) to maintain all Confidential   Information in confidence as set forth in Section 5.2.",
      "page_number": 1,
      "words": [
        {
          "text": "\"Acceptance\"' and \"Accept' have the meaning set forth in Article 3.4 of this Agreement.",
          "bbox": [
            446.0,
            481.0,
            2340.0,
            539.0
          ],
          "confidence": 0.977286696434021
        },
        {
          "text": "\"Acceptance Criteria' has the meaning set forth in the R&D Work Plan.",
          "bbox": [
            450.0,
            682.0,
            2008.0,
            731.0
          ],
          "confidence": 0.9961835145950317
        },
        {
          "text": "\"Acceptance Notification Period' has the meaning set forth in Article 3.3 of this Agreement..",
          "bbox": [
            450.0,
            879.0,
            2438.0,
            928.0
          ],
          "confidence": 0.9805790781974792
        },
        {
          "text": "\"Affiliate\" has the meaning set forth in the Asset Purchase Agreement",
          "bbox": [
            448.0,
            1071.0,
            1950.0,
            1124.0
          ],
          "confidence": 0.9933743476867676
        },
        {
          "text": "\"Agents\" means Third Parties who are acting under the direction or control of a Party.",
          "bbox": [
            448.0,
            1268.0,
            2284.0,
            1321.0
          ],
          "confidence": 0.9984568953514099
        },
        {
          "text": "\"Applicable Laws\" means all applicable federal, state, local and foreign laws, ordinances, rules, regulations, orders,.",
          "bbox": [
            448.0,
            1466.0,
            3025.0,
            1520.0
          ],
          "confidence": 0.9899159073829651
        },
        {
          "text": "writs, injunctions and decrees of any kind.",
          "bbox": [
            283.0,
            1566.0,
            1155.0,
            1614.0
          ],
          "confidence": 0.9892303943634033
        },
        {
          "text": "\"Asset Purchase Agreement\"' has the meaning set forth in the recitals",
          "bbox": [
            448.0,
            1762.0,
            1948.0,
            1811.0
          ],
          "confidence": 0.9865401983261108
        },
        {
          "text": "\"Change of Control'' has the meaning set forth in the Asset Purchase Agreement.",
          "bbox": [
            448.0,
            1955.0,
            2170.0,
            2010.0
          ],
          "confidence": 0.9961836338043213
        },
        {
          "text": "\"Claims\" has the meaning set forth in Article 7.3(a) of this Agreement.",
          "bbox": [
            446.0,
            2147.0,
            1947.0,
            2209.0
          ],
          "confidence": 0.9971343278884888
        },
        {
          "text": "\"Confidential Information\" has the meaning set forth in the Asset Purchase Agreement",
          "bbox": [
            448.0,
            2346.0,
            2335.0,
            2401.0
          ],
          "confidence": 0.999515175819397
        },
        {
          "text": "\"Conformis Background IP\" means any Invention, and all Intellectual Property rights underlying such Invention, that is,.",
          "bbox": [
            446.0,
            2540.0,
            3025.0,
            2602.0
          ],
          "confidence": 0.9841423630714417
        },
        {
          "text": "as of the Effective Date, owned or licensable by Conformis without causing a breach of, or incurring any obligation to, a third.",
          "bbox": [
            279.0,
            2644.0,
            3029.0,
            2699.0
          ],
          "confidence": 0.9918943643569946
        },
        {
          "text": "party, in each case to the extent necessary or reasonably useful to design, develop, manufacture, sell or otherwise exploit the KIB.",
          "bbox": [
            275.0,
            2739.0,
            3027.0,
            2798.0
          ],
          "confidence": 0.9918000102043152
        },
        {
          "text": "Product, and for the avoidance of doubt, excluding the Purchased Assets, Conformis Foreground IP, Stryker Background IP.",
          "bbox": [
            279.0,
            2843.0,
            3023.0,
            2893.0
          ],
          "confidence": 0.9966443181037903
        },
        {
          "text": "Improved Stryker Background IP and Improved Conformis Background IP",
          "bbox": [
            279.0,
            2938.0,
            1874.0,
            2990.0
          ],
          "confidence": 0.9942641854286194
        },
        {
          "text": "2",
          "bbox": [
            1633.0,
            3176.0,
            1669.0,
            3225.0
          ],
          "confidence": 0.9901198148727417
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1178.0,
            4477.0
          ],
          "confidence": 0.9950919151306152
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Anti-Assignment_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Anti-Assignment\" that should be reviewed by a lawyer. Details: Is consent or notice required of a party if the contract is assigned to a third party?",
      "answer_text": "Except as otherwise provided herein, a Party shall not have the right to   assign any of its rights or obligations under this Agreement (whether through a merger, sale of stock, or otherwise) without the   prior written consent of the other Party; except that, either Party shall be permitted, without any need for the other Party's   consent, to assign this Agreement (a) in whole or in part to an Affiliate (provided, however, that once such Person is no longer an   Affiliate of the assigning Party, such former Affiliate shall assign this Agreement back to the assigning Party), provided that the   assigning Party provides the other Party notice of any such assignment provided further that failure to provide such notice of such   assignment shall not render such assignment void; or (b) to a Third Party in connection with sale or transfer of all or substantially all   of the assigning Party's business or assets relating to the subject matter of this Agreement, whether by Change of Control, merger,   sale of assets or otherwise; provided, however, that, with respect to clause (b), (i) any assignment of this Agreement shall be void   and have no effect unless and until the assignee assumes the",
      "page_number": 0,
      "words": [
        {
          "text": "Execution Version",
          "bbox": [
            2601.0,
            294.0,
            3020.0,
            333.0
          ],
          "confidence": 0.9843302369117737
        },
        {
          "text": "Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause.",
          "bbox": [
            350.0,
            354.0,
            2953.0,
            404.0
          ],
          "confidence": 0.9875192642211914
        },
        {
          "text": "competitive harm to the Company, if publicly disclosed. Double asterisks denote omissions.",
          "bbox": [
            696.0,
            424.0,
            2610.0,
            470.0
          ],
          "confidence": 0.9918519854545593
        },
        {
          "text": "DEVELOPMENT AGREEMENT",
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ],
          "confidence": 0.9884270429611206
        },
        {
          "text": "This Development Agreement (\"this Agreement'') is entered into and effective as of September 30, 2019 (\"Effective.",
          "bbox": [
            448.0,
            795.0,
            3025.0,
            844.0
          ],
          "confidence": 0.9763412475585938
        },
        {
          "text": "Date') by and between Howmedica Osteonics Corp., a New Jersey corporation, also known as Stryker Orthopaedics",
          "bbox": [
            281.0,
            895.0,
            3023.0,
            939.0
          ],
          "confidence": 0.9990173578262329
        },
        {
          "text": "(\"Stryker'), and Conformis, Inc., a Delaware corporation having a principal place of business located at 600 Technology Park",
          "bbox": [
            279.0,
            987.0,
            3027.0,
            1043.0
          ],
          "confidence": 0.9912907481193542
        },
        {
          "text": "Drive, Billerica, MA O1821 (Conformis'). Stryker and Conformis are collectively referred to herein as the \"Parties' and",
          "bbox": [
            281.0,
            1091.0,
            3029.0,
            1135.0
          ],
          "confidence": 0.9795650243759155
        },
        {
          "text": "individually as a \"Party.\"",
          "bbox": [
            277.0,
            1186.0,
            814.0,
            1235.0
          ],
          "confidence": 0.9837418794631958
        },
        {
          "text": "WHEREAS, the Parties are concurrently entering into an asset purchase agreement for Stryker's purchase of certain",
          "bbox": [
            444.0,
            1281.0,
            3029.0,
            1338.0
          ],
          "confidence": 0.9927125573158264
        },
        {
          "text": "Conformis assets concerning Patient-Specific Instrumentation (\"Asset Purchase Agreement\"), and a License Agreement, a",
          "bbox": [
            275.0,
            1378.0,
            3029.0,
            1436.0
          ],
          "confidence": 0.9887849688529968
        },
        {
          "text": "Distribution Agreement and a Quality Agreement, as defined in and attached to the Asset Purchase Agreement (collectively, such",
          "bbox": [
            279.0,
            1482.0,
            3025.0,
            1531.0
          ],
          "confidence": 0.9973982572555542
        },
        {
          "text": "agreements are referred to herein as the \"Other Agreements')",
          "bbox": [
            277.0,
            1577.0,
            1640.0,
            1632.0
          ],
          "confidence": 0.9893602132797241
        },
        {
          "text": "WHEREAS, Stryker and its Affiliates have developed and commercialized an Off-The-Shelf Knee Implant offered under.",
          "bbox": [
            448.0,
            1678.0,
            3029.0,
            1727.0
          ],
          "confidence": 0.9939711093902588
        },
        {
          "text": "the trademark Triathlon.",
          "bbox": [
            281.0,
            1778.0,
            776.0,
            1820.0
          ],
          "confidence": 0.9796398282051086
        },
        {
          "text": "WHEREAS, Conformis currently offers Patient-Specific Instrumentation for use with its Patient-Specific Implants,",
          "bbox": [
            446.0,
            1869.0,
            3025.0,
            1926.0
          ],
          "confidence": 0.9971562623977661
        },
        {
          "text": "including partial and total knee and hip arthroplasty.",
          "bbox": [
            281.0,
            1970.0,
            1352.0,
            2025.0
          ],
          "confidence": 0.9856063723564148
        },
        {
          "text": "WHEREAS, Stryker desires that Conformis develop, in accordance with the R&D Program, certain Patient-Specific.",
          "bbox": [
            450.0,
            2072.0,
            3021.0,
            2116.0
          ],
          "confidence": 0.9856840372085571
        },
        {
          "text": "Instrumentation to be used with the current version of the Off-The-Shelf Knee Implant offered under the trademark Triathlon (such",
          "bbox": [
            281.0,
            2171.0,
            3023.0,
            2215.0
          ],
          "confidence": 0.9951096177101135
        },
        {
          "text": "Patient-Specific Instrumentation as so developed, the \"KIB Product')",
          "bbox": [
            283.0,
            2270.0,
            1784.0,
            2313.0
          ],
          "confidence": 0.9868863224983215
        },
        {
          "text": "THEREFORE, in consideration of the mutual representations, warranties and covenants herein and in the Other.",
          "bbox": [
            444.0,
            2363.0,
            3029.0,
            2414.0
          ],
          "confidence": 0.9940667748451233
        },
        {
          "text": "Agreements constituting good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties",
          "bbox": [
            279.0,
            2463.0,
            3025.0,
            2514.0
          ],
          "confidence": 0.9964366555213928
        },
        {
          "text": "hereby agree as follows:",
          "bbox": [
            279.0,
            2564.0,
            781.0,
            2608.0
          ],
          "confidence": 0.9871907234191895
        },
        {
          "text": "ARTICLE I",
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ],
          "confidence": 0.9906837940216064
        },
        {
          "text": "DEFINITIONS",
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ],
          "confidence": 0.9980525374412537
        },
        {
          "text": "1.1 Definitions. For purposes of this Agreement, the following terms shall have the following meanings, and to the extent",
          "bbox": [
            448.0,
            2854.0,
            2994.0,
            2907.0
          ],
          "confidence": 0.9955382943153381
        },
        {
          "text": "not defined in this section or otherwise in this Agreement, a term shall have the meaning ascribed to it in any of the Other.",
          "bbox": [
            275.0,
            2953.0,
            2800.0,
            3004.0
          ],
          "confidence": 0.99052894115448
        },
        {
          "text": "Agreements:",
          "bbox": [
            281.0,
            3053.0,
            540.0,
            3103.0
          ],
          "confidence": 0.9999290704727173
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1180.0,
            4479.0
          ],
          "confidence": 0.9975276589393616
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "DEVELOPMENT AGREEMENT",
          "page": 0,
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ]
        },
        {
          "text": "ARTICLE I",
          "page": 0,
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ]
        },
        {
          "text": "DEFINITIONS",
          "page": 0,
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ]
        }
      ]
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Anti-Assignment_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Anti-Assignment\" that should be reviewed by a lawyer. Details: Is consent or notice required of a party if the contract is assigned to a third party?",
      "answer_text": "Except as otherwise provided herein, a Party shall not have the right to   assign any of its rights or obligations under this Agreement (whether through a merger, sale of stock, or otherwise) without the   prior written consent of the other Party; except that, either Party shall be permitted, without any need for the other Party's   consent, to assign this Agreement (a) in whole or in part to an Affiliate (provided, however, that once such Person is no longer an   Affiliate of the assigning Party, such former Affiliate shall assign this Agreement back to the assigning Party), provided that the   assigning Party provides the other Party notice of any such assignment provided further that failure to provide such notice of such   assignment shall not render such assignment void; or (b) to a Third Party in connection with sale or transfer of all or substantially all   of the assigning Party's business or assets relating to the subject matter of this Agreement, whether by Change of Control, merger,   sale of assets or otherwise; provided, however, that, with respect to clause (b), (i) any assignment of this Agreement shall be void   and have no effect unless and until the assignee assumes the",
      "page_number": 1,
      "words": [
        {
          "text": "\"Acceptance\"' and \"Accept' have the meaning set forth in Article 3.4 of this Agreement.",
          "bbox": [
            446.0,
            481.0,
            2340.0,
            539.0
          ],
          "confidence": 0.977286696434021
        },
        {
          "text": "\"Acceptance Criteria' has the meaning set forth in the R&D Work Plan.",
          "bbox": [
            450.0,
            682.0,
            2008.0,
            731.0
          ],
          "confidence": 0.9961835145950317
        },
        {
          "text": "\"Acceptance Notification Period' has the meaning set forth in Article 3.3 of this Agreement..",
          "bbox": [
            450.0,
            879.0,
            2438.0,
            928.0
          ],
          "confidence": 0.9805790781974792
        },
        {
          "text": "\"Affiliate\" has the meaning set forth in the Asset Purchase Agreement",
          "bbox": [
            448.0,
            1071.0,
            1950.0,
            1124.0
          ],
          "confidence": 0.9933743476867676
        },
        {
          "text": "\"Agents\" means Third Parties who are acting under the direction or control of a Party.",
          "bbox": [
            448.0,
            1268.0,
            2284.0,
            1321.0
          ],
          "confidence": 0.9984568953514099
        },
        {
          "text": "\"Applicable Laws\" means all applicable federal, state, local and foreign laws, ordinances, rules, regulations, orders,.",
          "bbox": [
            448.0,
            1466.0,
            3025.0,
            1520.0
          ],
          "confidence": 0.9899159073829651
        },
        {
          "text": "writs, injunctions and decrees of any kind.",
          "bbox": [
            283.0,
            1566.0,
            1155.0,
            1614.0
          ],
          "confidence": 0.9892303943634033
        },
        {
          "text": "\"Asset Purchase Agreement\"' has the meaning set forth in the recitals",
          "bbox": [
            448.0,
            1762.0,
            1948.0,
            1811.0
          ],
          "confidence": 0.9865401983261108
        },
        {
          "text": "\"Change of Control'' has the meaning set forth in the Asset Purchase Agreement.",
          "bbox": [
            448.0,
            1955.0,
            2170.0,
            2010.0
          ],
          "confidence": 0.9961836338043213
        },
        {
          "text": "\"Claims\" has the meaning set forth in Article 7.3(a) of this Agreement.",
          "bbox": [
            446.0,
            2147.0,
            1947.0,
            2209.0
          ],
          "confidence": 0.9971343278884888
        },
        {
          "text": "\"Confidential Information\" has the meaning set forth in the Asset Purchase Agreement",
          "bbox": [
            448.0,
            2346.0,
            2335.0,
            2401.0
          ],
          "confidence": 0.999515175819397
        },
        {
          "text": "\"Conformis Background IP\" means any Invention, and all Intellectual Property rights underlying such Invention, that is,.",
          "bbox": [
            446.0,
            2540.0,
            3025.0,
            2602.0
          ],
          "confidence": 0.9841423630714417
        },
        {
          "text": "as of the Effective Date, owned or licensable by Conformis without causing a breach of, or incurring any obligation to, a third.",
          "bbox": [
            279.0,
            2644.0,
            3029.0,
            2699.0
          ],
          "confidence": 0.9918943643569946
        },
        {
          "text": "party, in each case to the extent necessary or reasonably useful to design, develop, manufacture, sell or otherwise exploit the KIB.",
          "bbox": [
            275.0,
            2739.0,
            3027.0,
            2798.0
          ],
          "confidence": 0.9918000102043152
        },
        {
          "text": "Product, and for the avoidance of doubt, excluding the Purchased Assets, Conformis Foreground IP, Stryker Background IP.",
          "bbox": [
            279.0,
            2843.0,
            3023.0,
            2893.0
          ],
          "confidence": 0.9966443181037903
        },
        {
          "text": "Improved Stryker Background IP and Improved Conformis Background IP",
          "bbox": [
            279.0,
            2938.0,
            1874.0,
            2990.0
          ],
          "confidence": 0.9942641854286194
        },
        {
          "text": "2",
          "bbox": [
            1633.0,
            3176.0,
            1669.0,
            3225.0
          ],
          "confidence": 0.9901198148727417
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1178.0,
            4477.0
          ],
          "confidence": 0.9950919151306152
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Ip Ownership Assignment_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Ip Ownership Assignment\" that should be reviewed by a lawyer. Details: Does intellectual property created  by one party become the property of the counterparty, either per the terms of the contract or upon the occurrence of certain events?",
      "answer_text": "Conformis by operation of law or by assignment by its employees or consultants; and to facilitate such assignment to Stryker,   Conformis agrees (i) to regularly ensure that its employees and consultants timely make any appropriate assignments to it of that   which constitutes Improved Stryker Background IP, and (ii) at Stryker's reasonable request, to execute and have its employees   and consultants execute, as necessary, all assignments and any other documentation necessary to perfect title in Stryker of such   Improved Stryker Background IP.",
      "page_number": 0,
      "words": [
        {
          "text": "Execution Version",
          "bbox": [
            2601.0,
            294.0,
            3020.0,
            333.0
          ],
          "confidence": 0.9843302369117737
        },
        {
          "text": "Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause.",
          "bbox": [
            350.0,
            354.0,
            2953.0,
            404.0
          ],
          "confidence": 0.9875192642211914
        },
        {
          "text": "competitive harm to the Company, if publicly disclosed. Double asterisks denote omissions.",
          "bbox": [
            696.0,
            424.0,
            2610.0,
            470.0
          ],
          "confidence": 0.9918519854545593
        },
        {
          "text": "DEVELOPMENT AGREEMENT",
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ],
          "confidence": 0.9884270429611206
        },
        {
          "text": "This Development Agreement (\"this Agreement'') is entered into and effective as of September 30, 2019 (\"Effective.",
          "bbox": [
            448.0,
            795.0,
            3025.0,
            844.0
          ],
          "confidence": 0.9763412475585938
        },
        {
          "text": "Date') by and between Howmedica Osteonics Corp., a New Jersey corporation, also known as Stryker Orthopaedics",
          "bbox": [
            281.0,
            895.0,
            3023.0,
            939.0
          ],
          "confidence": 0.9990173578262329
        },
        {
          "text": "(\"Stryker'), and Conformis, Inc., a Delaware corporation having a principal place of business located at 600 Technology Park",
          "bbox": [
            279.0,
            987.0,
            3027.0,
            1043.0
          ],
          "confidence": 0.9912907481193542
        },
        {
          "text": "Drive, Billerica, MA O1821 (Conformis'). Stryker and Conformis are collectively referred to herein as the \"Parties' and",
          "bbox": [
            281.0,
            1091.0,
            3029.0,
            1135.0
          ],
          "confidence": 0.9795650243759155
        },
        {
          "text": "individually as a \"Party.\"",
          "bbox": [
            277.0,
            1186.0,
            814.0,
            1235.0
          ],
          "confidence": 0.9837418794631958
        },
        {
          "text": "WHEREAS, the Parties are concurrently entering into an asset purchase agreement for Stryker's purchase of certain",
          "bbox": [
            444.0,
            1281.0,
            3029.0,
            1338.0
          ],
          "confidence": 0.9927125573158264
        },
        {
          "text": "Conformis assets concerning Patient-Specific Instrumentation (\"Asset Purchase Agreement\"), and a License Agreement, a",
          "bbox": [
            275.0,
            1378.0,
            3029.0,
            1436.0
          ],
          "confidence": 0.9887849688529968
        },
        {
          "text": "Distribution Agreement and a Quality Agreement, as defined in and attached to the Asset Purchase Agreement (collectively, such",
          "bbox": [
            279.0,
            1482.0,
            3025.0,
            1531.0
          ],
          "confidence": 0.9973982572555542
        },
        {
          "text": "agreements are referred to herein as the \"Other Agreements')",
          "bbox": [
            277.0,
            1577.0,
            1640.0,
            1632.0
          ],
          "confidence": 0.9893602132797241
        },
        {
          "text": "WHEREAS, Stryker and its Affiliates have developed and commercialized an Off-The-Shelf Knee Implant offered under.",
          "bbox": [
            448.0,
            1678.0,
            3029.0,
            1727.0
          ],
          "confidence": 0.9939711093902588
        },
        {
          "text": "the trademark Triathlon.",
          "bbox": [
            281.0,
            1778.0,
            776.0,
            1820.0
          ],
          "confidence": 0.9796398282051086
        },
        {
          "text": "WHEREAS, Conformis currently offers Patient-Specific Instrumentation for use with its Patient-Specific Implants,",
          "bbox": [
            446.0,
            1869.0,
            3025.0,
            1926.0
          ],
          "confidence": 0.9971562623977661
        },
        {
          "text": "including partial and total knee and hip arthroplasty.",
          "bbox": [
            281.0,
            1970.0,
            1352.0,
            2025.0
          ],
          "confidence": 0.9856063723564148
        },
        {
          "text": "WHEREAS, Stryker desires that Conformis develop, in accordance with the R&D Program, certain Patient-Specific.",
          "bbox": [
            450.0,
            2072.0,
            3021.0,
            2116.0
          ],
          "confidence": 0.9856840372085571
        },
        {
          "text": "Instrumentation to be used with the current version of the Off-The-Shelf Knee Implant offered under the trademark Triathlon (such",
          "bbox": [
            281.0,
            2171.0,
            3023.0,
            2215.0
          ],
          "confidence": 0.9951096177101135
        },
        {
          "text": "Patient-Specific Instrumentation as so developed, the \"KIB Product')",
          "bbox": [
            283.0,
            2270.0,
            1784.0,
            2313.0
          ],
          "confidence": 0.9868863224983215
        },
        {
          "text": "THEREFORE, in consideration of the mutual representations, warranties and covenants herein and in the Other.",
          "bbox": [
            444.0,
            2363.0,
            3029.0,
            2414.0
          ],
          "confidence": 0.9940667748451233
        },
        {
          "text": "Agreements constituting good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties",
          "bbox": [
            279.0,
            2463.0,
            3025.0,
            2514.0
          ],
          "confidence": 0.9964366555213928
        },
        {
          "text": "hereby agree as follows:",
          "bbox": [
            279.0,
            2564.0,
            781.0,
            2608.0
          ],
          "confidence": 0.9871907234191895
        },
        {
          "text": "ARTICLE I",
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ],
          "confidence": 0.9906837940216064
        },
        {
          "text": "DEFINITIONS",
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ],
          "confidence": 0.9980525374412537
        },
        {
          "text": "1.1 Definitions. For purposes of this Agreement, the following terms shall have the following meanings, and to the extent",
          "bbox": [
            448.0,
            2854.0,
            2994.0,
            2907.0
          ],
          "confidence": 0.9955382943153381
        },
        {
          "text": "not defined in this section or otherwise in this Agreement, a term shall have the meaning ascribed to it in any of the Other.",
          "bbox": [
            275.0,
            2953.0,
            2800.0,
            3004.0
          ],
          "confidence": 0.99052894115448
        },
        {
          "text": "Agreements:",
          "bbox": [
            281.0,
            3053.0,
            540.0,
            3103.0
          ],
          "confidence": 0.9999290704727173
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1180.0,
            4479.0
          ],
          "confidence": 0.9975276589393616
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "DEVELOPMENT AGREEMENT",
          "page": 0,
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ]
        },
        {
          "text": "ARTICLE I",
          "page": 0,
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ]
        },
        {
          "text": "DEFINITIONS",
          "page": 0,
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ]
        }
      ]
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Ip Ownership Assignment_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Ip Ownership Assignment\" that should be reviewed by a lawyer. Details: Does intellectual property created  by one party become the property of the counterparty, either per the terms of the contract or upon the occurrence of certain events?",
      "answer_text": "Conformis by operation of law or by assignment by its employees or consultants; and to facilitate such assignment to Stryker,   Conformis agrees (i) to regularly ensure that its employees and consultants timely make any appropriate assignments to it of that   which constitutes Improved Stryker Background IP, and (ii) at Stryker's reasonable request, to execute and have its employees   and consultants execute, as necessary, all assignments and any other documentation necessary to perfect title in Stryker of such   Improved Stryker Background IP.",
      "page_number": 1,
      "words": [
        {
          "text": "\"Acceptance\"' and \"Accept' have the meaning set forth in Article 3.4 of this Agreement.",
          "bbox": [
            446.0,
            481.0,
            2340.0,
            539.0
          ],
          "confidence": 0.977286696434021
        },
        {
          "text": "\"Acceptance Criteria' has the meaning set forth in the R&D Work Plan.",
          "bbox": [
            450.0,
            682.0,
            2008.0,
            731.0
          ],
          "confidence": 0.9961835145950317
        },
        {
          "text": "\"Acceptance Notification Period' has the meaning set forth in Article 3.3 of this Agreement..",
          "bbox": [
            450.0,
            879.0,
            2438.0,
            928.0
          ],
          "confidence": 0.9805790781974792
        },
        {
          "text": "\"Affiliate\" has the meaning set forth in the Asset Purchase Agreement",
          "bbox": [
            448.0,
            1071.0,
            1950.0,
            1124.0
          ],
          "confidence": 0.9933743476867676
        },
        {
          "text": "\"Agents\" means Third Parties who are acting under the direction or control of a Party.",
          "bbox": [
            448.0,
            1268.0,
            2284.0,
            1321.0
          ],
          "confidence": 0.9984568953514099
        },
        {
          "text": "\"Applicable Laws\" means all applicable federal, state, local and foreign laws, ordinances, rules, regulations, orders,.",
          "bbox": [
            448.0,
            1466.0,
            3025.0,
            1520.0
          ],
          "confidence": 0.9899159073829651
        },
        {
          "text": "writs, injunctions and decrees of any kind.",
          "bbox": [
            283.0,
            1566.0,
            1155.0,
            1614.0
          ],
          "confidence": 0.9892303943634033
        },
        {
          "text": "\"Asset Purchase Agreement\"' has the meaning set forth in the recitals",
          "bbox": [
            448.0,
            1762.0,
            1948.0,
            1811.0
          ],
          "confidence": 0.9865401983261108
        },
        {
          "text": "\"Change of Control'' has the meaning set forth in the Asset Purchase Agreement.",
          "bbox": [
            448.0,
            1955.0,
            2170.0,
            2010.0
          ],
          "confidence": 0.9961836338043213
        },
        {
          "text": "\"Claims\" has the meaning set forth in Article 7.3(a) of this Agreement.",
          "bbox": [
            446.0,
            2147.0,
            1947.0,
            2209.0
          ],
          "confidence": 0.9971343278884888
        },
        {
          "text": "\"Confidential Information\" has the meaning set forth in the Asset Purchase Agreement",
          "bbox": [
            448.0,
            2346.0,
            2335.0,
            2401.0
          ],
          "confidence": 0.999515175819397
        },
        {
          "text": "\"Conformis Background IP\" means any Invention, and all Intellectual Property rights underlying such Invention, that is,.",
          "bbox": [
            446.0,
            2540.0,
            3025.0,
            2602.0
          ],
          "confidence": 0.9841423630714417
        },
        {
          "text": "as of the Effective Date, owned or licensable by Conformis without causing a breach of, or incurring any obligation to, a third.",
          "bbox": [
            279.0,
            2644.0,
            3029.0,
            2699.0
          ],
          "confidence": 0.9918943643569946
        },
        {
          "text": "party, in each case to the extent necessary or reasonably useful to design, develop, manufacture, sell or otherwise exploit the KIB.",
          "bbox": [
            275.0,
            2739.0,
            3027.0,
            2798.0
          ],
          "confidence": 0.9918000102043152
        },
        {
          "text": "Product, and for the avoidance of doubt, excluding the Purchased Assets, Conformis Foreground IP, Stryker Background IP.",
          "bbox": [
            279.0,
            2843.0,
            3023.0,
            2893.0
          ],
          "confidence": 0.9966443181037903
        },
        {
          "text": "Improved Stryker Background IP and Improved Conformis Background IP",
          "bbox": [
            279.0,
            2938.0,
            1874.0,
            2990.0
          ],
          "confidence": 0.9942641854286194
        },
        {
          "text": "2",
          "bbox": [
            1633.0,
            3176.0,
            1669.0,
            3225.0
          ],
          "confidence": 0.9901198148727417
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1178.0,
            4477.0
          ],
          "confidence": 0.9950919151306152
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Ip Ownership Assignment_0",
      "question": "Highlight the parts (if any) of this contract related to \"Ip Ownership Assignment\" that should be reviewed by a lawyer. Details: Does intellectual property created  by one party become the property of the counterparty, either per the terms of the contract or upon the occurrence of certain events?",
      "answer_text": "Conformis agrees   to assign and hereby assigns to Stryker all right, title and interest in and to all Improved Stryker Background IP in which ownership   in same has vested in",
      "page_number": 0,
      "words": [
        {
          "text": "Execution Version",
          "bbox": [
            2601.0,
            294.0,
            3020.0,
            333.0
          ],
          "confidence": 0.9843302369117737
        },
        {
          "text": "Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause.",
          "bbox": [
            350.0,
            354.0,
            2953.0,
            404.0
          ],
          "confidence": 0.9875192642211914
        },
        {
          "text": "competitive harm to the Company, if publicly disclosed. Double asterisks denote omissions.",
          "bbox": [
            696.0,
            424.0,
            2610.0,
            470.0
          ],
          "confidence": 0.9918519854545593
        },
        {
          "text": "DEVELOPMENT AGREEMENT",
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ],
          "confidence": 0.9884270429611206
        },
        {
          "text": "This Development Agreement (\"this Agreement'') is entered into and effective as of September 30, 2019 (\"Effective.",
          "bbox": [
            448.0,
            795.0,
            3025.0,
            844.0
          ],
          "confidence": 0.9763412475585938
        },
        {
          "text": "Date') by and between Howmedica Osteonics Corp., a New Jersey corporation, also known as Stryker Orthopaedics",
          "bbox": [
            281.0,
            895.0,
            3023.0,
            939.0
          ],
          "confidence": 0.9990173578262329
        },
        {
          "text": "(\"Stryker'), and Conformis, Inc., a Delaware corporation having a principal place of business located at 600 Technology Park",
          "bbox": [
            279.0,
            987.0,
            3027.0,
            1043.0
          ],
          "confidence": 0.9912907481193542
        },
        {
          "text": "Drive, Billerica, MA O1821 (Conformis'). Stryker and Conformis are collectively referred to herein as the \"Parties' and",
          "bbox": [
            281.0,
            1091.0,
            3029.0,
            1135.0
          ],
          "confidence": 0.9795650243759155
        },
        {
          "text": "individually as a \"Party.\"",
          "bbox": [
            277.0,
            1186.0,
            814.0,
            1235.0
          ],
          "confidence": 0.9837418794631958
        },
        {
          "text": "WHEREAS, the Parties are concurrently entering into an asset purchase agreement for Stryker's purchase of certain",
          "bbox": [
            444.0,
            1281.0,
            3029.0,
            1338.0
          ],
          "confidence": 0.9927125573158264
        },
        {
          "text": "Conformis assets concerning Patient-Specific Instrumentation (\"Asset Purchase Agreement\"), and a License Agreement, a",
          "bbox": [
            275.0,
            1378.0,
            3029.0,
            1436.0
          ],
          "confidence": 0.9887849688529968
        },
        {
          "text": "Distribution Agreement and a Quality Agreement, as defined in and attached to the Asset Purchase Agreement (collectively, such",
          "bbox": [
            279.0,
            1482.0,
            3025.0,
            1531.0
          ],
          "confidence": 0.9973982572555542
        },
        {
          "text": "agreements are referred to herein as the \"Other Agreements')",
          "bbox": [
            277.0,
            1577.0,
            1640.0,
            1632.0
          ],
          "confidence": 0.9893602132797241
        },
        {
          "text": "WHEREAS, Stryker and its Affiliates have developed and commercialized an Off-The-Shelf Knee Implant offered under.",
          "bbox": [
            448.0,
            1678.0,
            3029.0,
            1727.0
          ],
          "confidence": 0.9939711093902588
        },
        {
          "text": "the trademark Triathlon.",
          "bbox": [
            281.0,
            1778.0,
            776.0,
            1820.0
          ],
          "confidence": 0.9796398282051086
        },
        {
          "text": "WHEREAS, Conformis currently offers Patient-Specific Instrumentation for use with its Patient-Specific Implants,",
          "bbox": [
            446.0,
            1869.0,
            3025.0,
            1926.0
          ],
          "confidence": 0.9971562623977661
        },
        {
          "text": "including partial and total knee and hip arthroplasty.",
          "bbox": [
            281.0,
            1970.0,
            1352.0,
            2025.0
          ],
          "confidence": 0.9856063723564148
        },
        {
          "text": "WHEREAS, Stryker desires that Conformis develop, in accordance with the R&D Program, certain Patient-Specific.",
          "bbox": [
            450.0,
            2072.0,
            3021.0,
            2116.0
          ],
          "confidence": 0.9856840372085571
        },
        {
          "text": "Instrumentation to be used with the current version of the Off-The-Shelf Knee Implant offered under the trademark Triathlon (such",
          "bbox": [
            281.0,
            2171.0,
            3023.0,
            2215.0
          ],
          "confidence": 0.9951096177101135
        },
        {
          "text": "Patient-Specific Instrumentation as so developed, the \"KIB Product')",
          "bbox": [
            283.0,
            2270.0,
            1784.0,
            2313.0
          ],
          "confidence": 0.9868863224983215
        },
        {
          "text": "THEREFORE, in consideration of the mutual representations, warranties and covenants herein and in the Other.",
          "bbox": [
            444.0,
            2363.0,
            3029.0,
            2414.0
          ],
          "confidence": 0.9940667748451233
        },
        {
          "text": "Agreements constituting good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties",
          "bbox": [
            279.0,
            2463.0,
            3025.0,
            2514.0
          ],
          "confidence": 0.9964366555213928
        },
        {
          "text": "hereby agree as follows:",
          "bbox": [
            279.0,
            2564.0,
            781.0,
            2608.0
          ],
          "confidence": 0.9871907234191895
        },
        {
          "text": "ARTICLE I",
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ],
          "confidence": 0.9906837940216064
        },
        {
          "text": "DEFINITIONS",
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ],
          "confidence": 0.9980525374412537
        },
        {
          "text": "1.1 Definitions. For purposes of this Agreement, the following terms shall have the following meanings, and to the extent",
          "bbox": [
            448.0,
            2854.0,
            2994.0,
            2907.0
          ],
          "confidence": 0.9955382943153381
        },
        {
          "text": "not defined in this section or otherwise in this Agreement, a term shall have the meaning ascribed to it in any of the Other.",
          "bbox": [
            275.0,
            2953.0,
            2800.0,
            3004.0
          ],
          "confidence": 0.99052894115448
        },
        {
          "text": "Agreements:",
          "bbox": [
            281.0,
            3053.0,
            540.0,
            3103.0
          ],
          "confidence": 0.9999290704727173
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1180.0,
            4479.0
          ],
          "confidence": 0.9975276589393616
        }
      ],
      "nearby_headers": [
        {
          "text": "DEVELOPMENT AGREEMENT",
          "page": 0,
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ]
        },
        {
          "text": "ARTICLE I",
          "page": 0,
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ]
        },
        {
          "text": "DEFINITIONS",
          "page": 0,
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ]
        }
      ]
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Ip Ownership Assignment_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Ip Ownership Assignment\" that should be reviewed by a lawyer. Details: Does intellectual property created  by one party become the property of the counterparty, either per the terms of the contract or upon the occurrence of certain events?",
      "answer_text": "Each Party to whom ownership is to vest in Joint IP by operation of law or by assignment by its employees or Agents agrees   to assign and hereby assigns to the other Party an undivided one-half right, title and interest in and to all Joint IP; and to facilitate   such assignment, the Party possessing such ownership agrees (i) to regularly ensure that its employees and consultants timely make   any appropriate assignments to it; and (ii) at the other Party's reasonable request, to execute and have its employees and   consultants execute, as necessary, all assignments and any other documentation to perfect the undivided one-half right, title and   interest in and to the other Party of such Joint IP.",
      "page_number": 0,
      "words": [
        {
          "text": "Execution Version",
          "bbox": [
            2601.0,
            294.0,
            3020.0,
            333.0
          ],
          "confidence": 0.9843302369117737
        },
        {
          "text": "Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause.",
          "bbox": [
            350.0,
            354.0,
            2953.0,
            404.0
          ],
          "confidence": 0.9875192642211914
        },
        {
          "text": "competitive harm to the Company, if publicly disclosed. Double asterisks denote omissions.",
          "bbox": [
            696.0,
            424.0,
            2610.0,
            470.0
          ],
          "confidence": 0.9918519854545593
        },
        {
          "text": "DEVELOPMENT AGREEMENT",
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ],
          "confidence": 0.9884270429611206
        },
        {
          "text": "This Development Agreement (\"this Agreement'') is entered into and effective as of September 30, 2019 (\"Effective.",
          "bbox": [
            448.0,
            795.0,
            3025.0,
            844.0
          ],
          "confidence": 0.9763412475585938
        },
        {
          "text": "Date') by and between Howmedica Osteonics Corp., a New Jersey corporation, also known as Stryker Orthopaedics",
          "bbox": [
            281.0,
            895.0,
            3023.0,
            939.0
          ],
          "confidence": 0.9990173578262329
        },
        {
          "text": "(\"Stryker'), and Conformis, Inc., a Delaware corporation having a principal place of business located at 600 Technology Park",
          "bbox": [
            279.0,
            987.0,
            3027.0,
            1043.0
          ],
          "confidence": 0.9912907481193542
        },
        {
          "text": "Drive, Billerica, MA O1821 (Conformis'). Stryker and Conformis are collectively referred to herein as the \"Parties' and",
          "bbox": [
            281.0,
            1091.0,
            3029.0,
            1135.0
          ],
          "confidence": 0.9795650243759155
        },
        {
          "text": "individually as a \"Party.\"",
          "bbox": [
            277.0,
            1186.0,
            814.0,
            1235.0
          ],
          "confidence": 0.9837418794631958
        },
        {
          "text": "WHEREAS, the Parties are concurrently entering into an asset purchase agreement for Stryker's purchase of certain",
          "bbox": [
            444.0,
            1281.0,
            3029.0,
            1338.0
          ],
          "confidence": 0.9927125573158264
        },
        {
          "text": "Conformis assets concerning Patient-Specific Instrumentation (\"Asset Purchase Agreement\"), and a License Agreement, a",
          "bbox": [
            275.0,
            1378.0,
            3029.0,
            1436.0
          ],
          "confidence": 0.9887849688529968
        },
        {
          "text": "Distribution Agreement and a Quality Agreement, as defined in and attached to the Asset Purchase Agreement (collectively, such",
          "bbox": [
            279.0,
            1482.0,
            3025.0,
            1531.0
          ],
          "confidence": 0.9973982572555542
        },
        {
          "text": "agreements are referred to herein as the \"Other Agreements')",
          "bbox": [
            277.0,
            1577.0,
            1640.0,
            1632.0
          ],
          "confidence": 0.9893602132797241
        },
        {
          "text": "WHEREAS, Stryker and its Affiliates have developed and commercialized an Off-The-Shelf Knee Implant offered under.",
          "bbox": [
            448.0,
            1678.0,
            3029.0,
            1727.0
          ],
          "confidence": 0.9939711093902588
        },
        {
          "text": "the trademark Triathlon.",
          "bbox": [
            281.0,
            1778.0,
            776.0,
            1820.0
          ],
          "confidence": 0.9796398282051086
        },
        {
          "text": "WHEREAS, Conformis currently offers Patient-Specific Instrumentation for use with its Patient-Specific Implants,",
          "bbox": [
            446.0,
            1869.0,
            3025.0,
            1926.0
          ],
          "confidence": 0.9971562623977661
        },
        {
          "text": "including partial and total knee and hip arthroplasty.",
          "bbox": [
            281.0,
            1970.0,
            1352.0,
            2025.0
          ],
          "confidence": 0.9856063723564148
        },
        {
          "text": "WHEREAS, Stryker desires that Conformis develop, in accordance with the R&D Program, certain Patient-Specific.",
          "bbox": [
            450.0,
            2072.0,
            3021.0,
            2116.0
          ],
          "confidence": 0.9856840372085571
        },
        {
          "text": "Instrumentation to be used with the current version of the Off-The-Shelf Knee Implant offered under the trademark Triathlon (such",
          "bbox": [
            281.0,
            2171.0,
            3023.0,
            2215.0
          ],
          "confidence": 0.9951096177101135
        },
        {
          "text": "Patient-Specific Instrumentation as so developed, the \"KIB Product')",
          "bbox": [
            283.0,
            2270.0,
            1784.0,
            2313.0
          ],
          "confidence": 0.9868863224983215
        },
        {
          "text": "THEREFORE, in consideration of the mutual representations, warranties and covenants herein and in the Other.",
          "bbox": [
            444.0,
            2363.0,
            3029.0,
            2414.0
          ],
          "confidence": 0.9940667748451233
        },
        {
          "text": "Agreements constituting good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties",
          "bbox": [
            279.0,
            2463.0,
            3025.0,
            2514.0
          ],
          "confidence": 0.9964366555213928
        },
        {
          "text": "hereby agree as follows:",
          "bbox": [
            279.0,
            2564.0,
            781.0,
            2608.0
          ],
          "confidence": 0.9871907234191895
        },
        {
          "text": "ARTICLE I",
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ],
          "confidence": 0.9906837940216064
        },
        {
          "text": "DEFINITIONS",
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ],
          "confidence": 0.9980525374412537
        },
        {
          "text": "1.1 Definitions. For purposes of this Agreement, the following terms shall have the following meanings, and to the extent",
          "bbox": [
            448.0,
            2854.0,
            2994.0,
            2907.0
          ],
          "confidence": 0.9955382943153381
        },
        {
          "text": "not defined in this section or otherwise in this Agreement, a term shall have the meaning ascribed to it in any of the Other.",
          "bbox": [
            275.0,
            2953.0,
            2800.0,
            3004.0
          ],
          "confidence": 0.99052894115448
        },
        {
          "text": "Agreements:",
          "bbox": [
            281.0,
            3053.0,
            540.0,
            3103.0
          ],
          "confidence": 0.9999290704727173
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1180.0,
            4479.0
          ],
          "confidence": 0.9975276589393616
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "DEVELOPMENT AGREEMENT",
          "page": 0,
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ]
        },
        {
          "text": "ARTICLE I",
          "page": 0,
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ]
        },
        {
          "text": "DEFINITIONS",
          "page": 0,
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ]
        }
      ]
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Ip Ownership Assignment_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Ip Ownership Assignment\" that should be reviewed by a lawyer. Details: Does intellectual property created  by one party become the property of the counterparty, either per the terms of the contract or upon the occurrence of certain events?",
      "answer_text": "Each Party to whom ownership is to vest in Joint IP by operation of law or by assignment by its employees or Agents agrees   to assign and hereby assigns to the other Party an undivided one-half right, title and interest in and to all Joint IP; and to facilitate   such assignment, the Party possessing such ownership agrees (i) to regularly ensure that its employees and consultants timely make   any appropriate assignments to it; and (ii) at the other Party's reasonable request, to execute and have its employees and   consultants execute, as necessary, all assignments and any other documentation to perfect the undivided one-half right, title and   interest in and to the other Party of such Joint IP.",
      "page_number": 1,
      "words": [
        {
          "text": "\"Acceptance\"' and \"Accept' have the meaning set forth in Article 3.4 of this Agreement.",
          "bbox": [
            446.0,
            481.0,
            2340.0,
            539.0
          ],
          "confidence": 0.977286696434021
        },
        {
          "text": "\"Acceptance Criteria' has the meaning set forth in the R&D Work Plan.",
          "bbox": [
            450.0,
            682.0,
            2008.0,
            731.0
          ],
          "confidence": 0.9961835145950317
        },
        {
          "text": "\"Acceptance Notification Period' has the meaning set forth in Article 3.3 of this Agreement..",
          "bbox": [
            450.0,
            879.0,
            2438.0,
            928.0
          ],
          "confidence": 0.9805790781974792
        },
        {
          "text": "\"Affiliate\" has the meaning set forth in the Asset Purchase Agreement",
          "bbox": [
            448.0,
            1071.0,
            1950.0,
            1124.0
          ],
          "confidence": 0.9933743476867676
        },
        {
          "text": "\"Agents\" means Third Parties who are acting under the direction or control of a Party.",
          "bbox": [
            448.0,
            1268.0,
            2284.0,
            1321.0
          ],
          "confidence": 0.9984568953514099
        },
        {
          "text": "\"Applicable Laws\" means all applicable federal, state, local and foreign laws, ordinances, rules, regulations, orders,.",
          "bbox": [
            448.0,
            1466.0,
            3025.0,
            1520.0
          ],
          "confidence": 0.9899159073829651
        },
        {
          "text": "writs, injunctions and decrees of any kind.",
          "bbox": [
            283.0,
            1566.0,
            1155.0,
            1614.0
          ],
          "confidence": 0.9892303943634033
        },
        {
          "text": "\"Asset Purchase Agreement\"' has the meaning set forth in the recitals",
          "bbox": [
            448.0,
            1762.0,
            1948.0,
            1811.0
          ],
          "confidence": 0.9865401983261108
        },
        {
          "text": "\"Change of Control'' has the meaning set forth in the Asset Purchase Agreement.",
          "bbox": [
            448.0,
            1955.0,
            2170.0,
            2010.0
          ],
          "confidence": 0.9961836338043213
        },
        {
          "text": "\"Claims\" has the meaning set forth in Article 7.3(a) of this Agreement.",
          "bbox": [
            446.0,
            2147.0,
            1947.0,
            2209.0
          ],
          "confidence": 0.9971343278884888
        },
        {
          "text": "\"Confidential Information\" has the meaning set forth in the Asset Purchase Agreement",
          "bbox": [
            448.0,
            2346.0,
            2335.0,
            2401.0
          ],
          "confidence": 0.999515175819397
        },
        {
          "text": "\"Conformis Background IP\" means any Invention, and all Intellectual Property rights underlying such Invention, that is,.",
          "bbox": [
            446.0,
            2540.0,
            3025.0,
            2602.0
          ],
          "confidence": 0.9841423630714417
        },
        {
          "text": "as of the Effective Date, owned or licensable by Conformis without causing a breach of, or incurring any obligation to, a third.",
          "bbox": [
            279.0,
            2644.0,
            3029.0,
            2699.0
          ],
          "confidence": 0.9918943643569946
        },
        {
          "text": "party, in each case to the extent necessary or reasonably useful to design, develop, manufacture, sell or otherwise exploit the KIB.",
          "bbox": [
            275.0,
            2739.0,
            3027.0,
            2798.0
          ],
          "confidence": 0.9918000102043152
        },
        {
          "text": "Product, and for the avoidance of doubt, excluding the Purchased Assets, Conformis Foreground IP, Stryker Background IP.",
          "bbox": [
            279.0,
            2843.0,
            3023.0,
            2893.0
          ],
          "confidence": 0.9966443181037903
        },
        {
          "text": "Improved Stryker Background IP and Improved Conformis Background IP",
          "bbox": [
            279.0,
            2938.0,
            1874.0,
            2990.0
          ],
          "confidence": 0.9942641854286194
        },
        {
          "text": "2",
          "bbox": [
            1633.0,
            3176.0,
            1669.0,
            3225.0
          ],
          "confidence": 0.9901198148727417
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1178.0,
            4477.0
          ],
          "confidence": 0.9950919151306152
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Joint Ip Ownership_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Joint Ip Ownership\" that should be reviewed by a lawyer. Details: Is there any clause providing for joint or shared ownership of intellectual property between the parties to the contract?",
      "answer_text": "Subject to the limitations set forth in this Agreement, the Joint IP may be used freely by either Party or   its Affiliates and licensed to Third Parties by Conformis and its Affiliates, on the one hand, outside of the Buyer Field or by Stryker   and its Affiliates, on the other hand, within the Buyer Field, in each case, without the consent of, or duty to account to or notify, the   other Party, but, except with respect to external licenses of the Improved Conformis Background IP by Conformis or its Affiliates   to Third Parties, any external Third Party license shall be governed in accordance with the last sentence of Section 4.3(c) of the   APA.",
      "page_number": 0,
      "words": [
        {
          "text": "Execution Version",
          "bbox": [
            2601.0,
            294.0,
            3020.0,
            333.0
          ],
          "confidence": 0.9843302369117737
        },
        {
          "text": "Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause.",
          "bbox": [
            350.0,
            354.0,
            2953.0,
            404.0
          ],
          "confidence": 0.9875192642211914
        },
        {
          "text": "competitive harm to the Company, if publicly disclosed. Double asterisks denote omissions.",
          "bbox": [
            696.0,
            424.0,
            2610.0,
            470.0
          ],
          "confidence": 0.9918519854545593
        },
        {
          "text": "DEVELOPMENT AGREEMENT",
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ],
          "confidence": 0.9884270429611206
        },
        {
          "text": "This Development Agreement (\"this Agreement'') is entered into and effective as of September 30, 2019 (\"Effective.",
          "bbox": [
            448.0,
            795.0,
            3025.0,
            844.0
          ],
          "confidence": 0.9763412475585938
        },
        {
          "text": "Date') by and between Howmedica Osteonics Corp., a New Jersey corporation, also known as Stryker Orthopaedics",
          "bbox": [
            281.0,
            895.0,
            3023.0,
            939.0
          ],
          "confidence": 0.9990173578262329
        },
        {
          "text": "(\"Stryker'), and Conformis, Inc., a Delaware corporation having a principal place of business located at 600 Technology Park",
          "bbox": [
            279.0,
            987.0,
            3027.0,
            1043.0
          ],
          "confidence": 0.9912907481193542
        },
        {
          "text": "Drive, Billerica, MA O1821 (Conformis'). Stryker and Conformis are collectively referred to herein as the \"Parties' and",
          "bbox": [
            281.0,
            1091.0,
            3029.0,
            1135.0
          ],
          "confidence": 0.9795650243759155
        },
        {
          "text": "individually as a \"Party.\"",
          "bbox": [
            277.0,
            1186.0,
            814.0,
            1235.0
          ],
          "confidence": 0.9837418794631958
        },
        {
          "text": "WHEREAS, the Parties are concurrently entering into an asset purchase agreement for Stryker's purchase of certain",
          "bbox": [
            444.0,
            1281.0,
            3029.0,
            1338.0
          ],
          "confidence": 0.9927125573158264
        },
        {
          "text": "Conformis assets concerning Patient-Specific Instrumentation (\"Asset Purchase Agreement\"), and a License Agreement, a",
          "bbox": [
            275.0,
            1378.0,
            3029.0,
            1436.0
          ],
          "confidence": 0.9887849688529968
        },
        {
          "text": "Distribution Agreement and a Quality Agreement, as defined in and attached to the Asset Purchase Agreement (collectively, such",
          "bbox": [
            279.0,
            1482.0,
            3025.0,
            1531.0
          ],
          "confidence": 0.9973982572555542
        },
        {
          "text": "agreements are referred to herein as the \"Other Agreements')",
          "bbox": [
            277.0,
            1577.0,
            1640.0,
            1632.0
          ],
          "confidence": 0.9893602132797241
        },
        {
          "text": "WHEREAS, Stryker and its Affiliates have developed and commercialized an Off-The-Shelf Knee Implant offered under.",
          "bbox": [
            448.0,
            1678.0,
            3029.0,
            1727.0
          ],
          "confidence": 0.9939711093902588
        },
        {
          "text": "the trademark Triathlon.",
          "bbox": [
            281.0,
            1778.0,
            776.0,
            1820.0
          ],
          "confidence": 0.9796398282051086
        },
        {
          "text": "WHEREAS, Conformis currently offers Patient-Specific Instrumentation for use with its Patient-Specific Implants,",
          "bbox": [
            446.0,
            1869.0,
            3025.0,
            1926.0
          ],
          "confidence": 0.9971562623977661
        },
        {
          "text": "including partial and total knee and hip arthroplasty.",
          "bbox": [
            281.0,
            1970.0,
            1352.0,
            2025.0
          ],
          "confidence": 0.9856063723564148
        },
        {
          "text": "WHEREAS, Stryker desires that Conformis develop, in accordance with the R&D Program, certain Patient-Specific.",
          "bbox": [
            450.0,
            2072.0,
            3021.0,
            2116.0
          ],
          "confidence": 0.9856840372085571
        },
        {
          "text": "Instrumentation to be used with the current version of the Off-The-Shelf Knee Implant offered under the trademark Triathlon (such",
          "bbox": [
            281.0,
            2171.0,
            3023.0,
            2215.0
          ],
          "confidence": 0.9951096177101135
        },
        {
          "text": "Patient-Specific Instrumentation as so developed, the \"KIB Product')",
          "bbox": [
            283.0,
            2270.0,
            1784.0,
            2313.0
          ],
          "confidence": 0.9868863224983215
        },
        {
          "text": "THEREFORE, in consideration of the mutual representations, warranties and covenants herein and in the Other.",
          "bbox": [
            444.0,
            2363.0,
            3029.0,
            2414.0
          ],
          "confidence": 0.9940667748451233
        },
        {
          "text": "Agreements constituting good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties",
          "bbox": [
            279.0,
            2463.0,
            3025.0,
            2514.0
          ],
          "confidence": 0.9964366555213928
        },
        {
          "text": "hereby agree as follows:",
          "bbox": [
            279.0,
            2564.0,
            781.0,
            2608.0
          ],
          "confidence": 0.9871907234191895
        },
        {
          "text": "ARTICLE I",
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ],
          "confidence": 0.9906837940216064
        },
        {
          "text": "DEFINITIONS",
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ],
          "confidence": 0.9980525374412537
        },
        {
          "text": "1.1 Definitions. For purposes of this Agreement, the following terms shall have the following meanings, and to the extent",
          "bbox": [
            448.0,
            2854.0,
            2994.0,
            2907.0
          ],
          "confidence": 0.9955382943153381
        },
        {
          "text": "not defined in this section or otherwise in this Agreement, a term shall have the meaning ascribed to it in any of the Other.",
          "bbox": [
            275.0,
            2953.0,
            2800.0,
            3004.0
          ],
          "confidence": 0.99052894115448
        },
        {
          "text": "Agreements:",
          "bbox": [
            281.0,
            3053.0,
            540.0,
            3103.0
          ],
          "confidence": 0.9999290704727173
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1180.0,
            4479.0
          ],
          "confidence": 0.9975276589393616
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "DEVELOPMENT AGREEMENT",
          "page": 0,
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ]
        },
        {
          "text": "ARTICLE I",
          "page": 0,
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ]
        },
        {
          "text": "DEFINITIONS",
          "page": 0,
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ]
        }
      ]
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Joint Ip Ownership_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Joint Ip Ownership\" that should be reviewed by a lawyer. Details: Is there any clause providing for joint or shared ownership of intellectual property between the parties to the contract?",
      "answer_text": "Subject to the limitations set forth in this Agreement, the Joint IP may be used freely by either Party or   its Affiliates and licensed to Third Parties by Conformis and its Affiliates, on the one hand, outside of the Buyer Field or by Stryker   and its Affiliates, on the other hand, within the Buyer Field, in each case, without the consent of, or duty to account to or notify, the   other Party, but, except with respect to external licenses of the Improved Conformis Background IP by Conformis or its Affiliates   to Third Parties, any external Third Party license shall be governed in accordance with the last sentence of Section 4.3(c) of the   APA.",
      "page_number": 1,
      "words": [
        {
          "text": "\"Acceptance\"' and \"Accept' have the meaning set forth in Article 3.4 of this Agreement.",
          "bbox": [
            446.0,
            481.0,
            2340.0,
            539.0
          ],
          "confidence": 0.977286696434021
        },
        {
          "text": "\"Acceptance Criteria' has the meaning set forth in the R&D Work Plan.",
          "bbox": [
            450.0,
            682.0,
            2008.0,
            731.0
          ],
          "confidence": 0.9961835145950317
        },
        {
          "text": "\"Acceptance Notification Period' has the meaning set forth in Article 3.3 of this Agreement..",
          "bbox": [
            450.0,
            879.0,
            2438.0,
            928.0
          ],
          "confidence": 0.9805790781974792
        },
        {
          "text": "\"Affiliate\" has the meaning set forth in the Asset Purchase Agreement",
          "bbox": [
            448.0,
            1071.0,
            1950.0,
            1124.0
          ],
          "confidence": 0.9933743476867676
        },
        {
          "text": "\"Agents\" means Third Parties who are acting under the direction or control of a Party.",
          "bbox": [
            448.0,
            1268.0,
            2284.0,
            1321.0
          ],
          "confidence": 0.9984568953514099
        },
        {
          "text": "\"Applicable Laws\" means all applicable federal, state, local and foreign laws, ordinances, rules, regulations, orders,.",
          "bbox": [
            448.0,
            1466.0,
            3025.0,
            1520.0
          ],
          "confidence": 0.9899159073829651
        },
        {
          "text": "writs, injunctions and decrees of any kind.",
          "bbox": [
            283.0,
            1566.0,
            1155.0,
            1614.0
          ],
          "confidence": 0.9892303943634033
        },
        {
          "text": "\"Asset Purchase Agreement\"' has the meaning set forth in the recitals",
          "bbox": [
            448.0,
            1762.0,
            1948.0,
            1811.0
          ],
          "confidence": 0.9865401983261108
        },
        {
          "text": "\"Change of Control'' has the meaning set forth in the Asset Purchase Agreement.",
          "bbox": [
            448.0,
            1955.0,
            2170.0,
            2010.0
          ],
          "confidence": 0.9961836338043213
        },
        {
          "text": "\"Claims\" has the meaning set forth in Article 7.3(a) of this Agreement.",
          "bbox": [
            446.0,
            2147.0,
            1947.0,
            2209.0
          ],
          "confidence": 0.9971343278884888
        },
        {
          "text": "\"Confidential Information\" has the meaning set forth in the Asset Purchase Agreement",
          "bbox": [
            448.0,
            2346.0,
            2335.0,
            2401.0
          ],
          "confidence": 0.999515175819397
        },
        {
          "text": "\"Conformis Background IP\" means any Invention, and all Intellectual Property rights underlying such Invention, that is,.",
          "bbox": [
            446.0,
            2540.0,
            3025.0,
            2602.0
          ],
          "confidence": 0.9841423630714417
        },
        {
          "text": "as of the Effective Date, owned or licensable by Conformis without causing a breach of, or incurring any obligation to, a third.",
          "bbox": [
            279.0,
            2644.0,
            3029.0,
            2699.0
          ],
          "confidence": 0.9918943643569946
        },
        {
          "text": "party, in each case to the extent necessary or reasonably useful to design, develop, manufacture, sell or otherwise exploit the KIB.",
          "bbox": [
            275.0,
            2739.0,
            3027.0,
            2798.0
          ],
          "confidence": 0.9918000102043152
        },
        {
          "text": "Product, and for the avoidance of doubt, excluding the Purchased Assets, Conformis Foreground IP, Stryker Background IP.",
          "bbox": [
            279.0,
            2843.0,
            3023.0,
            2893.0
          ],
          "confidence": 0.9966443181037903
        },
        {
          "text": "Improved Stryker Background IP and Improved Conformis Background IP",
          "bbox": [
            279.0,
            2938.0,
            1874.0,
            2990.0
          ],
          "confidence": 0.9942641854286194
        },
        {
          "text": "2",
          "bbox": [
            1633.0,
            3176.0,
            1669.0,
            3225.0
          ],
          "confidence": 0.9901198148727417
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1178.0,
            4477.0
          ],
          "confidence": 0.9950919151306152
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Joint Ip Ownership_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Joint Ip Ownership\" that should be reviewed by a lawyer. Details: Is there any clause providing for joint or shared ownership of intellectual property between the parties to the contract?",
      "answer_text": "Each Party to whom ownership is to vest in Joint IP by operation of law or by assignment by its employees or Agents agrees   to assign and hereby assigns to the other Party an undivided one-half right, title and interest in and to all Joint IP; and to facilitate   such assignment, the Party possessing such ownership agrees (i) to regularly ensure that its employees and consultants timely make   any appropriate assignments to it; and (ii) at the other Party's reasonable request, to execute and have its employees and   consultants execute, as necessary, all assignments and any other documentation to perfect the undivided one-half right, title and   interest in and to the other Party of such Joint IP.",
      "page_number": 0,
      "words": [
        {
          "text": "Execution Version",
          "bbox": [
            2601.0,
            294.0,
            3020.0,
            333.0
          ],
          "confidence": 0.9843302369117737
        },
        {
          "text": "Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause.",
          "bbox": [
            350.0,
            354.0,
            2953.0,
            404.0
          ],
          "confidence": 0.9875192642211914
        },
        {
          "text": "competitive harm to the Company, if publicly disclosed. Double asterisks denote omissions.",
          "bbox": [
            696.0,
            424.0,
            2610.0,
            470.0
          ],
          "confidence": 0.9918519854545593
        },
        {
          "text": "DEVELOPMENT AGREEMENT",
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ],
          "confidence": 0.9884270429611206
        },
        {
          "text": "This Development Agreement (\"this Agreement'') is entered into and effective as of September 30, 2019 (\"Effective.",
          "bbox": [
            448.0,
            795.0,
            3025.0,
            844.0
          ],
          "confidence": 0.9763412475585938
        },
        {
          "text": "Date') by and between Howmedica Osteonics Corp., a New Jersey corporation, also known as Stryker Orthopaedics",
          "bbox": [
            281.0,
            895.0,
            3023.0,
            939.0
          ],
          "confidence": 0.9990173578262329
        },
        {
          "text": "(\"Stryker'), and Conformis, Inc., a Delaware corporation having a principal place of business located at 600 Technology Park",
          "bbox": [
            279.0,
            987.0,
            3027.0,
            1043.0
          ],
          "confidence": 0.9912907481193542
        },
        {
          "text": "Drive, Billerica, MA O1821 (Conformis'). Stryker and Conformis are collectively referred to herein as the \"Parties' and",
          "bbox": [
            281.0,
            1091.0,
            3029.0,
            1135.0
          ],
          "confidence": 0.9795650243759155
        },
        {
          "text": "individually as a \"Party.\"",
          "bbox": [
            277.0,
            1186.0,
            814.0,
            1235.0
          ],
          "confidence": 0.9837418794631958
        },
        {
          "text": "WHEREAS, the Parties are concurrently entering into an asset purchase agreement for Stryker's purchase of certain",
          "bbox": [
            444.0,
            1281.0,
            3029.0,
            1338.0
          ],
          "confidence": 0.9927125573158264
        },
        {
          "text": "Conformis assets concerning Patient-Specific Instrumentation (\"Asset Purchase Agreement\"), and a License Agreement, a",
          "bbox": [
            275.0,
            1378.0,
            3029.0,
            1436.0
          ],
          "confidence": 0.9887849688529968
        },
        {
          "text": "Distribution Agreement and a Quality Agreement, as defined in and attached to the Asset Purchase Agreement (collectively, such",
          "bbox": [
            279.0,
            1482.0,
            3025.0,
            1531.0
          ],
          "confidence": 0.9973982572555542
        },
        {
          "text": "agreements are referred to herein as the \"Other Agreements')",
          "bbox": [
            277.0,
            1577.0,
            1640.0,
            1632.0
          ],
          "confidence": 0.9893602132797241
        },
        {
          "text": "WHEREAS, Stryker and its Affiliates have developed and commercialized an Off-The-Shelf Knee Implant offered under.",
          "bbox": [
            448.0,
            1678.0,
            3029.0,
            1727.0
          ],
          "confidence": 0.9939711093902588
        },
        {
          "text": "the trademark Triathlon.",
          "bbox": [
            281.0,
            1778.0,
            776.0,
            1820.0
          ],
          "confidence": 0.9796398282051086
        },
        {
          "text": "WHEREAS, Conformis currently offers Patient-Specific Instrumentation for use with its Patient-Specific Implants,",
          "bbox": [
            446.0,
            1869.0,
            3025.0,
            1926.0
          ],
          "confidence": 0.9971562623977661
        },
        {
          "text": "including partial and total knee and hip arthroplasty.",
          "bbox": [
            281.0,
            1970.0,
            1352.0,
            2025.0
          ],
          "confidence": 0.9856063723564148
        },
        {
          "text": "WHEREAS, Stryker desires that Conformis develop, in accordance with the R&D Program, certain Patient-Specific.",
          "bbox": [
            450.0,
            2072.0,
            3021.0,
            2116.0
          ],
          "confidence": 0.9856840372085571
        },
        {
          "text": "Instrumentation to be used with the current version of the Off-The-Shelf Knee Implant offered under the trademark Triathlon (such",
          "bbox": [
            281.0,
            2171.0,
            3023.0,
            2215.0
          ],
          "confidence": 0.9951096177101135
        },
        {
          "text": "Patient-Specific Instrumentation as so developed, the \"KIB Product')",
          "bbox": [
            283.0,
            2270.0,
            1784.0,
            2313.0
          ],
          "confidence": 0.9868863224983215
        },
        {
          "text": "THEREFORE, in consideration of the mutual representations, warranties and covenants herein and in the Other.",
          "bbox": [
            444.0,
            2363.0,
            3029.0,
            2414.0
          ],
          "confidence": 0.9940667748451233
        },
        {
          "text": "Agreements constituting good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties",
          "bbox": [
            279.0,
            2463.0,
            3025.0,
            2514.0
          ],
          "confidence": 0.9964366555213928
        },
        {
          "text": "hereby agree as follows:",
          "bbox": [
            279.0,
            2564.0,
            781.0,
            2608.0
          ],
          "confidence": 0.9871907234191895
        },
        {
          "text": "ARTICLE I",
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ],
          "confidence": 0.9906837940216064
        },
        {
          "text": "DEFINITIONS",
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ],
          "confidence": 0.9980525374412537
        },
        {
          "text": "1.1 Definitions. For purposes of this Agreement, the following terms shall have the following meanings, and to the extent",
          "bbox": [
            448.0,
            2854.0,
            2994.0,
            2907.0
          ],
          "confidence": 0.9955382943153381
        },
        {
          "text": "not defined in this section or otherwise in this Agreement, a term shall have the meaning ascribed to it in any of the Other.",
          "bbox": [
            275.0,
            2953.0,
            2800.0,
            3004.0
          ],
          "confidence": 0.99052894115448
        },
        {
          "text": "Agreements:",
          "bbox": [
            281.0,
            3053.0,
            540.0,
            3103.0
          ],
          "confidence": 0.9999290704727173
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1180.0,
            4479.0
          ],
          "confidence": 0.9975276589393616
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "DEVELOPMENT AGREEMENT",
          "page": 0,
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ]
        },
        {
          "text": "ARTICLE I",
          "page": 0,
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ]
        },
        {
          "text": "DEFINITIONS",
          "page": 0,
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ]
        }
      ]
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Joint Ip Ownership_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Joint Ip Ownership\" that should be reviewed by a lawyer. Details: Is there any clause providing for joint or shared ownership of intellectual property between the parties to the contract?",
      "answer_text": "Each Party to whom ownership is to vest in Joint IP by operation of law or by assignment by its employees or Agents agrees   to assign and hereby assigns to the other Party an undivided one-half right, title and interest in and to all Joint IP; and to facilitate   such assignment, the Party possessing such ownership agrees (i) to regularly ensure that its employees and consultants timely make   any appropriate assignments to it; and (ii) at the other Party's reasonable request, to execute and have its employees and   consultants execute, as necessary, all assignments and any other documentation to perfect the undivided one-half right, title and   interest in and to the other Party of such Joint IP.",
      "page_number": 1,
      "words": [
        {
          "text": "\"Acceptance\"' and \"Accept' have the meaning set forth in Article 3.4 of this Agreement.",
          "bbox": [
            446.0,
            481.0,
            2340.0,
            539.0
          ],
          "confidence": 0.977286696434021
        },
        {
          "text": "\"Acceptance Criteria' has the meaning set forth in the R&D Work Plan.",
          "bbox": [
            450.0,
            682.0,
            2008.0,
            731.0
          ],
          "confidence": 0.9961835145950317
        },
        {
          "text": "\"Acceptance Notification Period' has the meaning set forth in Article 3.3 of this Agreement..",
          "bbox": [
            450.0,
            879.0,
            2438.0,
            928.0
          ],
          "confidence": 0.9805790781974792
        },
        {
          "text": "\"Affiliate\" has the meaning set forth in the Asset Purchase Agreement",
          "bbox": [
            448.0,
            1071.0,
            1950.0,
            1124.0
          ],
          "confidence": 0.9933743476867676
        },
        {
          "text": "\"Agents\" means Third Parties who are acting under the direction or control of a Party.",
          "bbox": [
            448.0,
            1268.0,
            2284.0,
            1321.0
          ],
          "confidence": 0.9984568953514099
        },
        {
          "text": "\"Applicable Laws\" means all applicable federal, state, local and foreign laws, ordinances, rules, regulations, orders,.",
          "bbox": [
            448.0,
            1466.0,
            3025.0,
            1520.0
          ],
          "confidence": 0.9899159073829651
        },
        {
          "text": "writs, injunctions and decrees of any kind.",
          "bbox": [
            283.0,
            1566.0,
            1155.0,
            1614.0
          ],
          "confidence": 0.9892303943634033
        },
        {
          "text": "\"Asset Purchase Agreement\"' has the meaning set forth in the recitals",
          "bbox": [
            448.0,
            1762.0,
            1948.0,
            1811.0
          ],
          "confidence": 0.9865401983261108
        },
        {
          "text": "\"Change of Control'' has the meaning set forth in the Asset Purchase Agreement.",
          "bbox": [
            448.0,
            1955.0,
            2170.0,
            2010.0
          ],
          "confidence": 0.9961836338043213
        },
        {
          "text": "\"Claims\" has the meaning set forth in Article 7.3(a) of this Agreement.",
          "bbox": [
            446.0,
            2147.0,
            1947.0,
            2209.0
          ],
          "confidence": 0.9971343278884888
        },
        {
          "text": "\"Confidential Information\" has the meaning set forth in the Asset Purchase Agreement",
          "bbox": [
            448.0,
            2346.0,
            2335.0,
            2401.0
          ],
          "confidence": 0.999515175819397
        },
        {
          "text": "\"Conformis Background IP\" means any Invention, and all Intellectual Property rights underlying such Invention, that is,.",
          "bbox": [
            446.0,
            2540.0,
            3025.0,
            2602.0
          ],
          "confidence": 0.9841423630714417
        },
        {
          "text": "as of the Effective Date, owned or licensable by Conformis without causing a breach of, or incurring any obligation to, a third.",
          "bbox": [
            279.0,
            2644.0,
            3029.0,
            2699.0
          ],
          "confidence": 0.9918943643569946
        },
        {
          "text": "party, in each case to the extent necessary or reasonably useful to design, develop, manufacture, sell or otherwise exploit the KIB.",
          "bbox": [
            275.0,
            2739.0,
            3027.0,
            2798.0
          ],
          "confidence": 0.9918000102043152
        },
        {
          "text": "Product, and for the avoidance of doubt, excluding the Purchased Assets, Conformis Foreground IP, Stryker Background IP.",
          "bbox": [
            279.0,
            2843.0,
            3023.0,
            2893.0
          ],
          "confidence": 0.9966443181037903
        },
        {
          "text": "Improved Stryker Background IP and Improved Conformis Background IP",
          "bbox": [
            279.0,
            2938.0,
            1874.0,
            2990.0
          ],
          "confidence": 0.9942641854286194
        },
        {
          "text": "2",
          "bbox": [
            1633.0,
            3176.0,
            1669.0,
            3225.0
          ],
          "confidence": 0.9901198148727417
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1178.0,
            4477.0
          ],
          "confidence": 0.9950919151306152
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Joint Ip Ownership_0",
      "question": "Highlight the parts (if any) of this contract related to \"Joint Ip Ownership\" that should be reviewed by a lawyer. Details: Is there any clause providing for joint or shared ownership of intellectual property between the parties to the contract?",
      "answer_text": "All right, title and interest in and to the Improved Conformis Background IP and KIB Product IP (\"Joint IP\") shall be   owned jointly by the Parties.",
      "page_number": 0,
      "words": [
        {
          "text": "Execution Version",
          "bbox": [
            2601.0,
            294.0,
            3020.0,
            333.0
          ],
          "confidence": 0.9843302369117737
        },
        {
          "text": "Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause.",
          "bbox": [
            350.0,
            354.0,
            2953.0,
            404.0
          ],
          "confidence": 0.9875192642211914
        },
        {
          "text": "competitive harm to the Company, if publicly disclosed. Double asterisks denote omissions.",
          "bbox": [
            696.0,
            424.0,
            2610.0,
            470.0
          ],
          "confidence": 0.9918519854545593
        },
        {
          "text": "DEVELOPMENT AGREEMENT",
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ],
          "confidence": 0.9884270429611206
        },
        {
          "text": "This Development Agreement (\"this Agreement'') is entered into and effective as of September 30, 2019 (\"Effective.",
          "bbox": [
            448.0,
            795.0,
            3025.0,
            844.0
          ],
          "confidence": 0.9763412475585938
        },
        {
          "text": "Date') by and between Howmedica Osteonics Corp., a New Jersey corporation, also known as Stryker Orthopaedics",
          "bbox": [
            281.0,
            895.0,
            3023.0,
            939.0
          ],
          "confidence": 0.9990173578262329
        },
        {
          "text": "(\"Stryker'), and Conformis, Inc., a Delaware corporation having a principal place of business located at 600 Technology Park",
          "bbox": [
            279.0,
            987.0,
            3027.0,
            1043.0
          ],
          "confidence": 0.9912907481193542
        },
        {
          "text": "Drive, Billerica, MA O1821 (Conformis'). Stryker and Conformis are collectively referred to herein as the \"Parties' and",
          "bbox": [
            281.0,
            1091.0,
            3029.0,
            1135.0
          ],
          "confidence": 0.9795650243759155
        },
        {
          "text": "individually as a \"Party.\"",
          "bbox": [
            277.0,
            1186.0,
            814.0,
            1235.0
          ],
          "confidence": 0.9837418794631958
        },
        {
          "text": "WHEREAS, the Parties are concurrently entering into an asset purchase agreement for Stryker's purchase of certain",
          "bbox": [
            444.0,
            1281.0,
            3029.0,
            1338.0
          ],
          "confidence": 0.9927125573158264
        },
        {
          "text": "Conformis assets concerning Patient-Specific Instrumentation (\"Asset Purchase Agreement\"), and a License Agreement, a",
          "bbox": [
            275.0,
            1378.0,
            3029.0,
            1436.0
          ],
          "confidence": 0.9887849688529968
        },
        {
          "text": "Distribution Agreement and a Quality Agreement, as defined in and attached to the Asset Purchase Agreement (collectively, such",
          "bbox": [
            279.0,
            1482.0,
            3025.0,
            1531.0
          ],
          "confidence": 0.9973982572555542
        },
        {
          "text": "agreements are referred to herein as the \"Other Agreements')",
          "bbox": [
            277.0,
            1577.0,
            1640.0,
            1632.0
          ],
          "confidence": 0.9893602132797241
        },
        {
          "text": "WHEREAS, Stryker and its Affiliates have developed and commercialized an Off-The-Shelf Knee Implant offered under.",
          "bbox": [
            448.0,
            1678.0,
            3029.0,
            1727.0
          ],
          "confidence": 0.9939711093902588
        },
        {
          "text": "the trademark Triathlon.",
          "bbox": [
            281.0,
            1778.0,
            776.0,
            1820.0
          ],
          "confidence": 0.9796398282051086
        },
        {
          "text": "WHEREAS, Conformis currently offers Patient-Specific Instrumentation for use with its Patient-Specific Implants,",
          "bbox": [
            446.0,
            1869.0,
            3025.0,
            1926.0
          ],
          "confidence": 0.9971562623977661
        },
        {
          "text": "including partial and total knee and hip arthroplasty.",
          "bbox": [
            281.0,
            1970.0,
            1352.0,
            2025.0
          ],
          "confidence": 0.9856063723564148
        },
        {
          "text": "WHEREAS, Stryker desires that Conformis develop, in accordance with the R&D Program, certain Patient-Specific.",
          "bbox": [
            450.0,
            2072.0,
            3021.0,
            2116.0
          ],
          "confidence": 0.9856840372085571
        },
        {
          "text": "Instrumentation to be used with the current version of the Off-The-Shelf Knee Implant offered under the trademark Triathlon (such",
          "bbox": [
            281.0,
            2171.0,
            3023.0,
            2215.0
          ],
          "confidence": 0.9951096177101135
        },
        {
          "text": "Patient-Specific Instrumentation as so developed, the \"KIB Product')",
          "bbox": [
            283.0,
            2270.0,
            1784.0,
            2313.0
          ],
          "confidence": 0.9868863224983215
        },
        {
          "text": "THEREFORE, in consideration of the mutual representations, warranties and covenants herein and in the Other.",
          "bbox": [
            444.0,
            2363.0,
            3029.0,
            2414.0
          ],
          "confidence": 0.9940667748451233
        },
        {
          "text": "Agreements constituting good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties",
          "bbox": [
            279.0,
            2463.0,
            3025.0,
            2514.0
          ],
          "confidence": 0.9964366555213928
        },
        {
          "text": "hereby agree as follows:",
          "bbox": [
            279.0,
            2564.0,
            781.0,
            2608.0
          ],
          "confidence": 0.9871907234191895
        },
        {
          "text": "ARTICLE I",
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ],
          "confidence": 0.9906837940216064
        },
        {
          "text": "DEFINITIONS",
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ],
          "confidence": 0.9980525374412537
        },
        {
          "text": "1.1 Definitions. For purposes of this Agreement, the following terms shall have the following meanings, and to the extent",
          "bbox": [
            448.0,
            2854.0,
            2994.0,
            2907.0
          ],
          "confidence": 0.9955382943153381
        },
        {
          "text": "not defined in this section or otherwise in this Agreement, a term shall have the meaning ascribed to it in any of the Other.",
          "bbox": [
            275.0,
            2953.0,
            2800.0,
            3004.0
          ],
          "confidence": 0.99052894115448
        },
        {
          "text": "Agreements:",
          "bbox": [
            281.0,
            3053.0,
            540.0,
            3103.0
          ],
          "confidence": 0.9999290704727173
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1180.0,
            4479.0
          ],
          "confidence": 0.9975276589393616
        }
      ],
      "nearby_headers": [
        {
          "text": "DEVELOPMENT AGREEMENT",
          "page": 0,
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ]
        },
        {
          "text": "ARTICLE I",
          "page": 0,
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ]
        },
        {
          "text": "DEFINITIONS",
          "page": 0,
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ]
        }
      ]
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__License Grant_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"License Grant\" that should be reviewed by a lawyer. Details: Does the contract contain a license granted by one party to its counterparty?",
      "answer_text": "To the extent required and for the avoidance of doubt, Stryker hereby grants Conformis, and Conformis hereby   accepts, a non-exclusive license to the Stryker Background IP and Improved Stryker Background IP solely for purposes of   performing any obligations under this Agreement and the Distribution Agreement.",
      "page_number": 0,
      "words": [
        {
          "text": "Execution Version",
          "bbox": [
            2601.0,
            294.0,
            3020.0,
            333.0
          ],
          "confidence": 0.9843302369117737
        },
        {
          "text": "Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause.",
          "bbox": [
            350.0,
            354.0,
            2953.0,
            404.0
          ],
          "confidence": 0.9875192642211914
        },
        {
          "text": "competitive harm to the Company, if publicly disclosed. Double asterisks denote omissions.",
          "bbox": [
            696.0,
            424.0,
            2610.0,
            470.0
          ],
          "confidence": 0.9918519854545593
        },
        {
          "text": "DEVELOPMENT AGREEMENT",
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ],
          "confidence": 0.9884270429611206
        },
        {
          "text": "This Development Agreement (\"this Agreement'') is entered into and effective as of September 30, 2019 (\"Effective.",
          "bbox": [
            448.0,
            795.0,
            3025.0,
            844.0
          ],
          "confidence": 0.9763412475585938
        },
        {
          "text": "Date') by and between Howmedica Osteonics Corp., a New Jersey corporation, also known as Stryker Orthopaedics",
          "bbox": [
            281.0,
            895.0,
            3023.0,
            939.0
          ],
          "confidence": 0.9990173578262329
        },
        {
          "text": "(\"Stryker'), and Conformis, Inc., a Delaware corporation having a principal place of business located at 600 Technology Park",
          "bbox": [
            279.0,
            987.0,
            3027.0,
            1043.0
          ],
          "confidence": 0.9912907481193542
        },
        {
          "text": "Drive, Billerica, MA O1821 (Conformis'). Stryker and Conformis are collectively referred to herein as the \"Parties' and",
          "bbox": [
            281.0,
            1091.0,
            3029.0,
            1135.0
          ],
          "confidence": 0.9795650243759155
        },
        {
          "text": "individually as a \"Party.\"",
          "bbox": [
            277.0,
            1186.0,
            814.0,
            1235.0
          ],
          "confidence": 0.9837418794631958
        },
        {
          "text": "WHEREAS, the Parties are concurrently entering into an asset purchase agreement for Stryker's purchase of certain",
          "bbox": [
            444.0,
            1281.0,
            3029.0,
            1338.0
          ],
          "confidence": 0.9927125573158264
        },
        {
          "text": "Conformis assets concerning Patient-Specific Instrumentation (\"Asset Purchase Agreement\"), and a License Agreement, a",
          "bbox": [
            275.0,
            1378.0,
            3029.0,
            1436.0
          ],
          "confidence": 0.9887849688529968
        },
        {
          "text": "Distribution Agreement and a Quality Agreement, as defined in and attached to the Asset Purchase Agreement (collectively, such",
          "bbox": [
            279.0,
            1482.0,
            3025.0,
            1531.0
          ],
          "confidence": 0.9973982572555542
        },
        {
          "text": "agreements are referred to herein as the \"Other Agreements')",
          "bbox": [
            277.0,
            1577.0,
            1640.0,
            1632.0
          ],
          "confidence": 0.9893602132797241
        },
        {
          "text": "WHEREAS, Stryker and its Affiliates have developed and commercialized an Off-The-Shelf Knee Implant offered under.",
          "bbox": [
            448.0,
            1678.0,
            3029.0,
            1727.0
          ],
          "confidence": 0.9939711093902588
        },
        {
          "text": "the trademark Triathlon.",
          "bbox": [
            281.0,
            1778.0,
            776.0,
            1820.0
          ],
          "confidence": 0.9796398282051086
        },
        {
          "text": "WHEREAS, Conformis currently offers Patient-Specific Instrumentation for use with its Patient-Specific Implants,",
          "bbox": [
            446.0,
            1869.0,
            3025.0,
            1926.0
          ],
          "confidence": 0.9971562623977661
        },
        {
          "text": "including partial and total knee and hip arthroplasty.",
          "bbox": [
            281.0,
            1970.0,
            1352.0,
            2025.0
          ],
          "confidence": 0.9856063723564148
        },
        {
          "text": "WHEREAS, Stryker desires that Conformis develop, in accordance with the R&D Program, certain Patient-Specific.",
          "bbox": [
            450.0,
            2072.0,
            3021.0,
            2116.0
          ],
          "confidence": 0.9856840372085571
        },
        {
          "text": "Instrumentation to be used with the current version of the Off-The-Shelf Knee Implant offered under the trademark Triathlon (such",
          "bbox": [
            281.0,
            2171.0,
            3023.0,
            2215.0
          ],
          "confidence": 0.9951096177101135
        },
        {
          "text": "Patient-Specific Instrumentation as so developed, the \"KIB Product')",
          "bbox": [
            283.0,
            2270.0,
            1784.0,
            2313.0
          ],
          "confidence": 0.9868863224983215
        },
        {
          "text": "THEREFORE, in consideration of the mutual representations, warranties and covenants herein and in the Other.",
          "bbox": [
            444.0,
            2363.0,
            3029.0,
            2414.0
          ],
          "confidence": 0.9940667748451233
        },
        {
          "text": "Agreements constituting good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties",
          "bbox": [
            279.0,
            2463.0,
            3025.0,
            2514.0
          ],
          "confidence": 0.9964366555213928
        },
        {
          "text": "hereby agree as follows:",
          "bbox": [
            279.0,
            2564.0,
            781.0,
            2608.0
          ],
          "confidence": 0.9871907234191895
        },
        {
          "text": "ARTICLE I",
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ],
          "confidence": 0.9906837940216064
        },
        {
          "text": "DEFINITIONS",
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ],
          "confidence": 0.9980525374412537
        },
        {
          "text": "1.1 Definitions. For purposes of this Agreement, the following terms shall have the following meanings, and to the extent",
          "bbox": [
            448.0,
            2854.0,
            2994.0,
            2907.0
          ],
          "confidence": 0.9955382943153381
        },
        {
          "text": "not defined in this section or otherwise in this Agreement, a term shall have the meaning ascribed to it in any of the Other.",
          "bbox": [
            275.0,
            2953.0,
            2800.0,
            3004.0
          ],
          "confidence": 0.99052894115448
        },
        {
          "text": "Agreements:",
          "bbox": [
            281.0,
            3053.0,
            540.0,
            3103.0
          ],
          "confidence": 0.9999290704727173
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1180.0,
            4479.0
          ],
          "confidence": 0.9975276589393616
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "DEVELOPMENT AGREEMENT",
          "page": 0,
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ]
        },
        {
          "text": "ARTICLE I",
          "page": 0,
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ]
        },
        {
          "text": "DEFINITIONS",
          "page": 0,
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ]
        }
      ]
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__License Grant_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"License Grant\" that should be reviewed by a lawyer. Details: Does the contract contain a license granted by one party to its counterparty?",
      "answer_text": "To the extent required and for the avoidance of doubt, Stryker hereby grants Conformis, and Conformis hereby   accepts, a non-exclusive license to the Stryker Background IP and Improved Stryker Background IP solely for purposes of   performing any obligations under this Agreement and the Distribution Agreement.",
      "page_number": 1,
      "words": [
        {
          "text": "\"Acceptance\"' and \"Accept' have the meaning set forth in Article 3.4 of this Agreement.",
          "bbox": [
            446.0,
            481.0,
            2340.0,
            539.0
          ],
          "confidence": 0.977286696434021
        },
        {
          "text": "\"Acceptance Criteria' has the meaning set forth in the R&D Work Plan.",
          "bbox": [
            450.0,
            682.0,
            2008.0,
            731.0
          ],
          "confidence": 0.9961835145950317
        },
        {
          "text": "\"Acceptance Notification Period' has the meaning set forth in Article 3.3 of this Agreement..",
          "bbox": [
            450.0,
            879.0,
            2438.0,
            928.0
          ],
          "confidence": 0.9805790781974792
        },
        {
          "text": "\"Affiliate\" has the meaning set forth in the Asset Purchase Agreement",
          "bbox": [
            448.0,
            1071.0,
            1950.0,
            1124.0
          ],
          "confidence": 0.9933743476867676
        },
        {
          "text": "\"Agents\" means Third Parties who are acting under the direction or control of a Party.",
          "bbox": [
            448.0,
            1268.0,
            2284.0,
            1321.0
          ],
          "confidence": 0.9984568953514099
        },
        {
          "text": "\"Applicable Laws\" means all applicable federal, state, local and foreign laws, ordinances, rules, regulations, orders,.",
          "bbox": [
            448.0,
            1466.0,
            3025.0,
            1520.0
          ],
          "confidence": 0.9899159073829651
        },
        {
          "text": "writs, injunctions and decrees of any kind.",
          "bbox": [
            283.0,
            1566.0,
            1155.0,
            1614.0
          ],
          "confidence": 0.9892303943634033
        },
        {
          "text": "\"Asset Purchase Agreement\"' has the meaning set forth in the recitals",
          "bbox": [
            448.0,
            1762.0,
            1948.0,
            1811.0
          ],
          "confidence": 0.9865401983261108
        },
        {
          "text": "\"Change of Control'' has the meaning set forth in the Asset Purchase Agreement.",
          "bbox": [
            448.0,
            1955.0,
            2170.0,
            2010.0
          ],
          "confidence": 0.9961836338043213
        },
        {
          "text": "\"Claims\" has the meaning set forth in Article 7.3(a) of this Agreement.",
          "bbox": [
            446.0,
            2147.0,
            1947.0,
            2209.0
          ],
          "confidence": 0.9971343278884888
        },
        {
          "text": "\"Confidential Information\" has the meaning set forth in the Asset Purchase Agreement",
          "bbox": [
            448.0,
            2346.0,
            2335.0,
            2401.0
          ],
          "confidence": 0.999515175819397
        },
        {
          "text": "\"Conformis Background IP\" means any Invention, and all Intellectual Property rights underlying such Invention, that is,.",
          "bbox": [
            446.0,
            2540.0,
            3025.0,
            2602.0
          ],
          "confidence": 0.9841423630714417
        },
        {
          "text": "as of the Effective Date, owned or licensable by Conformis without causing a breach of, or incurring any obligation to, a third.",
          "bbox": [
            279.0,
            2644.0,
            3029.0,
            2699.0
          ],
          "confidence": 0.9918943643569946
        },
        {
          "text": "party, in each case to the extent necessary or reasonably useful to design, develop, manufacture, sell or otherwise exploit the KIB.",
          "bbox": [
            275.0,
            2739.0,
            3027.0,
            2798.0
          ],
          "confidence": 0.9918000102043152
        },
        {
          "text": "Product, and for the avoidance of doubt, excluding the Purchased Assets, Conformis Foreground IP, Stryker Background IP.",
          "bbox": [
            279.0,
            2843.0,
            3023.0,
            2893.0
          ],
          "confidence": 0.9966443181037903
        },
        {
          "text": "Improved Stryker Background IP and Improved Conformis Background IP",
          "bbox": [
            279.0,
            2938.0,
            1874.0,
            2990.0
          ],
          "confidence": 0.9942641854286194
        },
        {
          "text": "2",
          "bbox": [
            1633.0,
            3176.0,
            1669.0,
            3225.0
          ],
          "confidence": 0.9901198148727417
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1178.0,
            4477.0
          ],
          "confidence": 0.9950919151306152
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Affiliate License-Licensee_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Affiliate License-Licensee\" that should be reviewed by a lawyer. Details: Does the contract contain a license grant to a licensee (incl. sublicensor) and the affiliates of such licensee/sublicensor?",
      "answer_text": "Except as specifically provided in the Distribution Agreement, Conformis shall be prohibited from   developing or assisting another in developing, or causing another to develop, Patient-Specific Instrumentation for Off-The-Shelf   Knee Implants for any Third Party in the field of orthopedics until January 1, 2032 (or earlier, to the extent set forth in Section   2.3.3.4 or Section 2.3.5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates.",
      "page_number": 0,
      "words": [
        {
          "text": "Execution Version",
          "bbox": [
            2601.0,
            294.0,
            3020.0,
            333.0
          ],
          "confidence": 0.9843302369117737
        },
        {
          "text": "Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause.",
          "bbox": [
            350.0,
            354.0,
            2953.0,
            404.0
          ],
          "confidence": 0.9875192642211914
        },
        {
          "text": "competitive harm to the Company, if publicly disclosed. Double asterisks denote omissions.",
          "bbox": [
            696.0,
            424.0,
            2610.0,
            470.0
          ],
          "confidence": 0.9918519854545593
        },
        {
          "text": "DEVELOPMENT AGREEMENT",
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ],
          "confidence": 0.9884270429611206
        },
        {
          "text": "This Development Agreement (\"this Agreement'') is entered into and effective as of September 30, 2019 (\"Effective.",
          "bbox": [
            448.0,
            795.0,
            3025.0,
            844.0
          ],
          "confidence": 0.9763412475585938
        },
        {
          "text": "Date') by and between Howmedica Osteonics Corp., a New Jersey corporation, also known as Stryker Orthopaedics",
          "bbox": [
            281.0,
            895.0,
            3023.0,
            939.0
          ],
          "confidence": 0.9990173578262329
        },
        {
          "text": "(\"Stryker'), and Conformis, Inc., a Delaware corporation having a principal place of business located at 600 Technology Park",
          "bbox": [
            279.0,
            987.0,
            3027.0,
            1043.0
          ],
          "confidence": 0.9912907481193542
        },
        {
          "text": "Drive, Billerica, MA O1821 (Conformis'). Stryker and Conformis are collectively referred to herein as the \"Parties' and",
          "bbox": [
            281.0,
            1091.0,
            3029.0,
            1135.0
          ],
          "confidence": 0.9795650243759155
        },
        {
          "text": "individually as a \"Party.\"",
          "bbox": [
            277.0,
            1186.0,
            814.0,
            1235.0
          ],
          "confidence": 0.9837418794631958
        },
        {
          "text": "WHEREAS, the Parties are concurrently entering into an asset purchase agreement for Stryker's purchase of certain",
          "bbox": [
            444.0,
            1281.0,
            3029.0,
            1338.0
          ],
          "confidence": 0.9927125573158264
        },
        {
          "text": "Conformis assets concerning Patient-Specific Instrumentation (\"Asset Purchase Agreement\"), and a License Agreement, a",
          "bbox": [
            275.0,
            1378.0,
            3029.0,
            1436.0
          ],
          "confidence": 0.9887849688529968
        },
        {
          "text": "Distribution Agreement and a Quality Agreement, as defined in and attached to the Asset Purchase Agreement (collectively, such",
          "bbox": [
            279.0,
            1482.0,
            3025.0,
            1531.0
          ],
          "confidence": 0.9973982572555542
        },
        {
          "text": "agreements are referred to herein as the \"Other Agreements')",
          "bbox": [
            277.0,
            1577.0,
            1640.0,
            1632.0
          ],
          "confidence": 0.9893602132797241
        },
        {
          "text": "WHEREAS, Stryker and its Affiliates have developed and commercialized an Off-The-Shelf Knee Implant offered under.",
          "bbox": [
            448.0,
            1678.0,
            3029.0,
            1727.0
          ],
          "confidence": 0.9939711093902588
        },
        {
          "text": "the trademark Triathlon.",
          "bbox": [
            281.0,
            1778.0,
            776.0,
            1820.0
          ],
          "confidence": 0.9796398282051086
        },
        {
          "text": "WHEREAS, Conformis currently offers Patient-Specific Instrumentation for use with its Patient-Specific Implants,",
          "bbox": [
            446.0,
            1869.0,
            3025.0,
            1926.0
          ],
          "confidence": 0.9971562623977661
        },
        {
          "text": "including partial and total knee and hip arthroplasty.",
          "bbox": [
            281.0,
            1970.0,
            1352.0,
            2025.0
          ],
          "confidence": 0.9856063723564148
        },
        {
          "text": "WHEREAS, Stryker desires that Conformis develop, in accordance with the R&D Program, certain Patient-Specific.",
          "bbox": [
            450.0,
            2072.0,
            3021.0,
            2116.0
          ],
          "confidence": 0.9856840372085571
        },
        {
          "text": "Instrumentation to be used with the current version of the Off-The-Shelf Knee Implant offered under the trademark Triathlon (such",
          "bbox": [
            281.0,
            2171.0,
            3023.0,
            2215.0
          ],
          "confidence": 0.9951096177101135
        },
        {
          "text": "Patient-Specific Instrumentation as so developed, the \"KIB Product')",
          "bbox": [
            283.0,
            2270.0,
            1784.0,
            2313.0
          ],
          "confidence": 0.9868863224983215
        },
        {
          "text": "THEREFORE, in consideration of the mutual representations, warranties and covenants herein and in the Other.",
          "bbox": [
            444.0,
            2363.0,
            3029.0,
            2414.0
          ],
          "confidence": 0.9940667748451233
        },
        {
          "text": "Agreements constituting good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties",
          "bbox": [
            279.0,
            2463.0,
            3025.0,
            2514.0
          ],
          "confidence": 0.9964366555213928
        },
        {
          "text": "hereby agree as follows:",
          "bbox": [
            279.0,
            2564.0,
            781.0,
            2608.0
          ],
          "confidence": 0.9871907234191895
        },
        {
          "text": "ARTICLE I",
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ],
          "confidence": 0.9906837940216064
        },
        {
          "text": "DEFINITIONS",
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ],
          "confidence": 0.9980525374412537
        },
        {
          "text": "1.1 Definitions. For purposes of this Agreement, the following terms shall have the following meanings, and to the extent",
          "bbox": [
            448.0,
            2854.0,
            2994.0,
            2907.0
          ],
          "confidence": 0.9955382943153381
        },
        {
          "text": "not defined in this section or otherwise in this Agreement, a term shall have the meaning ascribed to it in any of the Other.",
          "bbox": [
            275.0,
            2953.0,
            2800.0,
            3004.0
          ],
          "confidence": 0.99052894115448
        },
        {
          "text": "Agreements:",
          "bbox": [
            281.0,
            3053.0,
            540.0,
            3103.0
          ],
          "confidence": 0.9999290704727173
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1180.0,
            4479.0
          ],
          "confidence": 0.9975276589393616
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "DEVELOPMENT AGREEMENT",
          "page": 0,
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ]
        },
        {
          "text": "ARTICLE I",
          "page": 0,
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ]
        },
        {
          "text": "DEFINITIONS",
          "page": 0,
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ]
        }
      ]
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Affiliate License-Licensee_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Affiliate License-Licensee\" that should be reviewed by a lawyer. Details: Does the contract contain a license grant to a licensee (incl. sublicensor) and the affiliates of such licensee/sublicensor?",
      "answer_text": "Except as specifically provided in the Distribution Agreement, Conformis shall be prohibited from   developing or assisting another in developing, or causing another to develop, Patient-Specific Instrumentation for Off-The-Shelf   Knee Implants for any Third Party in the field of orthopedics until January 1, 2032 (or earlier, to the extent set forth in Section   2.3.3.4 or Section 2.3.5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates.",
      "page_number": 1,
      "words": [
        {
          "text": "\"Acceptance\"' and \"Accept' have the meaning set forth in Article 3.4 of this Agreement.",
          "bbox": [
            446.0,
            481.0,
            2340.0,
            539.0
          ],
          "confidence": 0.977286696434021
        },
        {
          "text": "\"Acceptance Criteria' has the meaning set forth in the R&D Work Plan.",
          "bbox": [
            450.0,
            682.0,
            2008.0,
            731.0
          ],
          "confidence": 0.9961835145950317
        },
        {
          "text": "\"Acceptance Notification Period' has the meaning set forth in Article 3.3 of this Agreement..",
          "bbox": [
            450.0,
            879.0,
            2438.0,
            928.0
          ],
          "confidence": 0.9805790781974792
        },
        {
          "text": "\"Affiliate\" has the meaning set forth in the Asset Purchase Agreement",
          "bbox": [
            448.0,
            1071.0,
            1950.0,
            1124.0
          ],
          "confidence": 0.9933743476867676
        },
        {
          "text": "\"Agents\" means Third Parties who are acting under the direction or control of a Party.",
          "bbox": [
            448.0,
            1268.0,
            2284.0,
            1321.0
          ],
          "confidence": 0.9984568953514099
        },
        {
          "text": "\"Applicable Laws\" means all applicable federal, state, local and foreign laws, ordinances, rules, regulations, orders,.",
          "bbox": [
            448.0,
            1466.0,
            3025.0,
            1520.0
          ],
          "confidence": 0.9899159073829651
        },
        {
          "text": "writs, injunctions and decrees of any kind.",
          "bbox": [
            283.0,
            1566.0,
            1155.0,
            1614.0
          ],
          "confidence": 0.9892303943634033
        },
        {
          "text": "\"Asset Purchase Agreement\"' has the meaning set forth in the recitals",
          "bbox": [
            448.0,
            1762.0,
            1948.0,
            1811.0
          ],
          "confidence": 0.9865401983261108
        },
        {
          "text": "\"Change of Control'' has the meaning set forth in the Asset Purchase Agreement.",
          "bbox": [
            448.0,
            1955.0,
            2170.0,
            2010.0
          ],
          "confidence": 0.9961836338043213
        },
        {
          "text": "\"Claims\" has the meaning set forth in Article 7.3(a) of this Agreement.",
          "bbox": [
            446.0,
            2147.0,
            1947.0,
            2209.0
          ],
          "confidence": 0.9971343278884888
        },
        {
          "text": "\"Confidential Information\" has the meaning set forth in the Asset Purchase Agreement",
          "bbox": [
            448.0,
            2346.0,
            2335.0,
            2401.0
          ],
          "confidence": 0.999515175819397
        },
        {
          "text": "\"Conformis Background IP\" means any Invention, and all Intellectual Property rights underlying such Invention, that is,.",
          "bbox": [
            446.0,
            2540.0,
            3025.0,
            2602.0
          ],
          "confidence": 0.9841423630714417
        },
        {
          "text": "as of the Effective Date, owned or licensable by Conformis without causing a breach of, or incurring any obligation to, a third.",
          "bbox": [
            279.0,
            2644.0,
            3029.0,
            2699.0
          ],
          "confidence": 0.9918943643569946
        },
        {
          "text": "party, in each case to the extent necessary or reasonably useful to design, develop, manufacture, sell or otherwise exploit the KIB.",
          "bbox": [
            275.0,
            2739.0,
            3027.0,
            2798.0
          ],
          "confidence": 0.9918000102043152
        },
        {
          "text": "Product, and for the avoidance of doubt, excluding the Purchased Assets, Conformis Foreground IP, Stryker Background IP.",
          "bbox": [
            279.0,
            2843.0,
            3023.0,
            2893.0
          ],
          "confidence": 0.9966443181037903
        },
        {
          "text": "Improved Stryker Background IP and Improved Conformis Background IP",
          "bbox": [
            279.0,
            2938.0,
            1874.0,
            2990.0
          ],
          "confidence": 0.9942641854286194
        },
        {
          "text": "2",
          "bbox": [
            1633.0,
            3176.0,
            1669.0,
            3225.0
          ],
          "confidence": 0.9901198148727417
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1178.0,
            4477.0
          ],
          "confidence": 0.9950919151306152
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Uncapped Liability_0",
      "question": "Highlight the parts (if any) of this contract related to \"Uncapped Liability\" that should be reviewed by a lawyer. Details: Is a party’s liability uncapped upon the breach of its obligation in the contract? This also includes uncap liability for a particular type of breach such as IP infringement or breach of confidentiality obligation.",
      "answer_text": "EXCEPT FOR [**], IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE   OTHER PARTY FOR [**], EVEN IF SUCH PARTY WAS ADVISED OR AWARE OF THE POSSIBILITY OF SUCH   DAMAGES.",
      "page_number": 0,
      "words": [
        {
          "text": "Execution Version",
          "bbox": [
            2601.0,
            294.0,
            3020.0,
            333.0
          ],
          "confidence": 0.9843302369117737
        },
        {
          "text": "Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause.",
          "bbox": [
            350.0,
            354.0,
            2953.0,
            404.0
          ],
          "confidence": 0.9875192642211914
        },
        {
          "text": "competitive harm to the Company, if publicly disclosed. Double asterisks denote omissions.",
          "bbox": [
            696.0,
            424.0,
            2610.0,
            470.0
          ],
          "confidence": 0.9918519854545593
        },
        {
          "text": "DEVELOPMENT AGREEMENT",
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ],
          "confidence": 0.9884270429611206
        },
        {
          "text": "This Development Agreement (\"this Agreement'') is entered into and effective as of September 30, 2019 (\"Effective.",
          "bbox": [
            448.0,
            795.0,
            3025.0,
            844.0
          ],
          "confidence": 0.9763412475585938
        },
        {
          "text": "Date') by and between Howmedica Osteonics Corp., a New Jersey corporation, also known as Stryker Orthopaedics",
          "bbox": [
            281.0,
            895.0,
            3023.0,
            939.0
          ],
          "confidence": 0.9990173578262329
        },
        {
          "text": "(\"Stryker'), and Conformis, Inc., a Delaware corporation having a principal place of business located at 600 Technology Park",
          "bbox": [
            279.0,
            987.0,
            3027.0,
            1043.0
          ],
          "confidence": 0.9912907481193542
        },
        {
          "text": "Drive, Billerica, MA O1821 (Conformis'). Stryker and Conformis are collectively referred to herein as the \"Parties' and",
          "bbox": [
            281.0,
            1091.0,
            3029.0,
            1135.0
          ],
          "confidence": 0.9795650243759155
        },
        {
          "text": "individually as a \"Party.\"",
          "bbox": [
            277.0,
            1186.0,
            814.0,
            1235.0
          ],
          "confidence": 0.9837418794631958
        },
        {
          "text": "WHEREAS, the Parties are concurrently entering into an asset purchase agreement for Stryker's purchase of certain",
          "bbox": [
            444.0,
            1281.0,
            3029.0,
            1338.0
          ],
          "confidence": 0.9927125573158264
        },
        {
          "text": "Conformis assets concerning Patient-Specific Instrumentation (\"Asset Purchase Agreement\"), and a License Agreement, a",
          "bbox": [
            275.0,
            1378.0,
            3029.0,
            1436.0
          ],
          "confidence": 0.9887849688529968
        },
        {
          "text": "Distribution Agreement and a Quality Agreement, as defined in and attached to the Asset Purchase Agreement (collectively, such",
          "bbox": [
            279.0,
            1482.0,
            3025.0,
            1531.0
          ],
          "confidence": 0.9973982572555542
        },
        {
          "text": "agreements are referred to herein as the \"Other Agreements')",
          "bbox": [
            277.0,
            1577.0,
            1640.0,
            1632.0
          ],
          "confidence": 0.9893602132797241
        },
        {
          "text": "WHEREAS, Stryker and its Affiliates have developed and commercialized an Off-The-Shelf Knee Implant offered under.",
          "bbox": [
            448.0,
            1678.0,
            3029.0,
            1727.0
          ],
          "confidence": 0.9939711093902588
        },
        {
          "text": "the trademark Triathlon.",
          "bbox": [
            281.0,
            1778.0,
            776.0,
            1820.0
          ],
          "confidence": 0.9796398282051086
        },
        {
          "text": "WHEREAS, Conformis currently offers Patient-Specific Instrumentation for use with its Patient-Specific Implants,",
          "bbox": [
            446.0,
            1869.0,
            3025.0,
            1926.0
          ],
          "confidence": 0.9971562623977661
        },
        {
          "text": "including partial and total knee and hip arthroplasty.",
          "bbox": [
            281.0,
            1970.0,
            1352.0,
            2025.0
          ],
          "confidence": 0.9856063723564148
        },
        {
          "text": "WHEREAS, Stryker desires that Conformis develop, in accordance with the R&D Program, certain Patient-Specific.",
          "bbox": [
            450.0,
            2072.0,
            3021.0,
            2116.0
          ],
          "confidence": 0.9856840372085571
        },
        {
          "text": "Instrumentation to be used with the current version of the Off-The-Shelf Knee Implant offered under the trademark Triathlon (such",
          "bbox": [
            281.0,
            2171.0,
            3023.0,
            2215.0
          ],
          "confidence": 0.9951096177101135
        },
        {
          "text": "Patient-Specific Instrumentation as so developed, the \"KIB Product')",
          "bbox": [
            283.0,
            2270.0,
            1784.0,
            2313.0
          ],
          "confidence": 0.9868863224983215
        },
        {
          "text": "THEREFORE, in consideration of the mutual representations, warranties and covenants herein and in the Other.",
          "bbox": [
            444.0,
            2363.0,
            3029.0,
            2414.0
          ],
          "confidence": 0.9940667748451233
        },
        {
          "text": "Agreements constituting good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties",
          "bbox": [
            279.0,
            2463.0,
            3025.0,
            2514.0
          ],
          "confidence": 0.9964366555213928
        },
        {
          "text": "hereby agree as follows:",
          "bbox": [
            279.0,
            2564.0,
            781.0,
            2608.0
          ],
          "confidence": 0.9871907234191895
        },
        {
          "text": "ARTICLE I",
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ],
          "confidence": 0.9906837940216064
        },
        {
          "text": "DEFINITIONS",
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ],
          "confidence": 0.9980525374412537
        },
        {
          "text": "1.1 Definitions. For purposes of this Agreement, the following terms shall have the following meanings, and to the extent",
          "bbox": [
            448.0,
            2854.0,
            2994.0,
            2907.0
          ],
          "confidence": 0.9955382943153381
        },
        {
          "text": "not defined in this section or otherwise in this Agreement, a term shall have the meaning ascribed to it in any of the Other.",
          "bbox": [
            275.0,
            2953.0,
            2800.0,
            3004.0
          ],
          "confidence": 0.99052894115448
        },
        {
          "text": "Agreements:",
          "bbox": [
            281.0,
            3053.0,
            540.0,
            3103.0
          ],
          "confidence": 0.9999290704727173
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1180.0,
            4479.0
          ],
          "confidence": 0.9975276589393616
        }
      ],
      "nearby_headers": [
        {
          "text": "DEVELOPMENT AGREEMENT",
          "page": 0,
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ]
        },
        {
          "text": "ARTICLE I",
          "page": 0,
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ]
        },
        {
          "text": "DEFINITIONS",
          "page": 0,
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ]
        }
      ]
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Cap On Liability_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.",
      "answer_text": "CONFORMIS' LIABILITY ON A PER OCCURRENCE BASIS UNDER SECTION 7.3(A)(IV) SHALL NOT   EXCEED THE GREATER OF (I) $[**] AND (II) THE AMOUNT OF INSURANCE COVERAGE ACTUALLY PAID TO   CONFORMIS UNDER THEN-CURRENT INSURANCE POLICIES OF CONFORMIS IN RESPECT OF SUCH   DAMAGES.",
      "page_number": 0,
      "words": [
        {
          "text": "Execution Version",
          "bbox": [
            2601.0,
            294.0,
            3020.0,
            333.0
          ],
          "confidence": 0.9843302369117737
        },
        {
          "text": "Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause.",
          "bbox": [
            350.0,
            354.0,
            2953.0,
            404.0
          ],
          "confidence": 0.9875192642211914
        },
        {
          "text": "competitive harm to the Company, if publicly disclosed. Double asterisks denote omissions.",
          "bbox": [
            696.0,
            424.0,
            2610.0,
            470.0
          ],
          "confidence": 0.9918519854545593
        },
        {
          "text": "DEVELOPMENT AGREEMENT",
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ],
          "confidence": 0.9884270429611206
        },
        {
          "text": "This Development Agreement (\"this Agreement'') is entered into and effective as of September 30, 2019 (\"Effective.",
          "bbox": [
            448.0,
            795.0,
            3025.0,
            844.0
          ],
          "confidence": 0.9763412475585938
        },
        {
          "text": "Date') by and between Howmedica Osteonics Corp., a New Jersey corporation, also known as Stryker Orthopaedics",
          "bbox": [
            281.0,
            895.0,
            3023.0,
            939.0
          ],
          "confidence": 0.9990173578262329
        },
        {
          "text": "(\"Stryker'), and Conformis, Inc., a Delaware corporation having a principal place of business located at 600 Technology Park",
          "bbox": [
            279.0,
            987.0,
            3027.0,
            1043.0
          ],
          "confidence": 0.9912907481193542
        },
        {
          "text": "Drive, Billerica, MA O1821 (Conformis'). Stryker and Conformis are collectively referred to herein as the \"Parties' and",
          "bbox": [
            281.0,
            1091.0,
            3029.0,
            1135.0
          ],
          "confidence": 0.9795650243759155
        },
        {
          "text": "individually as a \"Party.\"",
          "bbox": [
            277.0,
            1186.0,
            814.0,
            1235.0
          ],
          "confidence": 0.9837418794631958
        },
        {
          "text": "WHEREAS, the Parties are concurrently entering into an asset purchase agreement for Stryker's purchase of certain",
          "bbox": [
            444.0,
            1281.0,
            3029.0,
            1338.0
          ],
          "confidence": 0.9927125573158264
        },
        {
          "text": "Conformis assets concerning Patient-Specific Instrumentation (\"Asset Purchase Agreement\"), and a License Agreement, a",
          "bbox": [
            275.0,
            1378.0,
            3029.0,
            1436.0
          ],
          "confidence": 0.9887849688529968
        },
        {
          "text": "Distribution Agreement and a Quality Agreement, as defined in and attached to the Asset Purchase Agreement (collectively, such",
          "bbox": [
            279.0,
            1482.0,
            3025.0,
            1531.0
          ],
          "confidence": 0.9973982572555542
        },
        {
          "text": "agreements are referred to herein as the \"Other Agreements')",
          "bbox": [
            277.0,
            1577.0,
            1640.0,
            1632.0
          ],
          "confidence": 0.9893602132797241
        },
        {
          "text": "WHEREAS, Stryker and its Affiliates have developed and commercialized an Off-The-Shelf Knee Implant offered under.",
          "bbox": [
            448.0,
            1678.0,
            3029.0,
            1727.0
          ],
          "confidence": 0.9939711093902588
        },
        {
          "text": "the trademark Triathlon.",
          "bbox": [
            281.0,
            1778.0,
            776.0,
            1820.0
          ],
          "confidence": 0.9796398282051086
        },
        {
          "text": "WHEREAS, Conformis currently offers Patient-Specific Instrumentation for use with its Patient-Specific Implants,",
          "bbox": [
            446.0,
            1869.0,
            3025.0,
            1926.0
          ],
          "confidence": 0.9971562623977661
        },
        {
          "text": "including partial and total knee and hip arthroplasty.",
          "bbox": [
            281.0,
            1970.0,
            1352.0,
            2025.0
          ],
          "confidence": 0.9856063723564148
        },
        {
          "text": "WHEREAS, Stryker desires that Conformis develop, in accordance with the R&D Program, certain Patient-Specific.",
          "bbox": [
            450.0,
            2072.0,
            3021.0,
            2116.0
          ],
          "confidence": 0.9856840372085571
        },
        {
          "text": "Instrumentation to be used with the current version of the Off-The-Shelf Knee Implant offered under the trademark Triathlon (such",
          "bbox": [
            281.0,
            2171.0,
            3023.0,
            2215.0
          ],
          "confidence": 0.9951096177101135
        },
        {
          "text": "Patient-Specific Instrumentation as so developed, the \"KIB Product')",
          "bbox": [
            283.0,
            2270.0,
            1784.0,
            2313.0
          ],
          "confidence": 0.9868863224983215
        },
        {
          "text": "THEREFORE, in consideration of the mutual representations, warranties and covenants herein and in the Other.",
          "bbox": [
            444.0,
            2363.0,
            3029.0,
            2414.0
          ],
          "confidence": 0.9940667748451233
        },
        {
          "text": "Agreements constituting good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties",
          "bbox": [
            279.0,
            2463.0,
            3025.0,
            2514.0
          ],
          "confidence": 0.9964366555213928
        },
        {
          "text": "hereby agree as follows:",
          "bbox": [
            279.0,
            2564.0,
            781.0,
            2608.0
          ],
          "confidence": 0.9871907234191895
        },
        {
          "text": "ARTICLE I",
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ],
          "confidence": 0.9906837940216064
        },
        {
          "text": "DEFINITIONS",
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ],
          "confidence": 0.9980525374412537
        },
        {
          "text": "1.1 Definitions. For purposes of this Agreement, the following terms shall have the following meanings, and to the extent",
          "bbox": [
            448.0,
            2854.0,
            2994.0,
            2907.0
          ],
          "confidence": 0.9955382943153381
        },
        {
          "text": "not defined in this section or otherwise in this Agreement, a term shall have the meaning ascribed to it in any of the Other.",
          "bbox": [
            275.0,
            2953.0,
            2800.0,
            3004.0
          ],
          "confidence": 0.99052894115448
        },
        {
          "text": "Agreements:",
          "bbox": [
            281.0,
            3053.0,
            540.0,
            3103.0
          ],
          "confidence": 0.9999290704727173
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1180.0,
            4479.0
          ],
          "confidence": 0.9975276589393616
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "DEVELOPMENT AGREEMENT",
          "page": 0,
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ]
        },
        {
          "text": "ARTICLE I",
          "page": 0,
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ]
        },
        {
          "text": "DEFINITIONS",
          "page": 0,
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ]
        }
      ]
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Cap On Liability_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.",
      "answer_text": "CONFORMIS' LIABILITY ON A PER OCCURRENCE BASIS UNDER SECTION 7.3(A)(IV) SHALL NOT   EXCEED THE GREATER OF (I) $[**] AND (II) THE AMOUNT OF INSURANCE COVERAGE ACTUALLY PAID TO   CONFORMIS UNDER THEN-CURRENT INSURANCE POLICIES OF CONFORMIS IN RESPECT OF SUCH   DAMAGES.",
      "page_number": 1,
      "words": [
        {
          "text": "\"Acceptance\"' and \"Accept' have the meaning set forth in Article 3.4 of this Agreement.",
          "bbox": [
            446.0,
            481.0,
            2340.0,
            539.0
          ],
          "confidence": 0.977286696434021
        },
        {
          "text": "\"Acceptance Criteria' has the meaning set forth in the R&D Work Plan.",
          "bbox": [
            450.0,
            682.0,
            2008.0,
            731.0
          ],
          "confidence": 0.9961835145950317
        },
        {
          "text": "\"Acceptance Notification Period' has the meaning set forth in Article 3.3 of this Agreement..",
          "bbox": [
            450.0,
            879.0,
            2438.0,
            928.0
          ],
          "confidence": 0.9805790781974792
        },
        {
          "text": "\"Affiliate\" has the meaning set forth in the Asset Purchase Agreement",
          "bbox": [
            448.0,
            1071.0,
            1950.0,
            1124.0
          ],
          "confidence": 0.9933743476867676
        },
        {
          "text": "\"Agents\" means Third Parties who are acting under the direction or control of a Party.",
          "bbox": [
            448.0,
            1268.0,
            2284.0,
            1321.0
          ],
          "confidence": 0.9984568953514099
        },
        {
          "text": "\"Applicable Laws\" means all applicable federal, state, local and foreign laws, ordinances, rules, regulations, orders,.",
          "bbox": [
            448.0,
            1466.0,
            3025.0,
            1520.0
          ],
          "confidence": 0.9899159073829651
        },
        {
          "text": "writs, injunctions and decrees of any kind.",
          "bbox": [
            283.0,
            1566.0,
            1155.0,
            1614.0
          ],
          "confidence": 0.9892303943634033
        },
        {
          "text": "\"Asset Purchase Agreement\"' has the meaning set forth in the recitals",
          "bbox": [
            448.0,
            1762.0,
            1948.0,
            1811.0
          ],
          "confidence": 0.9865401983261108
        },
        {
          "text": "\"Change of Control'' has the meaning set forth in the Asset Purchase Agreement.",
          "bbox": [
            448.0,
            1955.0,
            2170.0,
            2010.0
          ],
          "confidence": 0.9961836338043213
        },
        {
          "text": "\"Claims\" has the meaning set forth in Article 7.3(a) of this Agreement.",
          "bbox": [
            446.0,
            2147.0,
            1947.0,
            2209.0
          ],
          "confidence": 0.9971343278884888
        },
        {
          "text": "\"Confidential Information\" has the meaning set forth in the Asset Purchase Agreement",
          "bbox": [
            448.0,
            2346.0,
            2335.0,
            2401.0
          ],
          "confidence": 0.999515175819397
        },
        {
          "text": "\"Conformis Background IP\" means any Invention, and all Intellectual Property rights underlying such Invention, that is,.",
          "bbox": [
            446.0,
            2540.0,
            3025.0,
            2602.0
          ],
          "confidence": 0.9841423630714417
        },
        {
          "text": "as of the Effective Date, owned or licensable by Conformis without causing a breach of, or incurring any obligation to, a third.",
          "bbox": [
            279.0,
            2644.0,
            3029.0,
            2699.0
          ],
          "confidence": 0.9918943643569946
        },
        {
          "text": "party, in each case to the extent necessary or reasonably useful to design, develop, manufacture, sell or otherwise exploit the KIB.",
          "bbox": [
            275.0,
            2739.0,
            3027.0,
            2798.0
          ],
          "confidence": 0.9918000102043152
        },
        {
          "text": "Product, and for the avoidance of doubt, excluding the Purchased Assets, Conformis Foreground IP, Stryker Background IP.",
          "bbox": [
            279.0,
            2843.0,
            3023.0,
            2893.0
          ],
          "confidence": 0.9966443181037903
        },
        {
          "text": "Improved Stryker Background IP and Improved Conformis Background IP",
          "bbox": [
            279.0,
            2938.0,
            1874.0,
            2990.0
          ],
          "confidence": 0.9942641854286194
        },
        {
          "text": "2",
          "bbox": [
            1633.0,
            3176.0,
            1669.0,
            3225.0
          ],
          "confidence": 0.9901198148727417
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1178.0,
            4477.0
          ],
          "confidence": 0.9950919151306152
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Cap On Liability_7_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.",
      "answer_text": "Such termination, together with the provisions of Section 5.2 of the License Agreement,   constitutes as Stryker's sole remedy and Conformis' exclusive liability in the event of any such rejection or failure by Conformis to   deliver materially conforming Deliverables hereunder so long as such rejection or failure does not arise from Conformis' fraud,   willful misconduct, gross negligence or bad faith.",
      "page_number": 7,
      "words": [
        {
          "text": "ARTICLE II",
          "bbox": [
            1510.0,
            587.0,
            1802.0,
            625.0
          ],
          "confidence": 0.9558011889457703
        },
        {
          "text": "RESEARCH AND DEVELOPMENT PROGRAM",
          "bbox": [
            1060.0,
            682.0,
            2248.0,
            724.0
          ],
          "confidence": 0.9995172023773193
        },
        {
          "text": "2.1 R&D Work Plan. The Parties agree to conduct the R&D Program pursuant to the R&D Work Plan and to perform.",
          "bbox": [
            444.0,
            775.0,
            3025.0,
            831.0
          ],
          "confidence": 0.9856576323509216
        },
        {
          "text": "their respective obligations therein. To the extent Conformis' performance under the R&D Program is delayed due to Stryker's.",
          "bbox": [
            277.0,
            877.0,
            3025.0,
            928.0
          ],
          "confidence": 0.9899240136146545
        },
        {
          "text": "delay in performing any of its obligations in accordance with the timelines in the R&D Work Plan, the applicable timelines shall be.",
          "bbox": [
            281.0,
            978.0,
            3027.0,
            1027.0
          ],
          "confidence": 0.9879268407821655
        },
        {
          "text": "deemed extended by a period of time corresponding to the length of such portion of the delay attributable to Stryker, on a day-by-",
          "bbox": [
            277.0,
            1073.0,
            3016.0,
            1126.0
          ],
          "confidence": 0.9879088401794434
        },
        {
          "text": "day basis. The R&D Work Plan may be amended by mutual written agreement of the Parties from time to time.",
          "bbox": [
            283.0,
            1175.0,
            2605.0,
            1219.0
          ],
          "confidence": 0.983992874622345
        },
        {
          "text": "2.2 Agents or Third Parties. To the extent working with Agents or other Third Parties is permitted under the R&D Work",
          "bbox": [
            444.0,
            1268.0,
            3029.0,
            1319.0
          ],
          "confidence": 0.9932647347450256
        },
        {
          "text": "Plan, should a Party wish to engage an Agent or any other Third Party in connection with the R&D Work Plan or any other work.",
          "bbox": [
            277.0,
            1365.0,
            3025.0,
            1420.0
          ],
          "confidence": 0.9903751611709595
        },
        {
          "text": "under this Agreement, such Party must obtain in advance a written agreement by such Agent or other Third Party (i) to assign to",
          "bbox": [
            279.0,
            1466.0,
            3025.0,
            1519.0
          ],
          "confidence": 0.9911425709724426
        },
        {
          "text": "the Party all Inventions conceived, created or generated by the Agent or other Third Party, and (ii) to maintain all Confidential.",
          "bbox": [
            279.0,
            1566.0,
            3027.0,
            1615.0
          ],
          "confidence": 0.9855552315711975
        },
        {
          "text": "Information in confidence as set forth in Section 5.2",
          "bbox": [
            279.0,
            1665.0,
            1363.0,
            1709.0
          ],
          "confidence": 0.994902491569519
        },
        {
          "text": "ARTICLE III",
          "bbox": [
            1495.0,
            1856.0,
            1814.0,
            1904.0
          ],
          "confidence": 0.9935559630393982
        },
        {
          "text": "DELIVERABLES AND COMPLETION",
          "bbox": [
            1142.0,
            1948.0,
            2092.0,
            1984.0
          ],
          "confidence": 0.9832190275192261
        },
        {
          "text": "3.1 Deliverables. Subject to the remedies set forth in Section 3.4, Conformis shall furnish Stryker with the Deliverables",
          "bbox": [
            459.0,
            2083.0,
            3025.0,
            2127.0
          ],
          "confidence": 0.998319685459137
        },
        {
          "text": "as defined in the R&D Work Plan, and Stryker shall have the opportunity to analyze and test each Deliverable for the purposes of",
          "bbox": [
            290.0,
            2180.0,
            3030.0,
            2229.0
          ],
          "confidence": 0.9906426072120667
        },
        {
          "text": "determining Acceptance as set forth in the R&D Work Plan. Each Deliverable shall be deemed to be completed once such.",
          "bbox": [
            288.0,
            2271.0,
            3029.0,
            2330.0
          ],
          "confidence": 0.9885972738265991
        },
        {
          "text": "Deliverable has been Accepted (as defined below)..",
          "bbox": [
            286.0,
            2372.0,
            1361.0,
            2425.0
          ],
          "confidence": 0.9733381867408752
        },
        {
          "text": "3.2 Free from Infringement. Without the consent of Stryker, Conformis shall not introduce any structure or",
          "bbox": [
            457.0,
            2476.0,
            3025.0,
            2520.0
          ],
          "confidence": 0.9798612594604492
        },
        {
          "text": "methodology in the Deliverables (including a Deliverable within a Product or a Stryker Product) that (1) raise a colorable",
          "bbox": [
            288.0,
            2569.0,
            3027.0,
            2622.0
          ],
          "confidence": 0.9993765950202942
        },
        {
          "text": "argument of patent infringement in the manufacture, use, sale, offer for sale or importation of the Deliverable as such Deliverable",
          "bbox": [
            288.0,
            2668.0,
            2963.0,
            2721.0
          ],
          "confidence": 0.9908959865570068
        },
        {
          "text": "8",
          "bbox": [
            1632.0,
            2806.0,
            1674.0,
            2859.0
          ],
          "confidence": 0.9869064092636108
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1180.0,
            4479.0
          ],
          "confidence": 0.9963619112968445
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "ARTICLE II",
          "page": 7,
          "bbox": [
            1510.0,
            587.0,
            1802.0,
            625.0
          ]
        },
        {
          "text": "RESEARCH AND DEVELOPMENT PROGRAM",
          "page": 7,
          "bbox": [
            1060.0,
            682.0,
            2248.0,
            724.0
          ]
        },
        {
          "text": "ARTICLE III",
          "page": 7,
          "bbox": [
            1495.0,
            1856.0,
            1814.0,
            1904.0
          ]
        },
        {
          "text": "DELIVERABLES AND COMPLETION",
          "page": 7,
          "bbox": [
            1142.0,
            1948.0,
            2092.0,
            1984.0
          ]
        }
      ]
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Cap On Liability_8_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.",
      "answer_text": "Such termination, together with the provisions of Section 5.2 of the License Agreement,   constitutes as Stryker's sole remedy and Conformis' exclusive liability in the event of any such rejection or failure by Conformis to   deliver materially conforming Deliverables hereunder so long as such rejection or failure does not arise from Conformis' fraud,   willful misconduct, gross negligence or bad faith.",
      "page_number": 8,
      "words": [
        {
          "text": "is intended to be exploited under the Other Agreements, (2) misappropriate any Confidential Information of any Third Party, or.",
          "bbox": [
            288.0,
            490.0,
            3027.0,
            539.0
          ],
          "confidence": 0.9933919906616211
        },
        {
          "text": "(3) otherwise violate any Intellectual Property rights of any Third Party. For clarity, disclosure of a matter on the Disclosure",
          "bbox": [
            290.0,
            587.0,
            3027.0,
            638.0
          ],
          "confidence": 0.992388904094696
        },
        {
          "text": "Schedules to the Asset Purchase Agreement shall not be deemed consent by Stryker under this Section 3.2.",
          "bbox": [
            288.0,
            685.0,
            2548.0,
            735.0
          ],
          "confidence": 0.9861250519752502
        },
        {
          "text": "3.3 Completion. After a Deliverable has been furnished to Stryker, Stryker (or its Agent designee) will be entitled to.",
          "bbox": [
            457.0,
            784.0,
            3023.0,
            833.0
          ],
          "confidence": 0.9890926480293274
        },
        {
          "text": "analyze and test the Deliverable to determine if it operates in accordance with and otherwise conforms to the applicable",
          "bbox": [
            294.0,
            883.0,
            3023.0,
            932.0
          ],
          "confidence": 0.997725784778595
        },
        {
          "text": "Acceptance Criteria set forth in R&D Work Plan. Conformis shall provide such assistance as Stryker may reasonably request in",
          "bbox": [
            294.0,
            983.0,
            3021.0,
            1027.0
          ],
          "confidence": 0.9911972284317017
        },
        {
          "text": "such determination. Stryker shall have [**] (\"Acceptance Notification Period') following the date the Deliverable is received by.",
          "bbox": [
            288.0,
            1076.0,
            3023.0,
            1129.0
          ],
          "confidence": 0.9848026037216187
        },
        {
          "text": "Stryker to Accept or reject the Deliverable as described in Section 3.4..",
          "bbox": [
            288.0,
            1175.0,
            1789.0,
            1226.0
          ],
          "confidence": 0.9941655993461609
        },
        {
          "text": "3.4 Acceptance or Rejection. Respecting any Deliverable for Milestone #1 or Milestone #2, as set forth below, if",
          "bbox": [
            451.0,
            1270.0,
            3032.0,
            1327.0
          ],
          "confidence": 0.9936466217041016
        },
        {
          "text": "Stryker determines that a Deliverable operates in accordance with and otherwise conforms to the applicable Acceptance Criteria",
          "bbox": [
            294.0,
            1376.0,
            3025.0,
            1420.0
          ],
          "confidence": 0.9956822991371155
        },
        {
          "text": "reasonably determines that a Deliverable does not operate in accordance with or otherwise conform to the applicable Acceptance.",
          "bbox": [
            285.0,
            1568.0,
            3027.0,
            1619.0
          ],
          "confidence": 0.996597945690155
        },
        {
          "text": "Criteria, then Stryker will provide Conformis with a written notice of rejection within the Acceptance Notification Period",
          "bbox": [
            292.0,
            1670.0,
            3027.0,
            1714.0
          ],
          "confidence": 0.9965769052505493
        },
        {
          "text": "describing the defect in view of the relevant Acceptance Criteria and including sufficient detail with respect to such Stryker testing.",
          "bbox": [
            286.0,
            1762.0,
            3027.0,
            1820.0
          ],
          "confidence": 0.9844057559967041
        },
        {
          "text": "and testing results as Conformis reasonably requests (\"Failure Notice'). Conformis shall have [**] (or such longer period of time.",
          "bbox": [
            290.0,
            1864.0,
            3027.0,
            1913.0
          ],
          "confidence": 0.9857480525970459
        },
        {
          "text": "as may be agreed between the parties in good faith should the scope and complexity of the applicable Deliverable warrant some.",
          "bbox": [
            286.0,
            1961.0,
            3029.0,
            2012.0
          ],
          "confidence": 0.9931387305259705
        },
        {
          "text": "longer period of time) (\"Redelivery Period') following the date it receives the Failure Notice to correct and redeliver the.",
          "bbox": [
            286.0,
            2059.0,
            3027.0,
            2111.0
          ],
          "confidence": 0.980049192905426
        },
        {
          "text": "Deliverable. If Conformis timely delivers a corrected version of the Deliverable within the Redelivery Period, then Stryker will beo.",
          "bbox": [
            286.0,
            2156.0,
            2982.0,
            2207.0
          ],
          "confidence": 0.9910149574279785
        },
        {
          "text": "9",
          "bbox": [
            1632.0,
            2296.0,
            1669.0,
            2342.0
          ],
          "confidence": 0.9627326130867004
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1178.0,
            4477.0
          ],
          "confidence": 0.9950639009475708
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Cap On Liability_0",
      "question": "Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.",
      "answer_text": "EXCEPT FOR [**], IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE   OTHER PARTY FOR [**], EVEN IF SUCH PARTY WAS ADVISED OR AWARE OF THE POSSIBILITY OF SUCH   DAMAGES.",
      "page_number": 0,
      "words": [
        {
          "text": "Execution Version",
          "bbox": [
            2601.0,
            294.0,
            3020.0,
            333.0
          ],
          "confidence": 0.9843302369117737
        },
        {
          "text": "Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause.",
          "bbox": [
            350.0,
            354.0,
            2953.0,
            404.0
          ],
          "confidence": 0.9875192642211914
        },
        {
          "text": "competitive harm to the Company, if publicly disclosed. Double asterisks denote omissions.",
          "bbox": [
            696.0,
            424.0,
            2610.0,
            470.0
          ],
          "confidence": 0.9918519854545593
        },
        {
          "text": "DEVELOPMENT AGREEMENT",
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ],
          "confidence": 0.9884270429611206
        },
        {
          "text": "This Development Agreement (\"this Agreement'') is entered into and effective as of September 30, 2019 (\"Effective.",
          "bbox": [
            448.0,
            795.0,
            3025.0,
            844.0
          ],
          "confidence": 0.9763412475585938
        },
        {
          "text": "Date') by and between Howmedica Osteonics Corp., a New Jersey corporation, also known as Stryker Orthopaedics",
          "bbox": [
            281.0,
            895.0,
            3023.0,
            939.0
          ],
          "confidence": 0.9990173578262329
        },
        {
          "text": "(\"Stryker'), and Conformis, Inc., a Delaware corporation having a principal place of business located at 600 Technology Park",
          "bbox": [
            279.0,
            987.0,
            3027.0,
            1043.0
          ],
          "confidence": 0.9912907481193542
        },
        {
          "text": "Drive, Billerica, MA O1821 (Conformis'). Stryker and Conformis are collectively referred to herein as the \"Parties' and",
          "bbox": [
            281.0,
            1091.0,
            3029.0,
            1135.0
          ],
          "confidence": 0.9795650243759155
        },
        {
          "text": "individually as a \"Party.\"",
          "bbox": [
            277.0,
            1186.0,
            814.0,
            1235.0
          ],
          "confidence": 0.9837418794631958
        },
        {
          "text": "WHEREAS, the Parties are concurrently entering into an asset purchase agreement for Stryker's purchase of certain",
          "bbox": [
            444.0,
            1281.0,
            3029.0,
            1338.0
          ],
          "confidence": 0.9927125573158264
        },
        {
          "text": "Conformis assets concerning Patient-Specific Instrumentation (\"Asset Purchase Agreement\"), and a License Agreement, a",
          "bbox": [
            275.0,
            1378.0,
            3029.0,
            1436.0
          ],
          "confidence": 0.9887849688529968
        },
        {
          "text": "Distribution Agreement and a Quality Agreement, as defined in and attached to the Asset Purchase Agreement (collectively, such",
          "bbox": [
            279.0,
            1482.0,
            3025.0,
            1531.0
          ],
          "confidence": 0.9973982572555542
        },
        {
          "text": "agreements are referred to herein as the \"Other Agreements')",
          "bbox": [
            277.0,
            1577.0,
            1640.0,
            1632.0
          ],
          "confidence": 0.9893602132797241
        },
        {
          "text": "WHEREAS, Stryker and its Affiliates have developed and commercialized an Off-The-Shelf Knee Implant offered under.",
          "bbox": [
            448.0,
            1678.0,
            3029.0,
            1727.0
          ],
          "confidence": 0.9939711093902588
        },
        {
          "text": "the trademark Triathlon.",
          "bbox": [
            281.0,
            1778.0,
            776.0,
            1820.0
          ],
          "confidence": 0.9796398282051086
        },
        {
          "text": "WHEREAS, Conformis currently offers Patient-Specific Instrumentation for use with its Patient-Specific Implants,",
          "bbox": [
            446.0,
            1869.0,
            3025.0,
            1926.0
          ],
          "confidence": 0.9971562623977661
        },
        {
          "text": "including partial and total knee and hip arthroplasty.",
          "bbox": [
            281.0,
            1970.0,
            1352.0,
            2025.0
          ],
          "confidence": 0.9856063723564148
        },
        {
          "text": "WHEREAS, Stryker desires that Conformis develop, in accordance with the R&D Program, certain Patient-Specific.",
          "bbox": [
            450.0,
            2072.0,
            3021.0,
            2116.0
          ],
          "confidence": 0.9856840372085571
        },
        {
          "text": "Instrumentation to be used with the current version of the Off-The-Shelf Knee Implant offered under the trademark Triathlon (such",
          "bbox": [
            281.0,
            2171.0,
            3023.0,
            2215.0
          ],
          "confidence": 0.9951096177101135
        },
        {
          "text": "Patient-Specific Instrumentation as so developed, the \"KIB Product')",
          "bbox": [
            283.0,
            2270.0,
            1784.0,
            2313.0
          ],
          "confidence": 0.9868863224983215
        },
        {
          "text": "THEREFORE, in consideration of the mutual representations, warranties and covenants herein and in the Other.",
          "bbox": [
            444.0,
            2363.0,
            3029.0,
            2414.0
          ],
          "confidence": 0.9940667748451233
        },
        {
          "text": "Agreements constituting good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties",
          "bbox": [
            279.0,
            2463.0,
            3025.0,
            2514.0
          ],
          "confidence": 0.9964366555213928
        },
        {
          "text": "hereby agree as follows:",
          "bbox": [
            279.0,
            2564.0,
            781.0,
            2608.0
          ],
          "confidence": 0.9871907234191895
        },
        {
          "text": "ARTICLE I",
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ],
          "confidence": 0.9906837940216064
        },
        {
          "text": "DEFINITIONS",
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ],
          "confidence": 0.9980525374412537
        },
        {
          "text": "1.1 Definitions. For purposes of this Agreement, the following terms shall have the following meanings, and to the extent",
          "bbox": [
            448.0,
            2854.0,
            2994.0,
            2907.0
          ],
          "confidence": 0.9955382943153381
        },
        {
          "text": "not defined in this section or otherwise in this Agreement, a term shall have the meaning ascribed to it in any of the Other.",
          "bbox": [
            275.0,
            2953.0,
            2800.0,
            3004.0
          ],
          "confidence": 0.99052894115448
        },
        {
          "text": "Agreements:",
          "bbox": [
            281.0,
            3053.0,
            540.0,
            3103.0
          ],
          "confidence": 0.9999290704727173
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1180.0,
            4479.0
          ],
          "confidence": 0.9975276589393616
        }
      ],
      "nearby_headers": [
        {
          "text": "DEVELOPMENT AGREEMENT",
          "page": 0,
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ]
        },
        {
          "text": "ARTICLE I",
          "page": 0,
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ]
        },
        {
          "text": "DEFINITIONS",
          "page": 0,
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ]
        }
      ]
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Cap On Liability_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.",
      "answer_text": "Notwithstanding   anything to the contrary, Stryker's sole remedy and Conformis' exclusive liability for breach of Section 3.2 with respect to a   Product or a Stryker Product shall be as set forth in Section 10.1(i) of the Distribution Agreement.",
      "page_number": 0,
      "words": [
        {
          "text": "Execution Version",
          "bbox": [
            2601.0,
            294.0,
            3020.0,
            333.0
          ],
          "confidence": 0.9843302369117737
        },
        {
          "text": "Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause.",
          "bbox": [
            350.0,
            354.0,
            2953.0,
            404.0
          ],
          "confidence": 0.9875192642211914
        },
        {
          "text": "competitive harm to the Company, if publicly disclosed. Double asterisks denote omissions.",
          "bbox": [
            696.0,
            424.0,
            2610.0,
            470.0
          ],
          "confidence": 0.9918519854545593
        },
        {
          "text": "DEVELOPMENT AGREEMENT",
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ],
          "confidence": 0.9884270429611206
        },
        {
          "text": "This Development Agreement (\"this Agreement'') is entered into and effective as of September 30, 2019 (\"Effective.",
          "bbox": [
            448.0,
            795.0,
            3025.0,
            844.0
          ],
          "confidence": 0.9763412475585938
        },
        {
          "text": "Date') by and between Howmedica Osteonics Corp., a New Jersey corporation, also known as Stryker Orthopaedics",
          "bbox": [
            281.0,
            895.0,
            3023.0,
            939.0
          ],
          "confidence": 0.9990173578262329
        },
        {
          "text": "(\"Stryker'), and Conformis, Inc., a Delaware corporation having a principal place of business located at 600 Technology Park",
          "bbox": [
            279.0,
            987.0,
            3027.0,
            1043.0
          ],
          "confidence": 0.9912907481193542
        },
        {
          "text": "Drive, Billerica, MA O1821 (Conformis'). Stryker and Conformis are collectively referred to herein as the \"Parties' and",
          "bbox": [
            281.0,
            1091.0,
            3029.0,
            1135.0
          ],
          "confidence": 0.9795650243759155
        },
        {
          "text": "individually as a \"Party.\"",
          "bbox": [
            277.0,
            1186.0,
            814.0,
            1235.0
          ],
          "confidence": 0.9837418794631958
        },
        {
          "text": "WHEREAS, the Parties are concurrently entering into an asset purchase agreement for Stryker's purchase of certain",
          "bbox": [
            444.0,
            1281.0,
            3029.0,
            1338.0
          ],
          "confidence": 0.9927125573158264
        },
        {
          "text": "Conformis assets concerning Patient-Specific Instrumentation (\"Asset Purchase Agreement\"), and a License Agreement, a",
          "bbox": [
            275.0,
            1378.0,
            3029.0,
            1436.0
          ],
          "confidence": 0.9887849688529968
        },
        {
          "text": "Distribution Agreement and a Quality Agreement, as defined in and attached to the Asset Purchase Agreement (collectively, such",
          "bbox": [
            279.0,
            1482.0,
            3025.0,
            1531.0
          ],
          "confidence": 0.9973982572555542
        },
        {
          "text": "agreements are referred to herein as the \"Other Agreements')",
          "bbox": [
            277.0,
            1577.0,
            1640.0,
            1632.0
          ],
          "confidence": 0.9893602132797241
        },
        {
          "text": "WHEREAS, Stryker and its Affiliates have developed and commercialized an Off-The-Shelf Knee Implant offered under.",
          "bbox": [
            448.0,
            1678.0,
            3029.0,
            1727.0
          ],
          "confidence": 0.9939711093902588
        },
        {
          "text": "the trademark Triathlon.",
          "bbox": [
            281.0,
            1778.0,
            776.0,
            1820.0
          ],
          "confidence": 0.9796398282051086
        },
        {
          "text": "WHEREAS, Conformis currently offers Patient-Specific Instrumentation for use with its Patient-Specific Implants,",
          "bbox": [
            446.0,
            1869.0,
            3025.0,
            1926.0
          ],
          "confidence": 0.9971562623977661
        },
        {
          "text": "including partial and total knee and hip arthroplasty.",
          "bbox": [
            281.0,
            1970.0,
            1352.0,
            2025.0
          ],
          "confidence": 0.9856063723564148
        },
        {
          "text": "WHEREAS, Stryker desires that Conformis develop, in accordance with the R&D Program, certain Patient-Specific.",
          "bbox": [
            450.0,
            2072.0,
            3021.0,
            2116.0
          ],
          "confidence": 0.9856840372085571
        },
        {
          "text": "Instrumentation to be used with the current version of the Off-The-Shelf Knee Implant offered under the trademark Triathlon (such",
          "bbox": [
            281.0,
            2171.0,
            3023.0,
            2215.0
          ],
          "confidence": 0.9951096177101135
        },
        {
          "text": "Patient-Specific Instrumentation as so developed, the \"KIB Product')",
          "bbox": [
            283.0,
            2270.0,
            1784.0,
            2313.0
          ],
          "confidence": 0.9868863224983215
        },
        {
          "text": "THEREFORE, in consideration of the mutual representations, warranties and covenants herein and in the Other.",
          "bbox": [
            444.0,
            2363.0,
            3029.0,
            2414.0
          ],
          "confidence": 0.9940667748451233
        },
        {
          "text": "Agreements constituting good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties",
          "bbox": [
            279.0,
            2463.0,
            3025.0,
            2514.0
          ],
          "confidence": 0.9964366555213928
        },
        {
          "text": "hereby agree as follows:",
          "bbox": [
            279.0,
            2564.0,
            781.0,
            2608.0
          ],
          "confidence": 0.9871907234191895
        },
        {
          "text": "ARTICLE I",
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ],
          "confidence": 0.9906837940216064
        },
        {
          "text": "DEFINITIONS",
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ],
          "confidence": 0.9980525374412537
        },
        {
          "text": "1.1 Definitions. For purposes of this Agreement, the following terms shall have the following meanings, and to the extent",
          "bbox": [
            448.0,
            2854.0,
            2994.0,
            2907.0
          ],
          "confidence": 0.9955382943153381
        },
        {
          "text": "not defined in this section or otherwise in this Agreement, a term shall have the meaning ascribed to it in any of the Other.",
          "bbox": [
            275.0,
            2953.0,
            2800.0,
            3004.0
          ],
          "confidence": 0.99052894115448
        },
        {
          "text": "Agreements:",
          "bbox": [
            281.0,
            3053.0,
            540.0,
            3103.0
          ],
          "confidence": 0.9999290704727173
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1180.0,
            4479.0
          ],
          "confidence": 0.9975276589393616
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "DEVELOPMENT AGREEMENT",
          "page": 0,
          "bbox": [
            1254.0,
            645.0,
            2055.0,
            687.0
          ]
        },
        {
          "text": "ARTICLE I",
          "page": 0,
          "bbox": [
            1521.0,
            2662.0,
            1794.0,
            2701.0
          ]
        },
        {
          "text": "DEFINITIONS",
          "page": 0,
          "bbox": [
            1474.0,
            2761.0,
            1832.0,
            2799.0
          ]
        }
      ]
    },
    {
      "id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement__Cap On Liability_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.",
      "answer_text": "Notwithstanding   anything to the contrary, Stryker's sole remedy and Conformis' exclusive liability for breach of Section 3.2 with respect to a   Product or a Stryker Product shall be as set forth in Section 10.1(i) of the Distribution Agreement.",
      "page_number": 1,
      "words": [
        {
          "text": "\"Acceptance\"' and \"Accept' have the meaning set forth in Article 3.4 of this Agreement.",
          "bbox": [
            446.0,
            481.0,
            2340.0,
            539.0
          ],
          "confidence": 0.977286696434021
        },
        {
          "text": "\"Acceptance Criteria' has the meaning set forth in the R&D Work Plan.",
          "bbox": [
            450.0,
            682.0,
            2008.0,
            731.0
          ],
          "confidence": 0.9961835145950317
        },
        {
          "text": "\"Acceptance Notification Period' has the meaning set forth in Article 3.3 of this Agreement..",
          "bbox": [
            450.0,
            879.0,
            2438.0,
            928.0
          ],
          "confidence": 0.9805790781974792
        },
        {
          "text": "\"Affiliate\" has the meaning set forth in the Asset Purchase Agreement",
          "bbox": [
            448.0,
            1071.0,
            1950.0,
            1124.0
          ],
          "confidence": 0.9933743476867676
        },
        {
          "text": "\"Agents\" means Third Parties who are acting under the direction or control of a Party.",
          "bbox": [
            448.0,
            1268.0,
            2284.0,
            1321.0
          ],
          "confidence": 0.9984568953514099
        },
        {
          "text": "\"Applicable Laws\" means all applicable federal, state, local and foreign laws, ordinances, rules, regulations, orders,.",
          "bbox": [
            448.0,
            1466.0,
            3025.0,
            1520.0
          ],
          "confidence": 0.9899159073829651
        },
        {
          "text": "writs, injunctions and decrees of any kind.",
          "bbox": [
            283.0,
            1566.0,
            1155.0,
            1614.0
          ],
          "confidence": 0.9892303943634033
        },
        {
          "text": "\"Asset Purchase Agreement\"' has the meaning set forth in the recitals",
          "bbox": [
            448.0,
            1762.0,
            1948.0,
            1811.0
          ],
          "confidence": 0.9865401983261108
        },
        {
          "text": "\"Change of Control'' has the meaning set forth in the Asset Purchase Agreement.",
          "bbox": [
            448.0,
            1955.0,
            2170.0,
            2010.0
          ],
          "confidence": 0.9961836338043213
        },
        {
          "text": "\"Claims\" has the meaning set forth in Article 7.3(a) of this Agreement.",
          "bbox": [
            446.0,
            2147.0,
            1947.0,
            2209.0
          ],
          "confidence": 0.9971343278884888
        },
        {
          "text": "\"Confidential Information\" has the meaning set forth in the Asset Purchase Agreement",
          "bbox": [
            448.0,
            2346.0,
            2335.0,
            2401.0
          ],
          "confidence": 0.999515175819397
        },
        {
          "text": "\"Conformis Background IP\" means any Invention, and all Intellectual Property rights underlying such Invention, that is,.",
          "bbox": [
            446.0,
            2540.0,
            3025.0,
            2602.0
          ],
          "confidence": 0.9841423630714417
        },
        {
          "text": "as of the Effective Date, owned or licensable by Conformis without causing a breach of, or incurring any obligation to, a third.",
          "bbox": [
            279.0,
            2644.0,
            3029.0,
            2699.0
          ],
          "confidence": 0.9918943643569946
        },
        {
          "text": "party, in each case to the extent necessary or reasonably useful to design, develop, manufacture, sell or otherwise exploit the KIB.",
          "bbox": [
            275.0,
            2739.0,
            3027.0,
            2798.0
          ],
          "confidence": 0.9918000102043152
        },
        {
          "text": "Product, and for the avoidance of doubt, excluding the Purchased Assets, Conformis Foreground IP, Stryker Background IP.",
          "bbox": [
            279.0,
            2843.0,
            3023.0,
            2893.0
          ],
          "confidence": 0.9966443181037903
        },
        {
          "text": "Improved Stryker Background IP and Improved Conformis Background IP",
          "bbox": [
            279.0,
            2938.0,
            1874.0,
            2990.0
          ],
          "confidence": 0.9942641854286194
        },
        {
          "text": "2",
          "bbox": [
            1633.0,
            3176.0,
            1669.0,
            3225.0
          ],
          "confidence": 0.9901198148727417
        },
        {
          "text": "Source: CONFORMIS INC, 10-Q, 11/1/2019",
          "bbox": [
            332.0,
            4437.0,
            1178.0,
            4477.0
          ],
          "confidence": 0.9950919151306152
        }
      ],
      "multi_page": true,
      "part_of": 2
    }
  ]
}